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Résumé
Ce projet a consisté à adapter et à tester un cadre théorique intégratif de transfert
de connaissances, dérivé de celui proposé pat Kemmis et McTaggart (2001) et
incluant les trois catégories de connaissances proposées par Habermas
(1972,1974). Ce cadre fut employé dans la planification des programmes
d’immunisation au Canada, utilisant une méthodologie de recherche-action.
L’intervention principale dans ce projet a été le développement et l’implantation
d’un cadre analytique pour la prise de décision concernant des nouveaux
programmes d’immunisation. Bien que toutes les 13 juridictions provinciales et
territoriales du Canada aient été exposées à cette intervention, ce projet a. ciblé
deux contextes en particulier: le niveau fédéral et le niveau provincial au Québec.
En terme des trois niveaux de connaissances proposés par Habermas, seulement
les niveaux technique et pratique étaient présents au début du projet. Par contre,
l’approche par recherche-action a permis au projet de répondre spécifiquement aux
besoins des acteurs impliqués, questionnant la structure actuelle en immunisation
et proposant des changements organisationnels. Ceci correspond au niveau
critique proposé par Habermas. Le résultat de cette approche est le
développement et l’implantation réussie de l’outil et du changement
organisationnel, qui ont été supportés par les acteurs-clés. En ce qui concerne la
relation entre ces trois niveaux de connaissances, les résultats obtenus indiquent
que le niveau critique englobe le niveau pratique qui à sa tour englobe le niveau
technique, tel que proposé dans la littérature. Ces résultats indiquent que ce cadre
théorique et cette méthodologique d’intervention sont complémentaires aux
théories existantes, et peuvent aider à mieux réaliser des interventions et
comprendre le transfert de connaissances. Cet élargissement de perspective
intégrant les facteurs contextuels ressemble aux tendances récentes en recherche
sur les services de santé au Canada, en ce qui a trait à la prise de décision et au
transfert de connaissances. Des efforts similaires à ce projet devraient être
entrepris dans d’autres champs de services de la santé et de la coordination inter
juridictionnelle au Canada, pour implanter des changements bénéfiques et
développer ce modèle théorique intégratif pour le transfert de connaissances.
Mots-clés: planification des programmes d’immunisation (Canada), cadre analytique,
transfert de connaissances, prise de décision, recherche-action, Habermas
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Su mmary
This project adapted and tested an integrative theoretical framework for knowledge
transfer derived from a model proposed by Kemmis and McTaggart (2001),
including the three categories of knowledge-constitutive interests proposed by
Habermas (1972,1 974). This ftamework was applied to an intervention in the area
of immunization program planning in Canada, using an action research
methodology. This intervention was centered on the development and
implementation of an analytical framework for decision-making regarding new
immunization programs. While aIl 13 provincial and territorial jurisdictions in
Canada were exposed to this intervention, the project focused on two contexts in
particular: the federal context and the provincial context in Quebec. Regarding the
three levels of knowledge-constitutive interests proposed by Habermas, only the
technïcal and practical levels were present at the outset of this project. However,
the action research approach allowed the project to be responsive to the specific
needs cf the actors invotved, questioning the current structures in immunization
and proposing organizational changes. This corresponds to the critical level
proposed by Habermas. The overall result of this approach was the successful
development and implementation of organizational change and the tool for
decision-making in Canada. Concerning the relationship between these three levels
of knowledge-constitutive interests, these results indicate that the critical level
encompasses the practical level, which in turn encompasses the technical level, as
proposed in the literature by certain authors. This project also indicates that the
integrative theoretical framework and this methodology of intervention are
complementary to existing theories, and can help to achieve successful
implementation and understanding of specific knowledge transfer efforts. This
broadening of perspective to integrate contextual factors parallels recent directions
of health services research in Canada regarding decision-making and knowledge
transfer. Efforts similar to this project should be conducted in other areas of health
services and interjurisdictional coordination in Canada, to implement benefïcial
changes and also continue ta develop this integrative theoretical model for
knowledge transfer.
Keywords: planning cf immunization programs (Canada), analytical framework, knowledge
transfer, decision-making, action research, Habermas
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1Introduction
Many efforts in health services research in Canada in recent yeats have
aimed to improve the use of research in decision-making at the clinical,
institutional, regional, provincial and federal Jevels. A considerable quantity
of health-related research is produced in Canada each year, however,
current practices across the country are often quite variable and do not
reflect the best current evidence (Tranmer, 1998). Therefore, there is
interest in improvïng the Iinks between research and practice in various
areas of health care, and numerous structures and processes and research
funds have been created to assist in the coordination and diffusion of
research resuits to improve decision-making in Canada. At the clinical level,
an example is the evidence-based medicine movement, which encourages
systematic literature review by clinicians to promote clinical practice based
on the best current evidence. At the institutional level, hospitals are
increasingly developing expertise on health technology assessment (Baffista
et al., 2003), to ensure optimal use of available technologies. At the
provincial level, health technology assessment agencies have been
established in many jurisdictions ta advise Ministries of Health regarding the
optimal use of new health technologies. At the national level, the Canadian
Institutes of Health Research (CIHR) and the Canadian Health Services
Research Foundation (CHSRF) are increasingly concerned with knowledge
transfer and initiatives to improve decision-making.
There is considerable interest in how to beller transfer research into
practice, which has led ta the development of new terms and areas of study
(such as ‘knowledge transfer’, ‘knowledge brokering’ etc.), which reflect a
broadening of perspective, with increased interest in and attention ta
contexts in decision-making. It has become apparent that simple production
2of research is flot enough to influence decision-making. It has been
recognized that the classical linear conception of this relationship in which
research is transmiffed to decision-makers who implement this research into
practice is incomplete, and must be replaced by a more complex model that
recognizes the complex nature of decision-making and the various links
between decision-makers and research. Whïle various theoretical
approaches exïst, there have been few efforts to integrate the varlous
theoretical approaches, and an integrative theoretical approach is lacking
and needed in thïs area. This project focuses on the area of decision
making in the area of immunization in Canada to test such an approach, as
well asthe action research method 0f inquiry, to implement positive changes
in knowledge transfer in this area and draw general theoretical and practical
conclusions to guide future efforts in this area.
Existing decision-making structures and processes were studied, and key
persons involved in this process were involved in wide and multiple
consultations. An analytical framework was developed in collaboration with
key experts in this area in Canada in an effort to make this decision-making
and knowledge transfer process more efficient and systematic. Thïs
framework was then distributed across the country in multiple contexts and
its use was evaluated. Because of the flexible, action research approach of
this project, its scope was unexpectedly broadened on the national level to
evaluate organziational structures and processes in the area of
immunization planning in Canada, and propose new ones. lndeed, this
contributed to the emergence of a new Canadian Immunization Commiftee
(which first met in November 2003), and discussion of an expanded role of
the National Advisory Committee on lmmunïzation (NACI).
Overall, the project aimed to develop a method that combined a research
synthesis or information component with an organizational development
3component, which can be applied in other contexts in which increased
support and coordination of decision-making in Canada are desired. While
this type of effort cannot overcome the various budgetary Iimïtations and
political constraints and tensions present in Canadian federal-provincial
relations, it can help to optimize the use of the considerable expertise in this
area, leading to beffer use of immunization across Canada and uItimately
beffer health benefits for Canadians. There are many other contexts in
which such an effort could be beneficial in the coordination of health
services across Canadian jurisdictions. In the broader context of knowledge
transfer, this effort enabIed development and refinement of a
comprehensive theoretical framework for knowledge transfer activities
integrating subjective and objective elements, at the level cf the individual
and the system, and also the technicai, practicai and critical levels of
knowledge-constitutive interests proposed by Habermas.
This project aimed to facilitate the decision-making process pertaining to
pubiicly funded immunization programs in Canadian provinces and
territories by developing and testing an analytical framework for
immunization program planning. This project aIse examined organizational
structures. and processes for immunization program planning in Canada,
and made proposais for change. General criteria that are important in the
process of consideration and evaluation of a candidate vaccine in Canada
were coIIected from experts, literature review, and a questionnaire
administered to key persons involved in immunization planning across
Canada. The resulting framework was then tested on the federal level in
various national meetings on immunization in collaboration with Health
Canada as part of a larger project associated with the development of the
National Immunization Strategy. In Québec, the analytical framework was
tested by integration into activities of the Comité d’immunisation du Québec
(CIQ). A follow-up questionnaire was administered to key persons across
Canada to examine awareness and appreciation of the framework. The
4ftamework was also used as an educational tool for health professionals
and has been proposed for use by the general public. In the fali of 2003, the
framework was presented to the National Advisory Committee on
Immunization (NACI) for use with the new Canadian Immunization
Commiffee (CIC). By integrating the analytical framework with existing and
emerging structures and processes for immunization program planning in
Canada, the impact and number of interactions should be maximized. It is
proposed that using a systemic action research approach and integrative
theoretical framework for knowledge transfer in other health services
research initiatives in Canada wiII also maximize benefits.
CHAPTER I: CONTEXT- IMMUNIZATION PROGRAM PLANNING IN
CANADA
Background
Vaccination has been recognized as one of the great public health
achievements 0f the last century (CDC, I 999a), with eradication, elimination
or drastïc reductions in smallpox, polio, measles, and Hib invasive disease,
to name a few. Remarkable progress has been made in the development
and use of immunization, which has created an increasingly complex
vaccination schedule. Many new (and more costly) vaccines wilI soon be
available. Furthermore, many new modes of vaccine administration other
than injection are being developed, such as nasal spray vaccines,
transdermic LpatchesY, and even edible vaccines (Liu, 1999; WHO, 2002;
Tacket et al., 1998). This situation has resulted in many challenges such as
informing the public and health-care providers about new developments and
recommendations, vaccine procurement and financing. I ncreasingly
complex questions must be addressed regarding safety, efficacy, vaccine
delivery, information and administration systems.
There has been some recent progress in funding of new programs in
Canada. However, there have been some examples of inertia, lack of
coordination and situations in which improvement is possible (Duval, 2000;
McDonald, 1997; Spïka & Duclos, 1997). Currently, despite the supposedly
universal nature of health care in Canada, the Canada Health Act requires
provinces and territories to fund ‘medically necessary’ services, however
individual jurisdictions do flot have to respond to national standards and
therefore have a certain leeway in interpretation of this requirement and the
resulting coverage of services such as immunization, long term care or
rehabilitation services (CHSRF, 2002). Therefore, the selection of publicly
funded vaccines depends on the province of residence as is illustrated in
6Table I, with variable funding of meningococcal conjugate, adolescent
pertussïs, pneumococcal conjugate and varicella vaccine programs among
Canadian provinces and territories (Sibbald, 2003).
Table I: Vaccination programs funded by Canadian jurisdictions, January 2003
Province /territory Childhood Meningococcal Adolescent Pneumococcal Varicella
vaccines conjugate pertussis conjugate
British Columbia X
Alberta X X X X
Saskatchewan X Xt
Manitoba X
Ontario X X
Quebec X X Xt Xt
New Brunswick X X
Nova Scotia X X
Prince Edward X Xt Xt X
Island
Newfoundland & X X
Labrador
Yukon X
Northwest X X X
Territories
Nunavut X X X X
Diphtheria, hepatitis B, Haemophilis influenzae type b, measles, mumps, pertussis, polio, rubella and tetanus.
t. limited implementation
Source: Health Canada, Jan 6, 2003 in Sibbald (2003);
Hepatitis B, varicelia, and influenza are examples of immunization programs
having an important variability in goals and objectives, target groups, and
delivery strategies between provinces and territories in Canada. Another
problem is the lack of knowledge about immunization coverage (Squires &
Pelletier, 2000), or how many Canadian chiidren receive ail recommended
immunizations on schedule (CIHI, 2000a). While recognizing the strengths
of immunization in the current health system in Canada, we must aiso
examine areas which can be improved and take appropriate action.
Evaiuations of different international approaches to immunization indicate
7that countries having the most successful immunization programs are those
with the best coordination 0f national activities (Spika & Duclos, 1997). This
is definitely an area in which there is a need for improvement in Canada.
The Decision-making Process for Immunization Programs in Canada
At an ever-increasing pace, new vaccines are being developed, licensed,
and commercialized in Canada due to initiatives of pharmaceutical
companies. New products are evaluated by the National Advisory
Committee on Immunization, which determines the optimal conditions of use
of the vaccine in the epidemiological context of Canada (Canadian
immunization Guide 2002). Other expert committees such as the Canadian
Task Force on Preventive Health Care or the Committee to Advise on
Tropical Medicine and Travel may also produce recommendations or
guidelines for health professionals. integration of a new vaccine into a
publicly-funded immunization program is the responsibility of provinces and
territories, and each jurisdiction decides which products will be purchased
and offered free of charge to certain target groups.
In Canada, vaccine licensing is a federal responsibility. However,
determination of immunization policy and the implementation of publicly
funded vaccination programs are provincial and territorial responsibilities.
Health Canada has a coordinating role, organizing national consensus
conferences on certain candidate immunization programs, setting national
goals, as well as supporting committees of scientific experts and
provinciai/territorial officiais. National expert commiffees that treat
vaccination issues include the National Advisory Committee on
Immunization (NACI) and the Task Force on Preventive Heaith Care.
8However, these committees make recommendations for optimal use of
C Iicensed vaccines by individual clinicians in private and public practice, and
do flot address decision-making involving publicly financed immunization
programs. Specifically, NACI produces recommendations for the Canadian
Immunization Guide, while the Task Force on Preventive Health Care
produces recommendations regarding vaccination for the Canadian Guide to
Clinical Preventive Health Care (Canadian Task Force on the Periodic
Health Examination, 1994).
Federal Decision-Making Process for PubIicIy Funded Immunization
Programs
An important federal body is the Therapeutic Products Programme (TPP,
formerly the Bureau of Biologics), which is responsible for licensing of
vaccines. Another federal structure is the Bureau of lnfectious Diseases,
C which is one of four bureaus of the Centre for lnfectious Disease Prevention
and Controi which in turn is one of 9 directorates of the Population and
Public Health Branch of Health Canada. The Bureau of lnfectious Diseases
“provides leadership and expertise in infectious diseases of national and/or
provincial/territorial importance” (Health Canada, 2000). Activities are stated
to focus on surveillance of infectious diseases, identification and
quantification of risk factors and emerging threats to health, assessment of
proposed prevention strategies, evaluation of existing surveillance,
prevention and control activities and the pursuit of research initiatives
(Health Canada, 2000).
Implementation of new Vaccines & Immunization programs in Canada
The process leading to implantation of new immunization programs can be
divided into 4 successive phases (Figure 1):
C
91. The « industrial phase», which is the initiative of a private company,
which develops a vaccine. A license is obtained from the Bureau of
Biological Products specifying conditions of use of the vaccine.
2. Scientific expert committees specify conditions of use of the vaccine
(which can be different from those specified by the vaccine
manufacturer) and make recommendations for health professionals and
public health authorities. These expert committees exist at the national
level (i.e. NACI, the Task Force on Preventive Health Care) and also in
some provinces (i.e. the Comité dimmunisation du Québec).
3. Provincial decisïon-makers determine policy regarding financing and
implementation of vaccination programs to be offered (free of charge) to
specific populations in theirjurisdictions.
4. Immunization programs are planned by public health authorities in
various provinces and territories and ïmplemented by regional and local
health units and private practitioners.
Figure 1: Phases in Vaccine Licensing and Utilization in canada
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Shortcomîngs of the Current Situation
At the national level, there is no committee specïficaliy mandated for making
recommendations to provincial/territorial public health authorities or to play a
permanent role in coordination. The policy-makïng process for immunization
programs varies greatly between provinces and territories (Duclos & Spika,
1997). For example, Québec has a formai expert Committee on
Immunization (CIQ), whereas the other provinces have iess formai groups of
scientific experts. Experience in recent years has shown that the decision
making process is quite different between provinces and aiso from one
vaccine to another (Duclos & Spika, 1997). National goals and targets have
been established for a majority of vaccine-preventable diseases, but they
have flot been endorsed at political level in ail jurisdictions (LCDC, 1999a;
1998a). At the present time, significant differences are seen in schedules
and age of administration of several vaccines in different jurisdictions
(Sibbald, 2003; LCDC, 1999a; Duclos & Spika, 1997, Embree 2003, Naus et
al. 2003). in several instances, total disharmony was observed in the
impiementation of a new program and catch-up programs (Duclos & Spika,
1997).
Decision-making structures and processes for immunization vary greatly
between Canadian provinces and territories, and it has been observed that
decision-making criteria may vary between different vaccines in the same
jurisdiction (Erickson & De Wais, 2003). This lack of standardization and
reproducibility in the vaccine evaluation process has negative consequences
on the homogeneity and equity of immunization programs across Canada
(Sibbaid, 2003). b help improve this situation, in the context of the
development of a National Immunization Strategy (Embree 2003, Naus et al.
2003), there have been calis for greater harmonization and accessibility of
vaccines recommended by experts in Canada.
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Proposais for Change
At the National Immunization Conference in 1996, NACI passed a formai
resolution cailing for national coordination in immunization program planning
(NACI, 1996). At the National Consensus Conference on Varicella in 1999,
a recommendation expressed the need for development of « a mechanism
to prïontize and introduce new vaccines with a view to harmonizing
programs across the country. » (LCDC, 1999b). A recommendation that
Health Canada act as a clearing house for information, providing each
province and territory with a critique of current literature on cost
effectiveness to assist provincial and territorial decision-makers was
expressed at a previous consensus conference on the pneumococcal
polysaccharide vaccine in 1998 (LCDC, 1998b). In addition, the Director of
the Division of Immunization at Health Canada has recently proposed a
national program to support provincial and territorial immunization programs,
citing the general observation that excellent national coordination is
observed in countries with the most successful immunization programs
(such as Australia, which has a similar division cf responsibilities between
federal and state/provincial authorities) (Duclos & Spika, 1997).
Also, the National Sub-Commiffee on Immunization cf the Public Health
Wotking Group (PHWG) has identified the priority of ensuring that vaccines
are delivered in a cost-effective manner across Canada, in concordance
with national immunization objectives (PHWG, 2000). The PHWG receives
its mandate from, and serves as a resource and advisor to, the Advisory
Commiffee on Population Health (ACPH). The PHWG’s work and
deliberations focus on, but are flot Iimited to, public health issues and
services delivered through government-funded public health agencies at the
Co
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federai, provincial/territorial and regionai/Iocai levels. Part of the PHWG’s
mandate is to develop recommendations to achieve more effective and
better integrated federai/provincial/territorial public heaith systems. The
PHWG’s activities in the area of immunization planning have demonstrated
both the need and the expressed interest of stakeholders for improved
organization and availability of information relevant for poiicy-making in
Canada.
Provincial and territorial authorities ultimateiy make policy in this area in
collaboration with scientific experts; therefore efforts to facilitate policy
making should be targeted at this level. While these entities face similar
problems when making poiicy decisions about a particuiar immunization
program, there is much difference between their respective contexts. This
project proposai aims to facilitate Canadian immunization program planning
in collaboration with these policy-makers across Canada.
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International examples: National Coordination of Immunization
Planning
To guide efforts for improvement in thïs area in Canada, it is useful to
consider some international examples of national coordination of
immunization, specifically in the United Kingdom, the United States, and
Australia. The case 0f Australia is particulàrly interesting in that their national
strategy on immunization has been particularly successful and the structure
of governance is similar to the federal system in Canada. A summary of
similarities and differences between immunization planning structures in
these countries is presented in Table li.
The United Kingdom
The United Kingdom has made great progress in increasing immunization
coverage in recent years, and several initiatives, including the development
of a National Immunization Communication Strategy, developed jointly by
the Department of Health and the Health Education Authority, with a budget
equivalent to $ 2 million U.S per year (Salisbury & Dillman, 1999). These
funds are used for market research (public perceptions of immunization),
and media and information campaigns including television ads regarding
immunization programs (i.e. varicella and more recently, meningococcal).
Also, physicians have pay incentives tied to reaching immunization targets;
there is central purchase cf vaccines, computerized cold chain
management, and weekly distribution of vaccines to general practitioners.
High national profile of immunization and government commitment has been
seen in the recent mass immunization campaign with meningococcal
conjugate vaccine.
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Table II: Comparative Table- Immunization Planning in Selected Countries
UK USA Australia Canada- Canada
(Australian Existing Proposed
Department of
HeaIth,_2003)
Technical Advisory ACIP
Committees on Joint Committee on AAP ATAG1 NACI
Immunization Vaccination and AAFP
National Committee on Immunisation Canadian
Jmmunization Programs Services NVAC NCI Immunization
Committee
(fall 2003)
National Goals and Yes Yes
Objectives for -closely monitored
Immunization No specific goals yet
for ail P/Ts
Centralized vaccine
purchasc yes minimal- Yes Current program Proposed- being
being reviewed studied
Coordinated National Yes Yes
Media & some
Communications
Strategies
Incentives for Physicians Yes Yes
financial or other some examples Yes
Incentives for Parents (Orenstein &
Bemier,_1994)
National Immunization Since 1996- Being developed
Registry yes (at birth) Australian
Childhood
Immunization
Register (ACIR)
Framework for OVCD- Overview of
Decision-Making Communicable Vaccines for the National and Proposed National
Disease tool for 2 1St Century Tool Provincial Framework
priority-setting in (cost-effectiveness frameworks
communicable rankings)
disease(PHLS, 1999), (10M, 2001)
broader frametvork
proposed
Other ChiefMedical Officer
has chaired a
“Communicable
Disease Strategy
Group” mandated to
recommend a national
slrategy in 2001
(DOH-UK,_1999)
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There is a national advisory commiffee: the Joint Committee for Vaccination
and Immunisation Services. The terms 0f reference are to “advise
secretaries of state for ScotlancJ Wales and Northern Ireland on matters
relating to communicable disease, preventable and potentially preventable
through immunisation” . A project entitled the “Overview of Communicable
Diseases (OVCD)” aims to guide rational planning and priority seffing in
communicable disease control (PHLS, 1999). This project involved using a
priority-sefting process in which key stakeholders were asked to rank
diseases using the following criteria (on a scale of importance from 1 to 5):
• Burden of ill-heaith
• Social/economic impact
• Potential threat
• Health gain opportunity
• Public concern
Stakeholders were also asked to identify in which areas further work was
needed. Work is ongoing and there are plans to create a decision-making
framework which integrates other concerns (political, national initiatives,
etc.). More study of immunization planning in the UK is warranted.
Australia
Australia has many impressive initiatives in the area of immunization,
including the Immunise Australia program, and the Seven Point Plan. These
initiatives include financial incentïves to general practitioners and parents,
special immunisation days, and education campaigns (Australian
Department of Health, 2003). There is a National Childhood Immunisation
Program, which inciudes the provision of free vaccines to ail providers. The
Australian Childhood Immunisation Regïster has aiso been estabiished.
The Commonwealth provides funds to States and Territories for the
purchase of vaccines. It is the responsibiiity of State and Territory
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governments to implement programs to deliver these vaccines. In specific
instances the Commonwealth contributes directly to service delivery costs,
such as for hepatitis B vaccine school-based programs. A National
Immunisation Committee (NIC) exïsts f0 provide leadership and take
responsibility for policy development, implementation and review of the
National Immunisation Program. The NIC has representatives from
Commonwealth, State, and Territorial health authorities, the Royal
Australian College of General Ptactitioners, Australian Divisions of General
Practice and the National Aboriginal Community Controlled Health
Organisation. The Australian Technical Advisory Group on Immunisation
(A TAG!), provides expert advice on the Immunise Australia Program and
works on issues such as the Australian Standard Vaccination Schedule
(Australian Department of Health, 2003).
The Seven Point Plan was Iaunched in 1997, and initiatives include linking
of maternity and childcare benefits to immunization status, incentives for
general practitioners for immunization coverage, and release of data on
immunization rates from the Australian Childhood Immunisation Register to
encourage competition and increased coverage. There is also
implementation of communication strategies for immunization service
providers and the community, and the establishment of a National Centre for
Immunisation Research and Surveillance of Vaccine Preventable Diseases.
School entry requirements have been introduced so that parents must
submit details of a child’s immunization history. Other initiatives include
provision of funds to States and Territories for purchase of DTPa
(diphtheria-tetanus-acellular pertussis) vaccine (from 1999), free influenza
vaccines for those over 65 (from 1999), universal infant hepatitis B
vaccination, including a birth dose of monovalent hepatitis B vaccine (from
2000), $ 20 million for MMR (measles-mumps-rubella) vaccination for 18-30
year olds (Australian Department of Health, 2003). This initiative is a definite
success story from which much can be learned for immunization in Canada.
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The United States
In the United States only an estimated 10% cf adult immunization is publicly
funded (Fedson, 1994). National bodies make recommendations regarding
the use cf various vaccines; the Advisory Committee on Immunization
Practices (ACIP), the American Association cf Pediatrics (AAP), and aiso
the American Association cf Family Practitioners (AAFP). They also
contribute te the revision cf the Childhood Immunization Schedule, which is
revised and published every 2-4 years. In 1986, a National Vaccine Program
was established with a National Vaccine Advisory Commiffee. This
committee was to concentrate on program policies and strategies in conttast
to ACIP which provides primarily technical recommendations. The program
and committee are described as foilows (Fedson, 1994):
“The National Vaccine Program was established in 1986 by the Public
Health Service Act to achieve optimal prevention cf infectious disease
through immunization and optimal prevention cf adverse reactions te
vaccines. The program is responsible for coordination and direction of
government and non-government activities on research, licensing,
production, distribution, and use of vaccines. The director is the assistant
secretary for health, with the National Vaccine Advisory Committees serving
as advisors. The committee consists of 15 voting members appointed by the
director, in consultation with the National Academy cf Sciences, including
individuais in vaccine research or manufacture, physicians, members of
partner organizations, and representatives cf health agencies and public
health organizations. The committee aise includes five nonvoting members
from the National Institutes cf Health, the Food and Drug Administration, the
Centers for Disease Control and Prevention, the Agency for international
Development, and the Department of Defence.”
A key federal program is the Section 317 immunization program (Public
Health Service Act, US Congress, 1970), which provides grants to states
and iocalities for vaccine purchase and activities te improve vaccination
coverage. Grants can support immunization infrastructure including
outreach, service delivery, surveillance, outbreak control, public education
and registry deveiopment (Johnson et al., 2000). The program is
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administered by the CDC (Centers for Disease Control and Prevention) as
part of the National Immunization Program. A recent report (10M, 2000)
stated that “the public health infrastructure that supports the national
immunization system is fragile and unstable”, citing three trends contributing
to this: 1) rapid acceleration in the science of vaccine research and
production; 2) increasing complexity of the health care services environment
of the United States; 3) recent reductions in federal immunizatïon grants to
states.
Several problems within the national system were also identified, such as
the need to sustain and document high levels of immunization coverage for
a growing number of vaccines delivered within multiple health care seffings.
Persistent disparities in childhood levels 0f immunization coverage were also
identified, as well as low coverage rates and racial and ethnic disparities for
adult vaccines, and serious gaps and inconsistencies in the co-ordination,
support, and documentation of immunization efforts. The report reached
several conclusions, mentioning in particular that the instability of funding for
state immunization programs has created instability and uncertainty, eroding
planning and the success of immunization activities. It was also noted that
immunization policy needs to be national in scope, but implementatïon must
be flexible enough to respond to special circumstances at the state and local
levels. Also, federal and state governments have important roles in
supporting vaccine purchase, and also infrastructure efforts that can achieve
and sustain national immunization goals.
An analysis of the history of federal immunization policy and funding in the
United States has concluded that there is a “history of responding to crises”
(Johnson et al., 2000), noting that many recommendations for policy change
have only been ïmplemented following the occurrence of crises. The
capacity of the federal government to commit resources to improving
immunization in the absence of a crisïs is questioned. In the 1980s, low
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coverage levels were noted in young children, but a Iack of consensus
among experts on how to improve them coupled with budgetary pressures
at various levels of government leU to inaction on this issue.
In 1987 a report from the Children’s Defense Fund warned that the nation
would fail to meet many of the Surgeon General’s 1990 objectives for
immunization (Johnson K, 1987). In addition to poor coverage levels,
ïncreased vaccine prices and complacency were additional problems. Lack
of consensus about the nature of the problem, the role of federal financing,
and the policies continued into policy discussions into the 1990s (Johnson et
al., 2000). However, in 1990 response to the measles epidemic was shaped
by a new force in policy analysis, the NVAC (National Vaccine Advisory
Committee) took unprecedented leadership, producing a Measles White
Paper making key recommendations for response to this epidemic. A
federal interagency coordinating committee was then formed to outiine an
implementation plan, and met quarterly for 18 months, creating an action
plan with 14 goals and 120 action steps for improving immunization
services. This plan received attention from the President and the national
media (Johnson et aI., 2000). The NVAC also issued a report in 1998
entitled Strategies to Sustain Success in Childhood Immunization.
Unfortunately, there has been hile policy action, perhaps because there is
no apparent crisis. For Canada, we should retain the fact that additional
funding is usually available in times of crisis, and is facilitated by having a
well-deflned problem. As in other areas of prevention, proactive measures
are desirable but are difficult to implement.
A decision-making framework has also been created in the project Vaccines
for the 21st Century: A Tool for Decision-making (10M, 2001). The goal of
this report is to consider provide a mechanism for determining priorities for
vaccine licensure and research in coming years. The model is essentially
based on cost-effectiveness and tanks potential programs in terms of cost
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effectiveness indices into 3 categories: most favorable, favorable, and least
favorable. However, it ïs uncertain to what extent this type of method based
primarily on rankings of cost-effectiveness can effectively include important
factors in decision-making. Therefore, broader approaches consïdering
contextual factors should be considered.
Examples of Federal/ProvïnciallTerritorial Coordination in the
Canadian Health Sector
Some examples from the health sector follow. A tecent publication mentions
the importance of intersectorial action in population health in Canada
(ACPH, 1999). While there are some positive examples in specific health
areas, there is much room for improvement in this area.
1999 Auditor General’s Report- Observations and Recommendations
This report (Office of the Auditor General, 1999) mentioned the lack of a
structure for federal coordination in public health:
‘14.21 The provinces and territories are responsible for providing
many public health services; Health Canada is responsible for
protecting Canadians against risks to health and the spread of
diseases. However there is no specific legislation, policy, or
agreement that links separate components of public health functions
at the vanous levels of govemment.
14.24 While each province and temtory has a legis!ated public health
function, at the national level there is no formaI public heaith function
established that links the separate components in the provinces and
territories. lnstead there is an informaI system that relies on personal
contacts rather than formai arrangements. As we note later in the
chapter there is a voici; current health surveillance activilles are
largely camed out on an ad hoc basis.’
The report goes on to discuss the need for this type of coordination for
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influenza pandemic preparation- this initiative is an important model for this
type of needed collaboration, which could be useful in preparing for
improvement in the area or regular immunization.
CCOHTA
The Canadian Coordinating Office of Health Technology Assessment
(CCOHTA) has the mandate of conducting and coordinating research on
medical technologies and providing useful information to decision-makers
regarding these technologies. Their board of directors has individuals
representing the ProvinciallTerritorial Deputy Ministers and meets twice a
year to determine priorities. The Canadian Health Technology Assessment
Network regroups CCOHTA and provincial organizations, which also meet
periodically and exchange information (i.e. ongoing research projects). The
objective of CHTA Network is to develop and maintain a systematic,
effective and efficient programme of government-funded health technology
assessment in Canada. Following the Romanow Report, funding of
approximately $ 45 million has been proposed for national coordination of
health technology assessment by CCOHTA. Some of these resources may
be available for evaluation of vaccines of national interest, but this remains
to be determined.
National Transplantation Council
One interesting example of F/PTF coordination in the area of health is the
current initiative in organ transplantation, entitled Principles for a co
ordinated, comprehensive and integrated donation and transplantation
strategy for Canada , which includes many initiatives to improve F/P/T co
ordination in this area and can provide some potential paths of action in the
area of immunization (Health Canada, 1999). This includes a national goal,
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and a co-ordinated, comprehensive strategy, directed by a Council
appointed by the Federai, Provincial and Territorial Governments with a
regular reporting link to Ministers of Health through the Advisory Committee
on Heaith Services. The Council should have an ongoing Secretariat to
support Health Ministries and services providers to create and maintain
components of the strategy, and should be funded by Health Canada. This
initiative should be studied in more detail to examine the pertinence of this
model for a National lmmunization Strategy.
Canadian Blood Services
Following careful consideration, Federal, Provincial and Territorial Health
Ministers (with the exception of Québec) decided to create a new national
blood authority, Canadian Blood Services (CBS, 2000). This was consistent
with the conclusions of the Krever report, which called for a single integratedÇ entity responsible and accountable for Canada’s blood supply (the Province
of Québec created their own entity for this purpose, Héma-Québec). On
September 10, 1996, some key guiding principles were articulated, including
the pursuit of national self-sufficiency, adequacy and security of supply,
safety of ail blood components and fractions, achievement of a cost
effective, cost-efficient program, and maintenance of a national blood
program. It was agreed that this new authority should operate at arms length
from ail governments and that it wouid be responsible for managing ail
aspects of an accountable and fully integrated blood supply system. The
shareholders of CBS are the Provincial and Territorial Health Ministers, and
appoint the board of directors, which is composed of representatives from
different regions, the general public, and those providing medical, scientific,
technical, business and public heaith expertise. Overall, the management
structure for CBS is said to ‘balance the need for ministerial/territorial
responsibility and accountability for spending public monies and for setting
health policy objectives’ (CBS, 2000).
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Hepatitis C Initiatives
These include the creation of a Hepatitis C Division of the Centre for
lnfectious Disease Prevention and Control of Health Canada, which
administers a $50 million Hepatitis C prevention, support and research
program, will manage a transfer of over $300 million over 20 years to the
provinces, and will also administrate $25-50 million to cover haif of the cost
of provincial/territorial hepatitis C tracing initiatives (Health Canada, 1998a).
Social Union Framework
This agreement was ratified on February 4, 1999, and includes respecting
the 5 underlying principles of Canadian Medicare. Within 3 years,
governments have commiffed to eliminating “any residency based policies
or practices which constrain access to post-secondary education, training,
health and social services” unless they can “be demonstrated to be
reasonable and consistent with the principles of the Social Union
Framework” (Government of Canada 1999).
There is also a commitment to joint planning and collaboration when this will
result in more effective and efficient service to Canadians, including as
appropriate joint development of objectives and principles, clarification of
rotes and responsibilities, and flexible implementation to respect diverse
needs and circumstances, complement existing measures and avoid
duplication. The federal government is committed to working collaboratively
with ail provincial and territorial governments to identify Canada-wide
priorities and objectives, and not to introduce such measures without the
agreement of a majority of provincial governments. The existence of this
agreement represents an opportunity to get immunization on the national
political agenda and increase financial support for planning and
implementation of immunization programs.
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Foliowing the Romanow Report and the report on the SARS crisis (National
Commiftee on SARS and Public Health, 2003), there is increased interest in
collaboration between jurisdictions in the area of public health. More
recently, a Council of the Federation has been proposed as a mechanism
for collaboration between provinces, which could provide new iinks and
modes of exchange between Canadian jurisdictions. This resulted in the
signing of a formai agreement between the leaders of the 13 Canadian
provinces and territories on December 5111 2003. This council is scheduled
to meet twice yearly and to focus on ïssues of interprovincial-territorial
cooperation in areas of common interest, havïng health care as a priority
(Dougherty, 2003).
Canadian Initiatives- Coordination in the Area of Immunization
At the National Consensus Conference on Varicella in 1999, a
recommendation expressed the need for development of a mechanism to
prioritize and introduce new vaccines with a view to harmonizing programs
across the country (LCDC, 1999). A recommendation that Health Canada
act as a clearing house for information, providïng each province and territory
wïth a critique of current literature on cost-effectiveness to assist provincial
and territorial decision-makers was expressed at a previous consensus
conference on the pneumococcal polysaccharide vaccine in 1998 (LCDC,
1998). The National Advisoty Committee on Immunization (NACI) stressed
the conclusion reached at the National Immunization Conference in
December 1996 regarding the need to taise the national profile of
immunization as a useful population health strategy, and passed a formai
resolution emphasizing the foilowing points:
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“immunization against infectïous disease is amongst.the oldest, most
important and most effective public health measures for primary
prevention in Canada. The success cf immunization in reducing
disease transmission and incidence, in reducing short and long term
heaith costs and extending heaith life have been well documented.
Provinces and tertitories have been actively engaged in immunization
for decades and continue to refine, modify and expand programs, as
one of the primary public health priorities, because of ifs
demonsfrafed success.
Whlle immunization policy and program impiementation are the
primary responsibility of provinces and territories, infectious disease
contrai needs a more coordinated, interjurisdictional approach than
non-transmissible disease. It is therefore essential that there be
nationai_recommendations, guidelines, coordination and leadership
for immunization programs and practices in Canada. Health Canada
has an integral raie f0 play in ensuring that this national effort occurs.
The roie inciudes but is flot limited to surveillance and must also
include:
• regulatory activities ta ensure vaccine efficacy and safety
(licensure)
• consensus development
• facilitating national goal development
• national advisory committee support
• targeted research on vaccine efficacy, cost-utility and safety
• monitoring of vaccine program impact
• generai and specific support to provincial and territorial
immunization programs
• leadership in issues of national concern
If is only through partnership and participation of ail levels of
government that Canadians will achieve optimum benefit from
immunization.” (NACI, 1996).
These exampies indicate the expressed need for improved national
coordination in the area of immunization in Canada, as expressed publicly in
many different forums. This has also been confirmed in many recent
publications (Embree, 2002, Naus & Scheifele, 2003, Sibbaid, 2003).
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Global Initiatives- Coordination in the Area of Immunization
In a 1997 report entitiled National Program on Immunization to Support
Provincial and Territorial Immunization Programs (Spika & Duclos, 1997),
the authors cite these examples of global initiatives from the World Health
Organization (WHO), and the Pan-American Health Organization (PAHO).
Canada is a member 0f the WHO, which has recommended that there be a
national authority in each vaccine producing country to license vaccines,
evaluate clinical performance and monitor performance via post-market
surveillance, control and release each batch or lot of vaccine individually (for
risk mànagement and quality control purposes), perform laboratory testing,
and inspect manufacturing facilities and processes regularly.
Canada is also a member of the PAHO Technical Advisory Group on
Vaccine-Preventable Diseases, which recommended in 1997 that national
governments maintain capabilities to effectively monitor the implementation
of immunization programs at the state and local level and to take corrective
actions wherever warranted. This recommendation reflects PAHO’s
recognition of the importance of a national perspective in the planning,
implementation and ongoing monitoring of immunization programs,
especially in countries such as Canada where responsibility for
immunization programs is vested in provincial/state-level authorities (Spika
& Duclos, 1997).
Use of Research for Policy-Making in the area of Immunization
With rapid development of numerous new vaccines, this area represents a
challenge for policy decisions. Long-term benefits and costs of a particular
program have to be estimated, in addition to the relative benefits and costs
of different vaccination strategies within a program, of different immunization
programs targeting different diseases. This situation has increased interest
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in, and use of cost-effectiveness analysis (CEA) to support decision-making.
In Canada, economic evaluation studies have been commissioned for ail
recent candidate immunization programs such as varicella (Getsios, 2002)
and measles second dose programs (Magna P, 1997), pneumococcal
conjugate vaccine (De Wals et ai, in press), and meningococcal conjugate
vaccine (De Wais, et ai., in progress) with varied methodoiogies and impacts
(King & DeWals, 1999). In the United States, this has leU to the Vaccines
for the 21st Century Project of the American institute of Medicine, which
strives to improve decision making for development of new vaccines with a
standard cost-effectiveness model which can be appiied to ail vaccines
(10M, 2000). Perhaps the most innovative aspect of this project is the
inclusion of Excel spreadsheets to allow interaction and modification of
various parameters for a candidate vaccine by decision-makers. The
pertinence of this type of approach should be examined for decision-making
in Canada. However, a strict cost-effectiveness approach is limited in that it
often does not take important social and politicai factors into account.
Study on use of evidence in decisïon-making for immunizatïon
measles second dose programs
As part of the National Forum on Heaith, Tranmer and coiiaborators (1998)
conducted a study examining the use of evidence in various health care
planning decisions. One of these cases was the decision to implement a
program giving a second dose of measies immunization in Canada. In 1995,
the Measles Consensus Conference recommended national measles
eradication by 2005. However, in this study, results were collected in Match
1996 for the 12 Canadian provinces and territories. At that time, thtee
regions still had flot impiemented the second dose program, despite the
national consensus statement (Table iii).
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Table III: Measles Second Dose Immunization Programs in Canada, 1996
Province or Territory Routine Second Dose Measles Immunization
Program
British Columbia Yes
Alberta Yes
Saskatchewan Yes
Manitoba Yes
Ontario Yes
Québec Yes
Nova Scotia Possible in 199697*
New Brunswick No*
Prince Edward Island Yes
Newfoundland Possible, January 1997*
Yukon Yes
Northwest Territories Yes
* at time ofstudy
Source: Kingston, Frontenac, and Lennox and Addington Health Unit, Kingston, Ontario; in: Tranmer et aI., 1998)
Despite this, the authors observed that this program was relatively weII
C adopted. However, an obstacle to implementation observed was the
weakness of the relationship between available evidence, local planning and
implementation cf programs. Factors favoring implementation of the
program wete the quality of data, the existence 0f a national goal for this
disease, and diffusion of this recommended program via a national
consensus conference.
Several observations regarding the use of evidence in Canadian
jurisdictions were noted in this case. For example, epidemiological data from
other countries, especially those having implemented a second dose
measles program, were very convincing. However, some regions noted that
this evidence did not apply to their local setting as they observed only
sporadic cases of measles. In the Northwest Territories, cost-effectiveness
0f a second dose 0f this vaccine was easy to estimate, as most 0f those
infected received a medical certificate to permit air transportation to a
hospital. In addition, recrudescence of this disease recurred in 6-7 year
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cycles. In contrast, in Nova Scotia, disease costs were considered to be
minimal as only very few sporadic cases were reported.
The National Consensus Conference on Measles was seen as an important
mechanism to reach a consensus regarding this immunization program. The
presence of international experts having experience in measles vaccination
campaigns was very important, and this conference created dynamism that
favored implementation. Evidence regarding content and implementation of
the program was diffused by various means (such as newsletters or
communiqués) to physicians. Nationally, political orientations had great
influence. In provinces, there was a domino effect in which provinces did not
want to deviate from the national trend. On the administrative level, little
data were available to facilitate planning and implementation of policy
including timelines for the second dose programs. Other factors were
important, such as communities, responsibilities of physicians, other
C immunization programs (such as hepatitis B), and other priorities in public
health. There were some concerns about relationships between political
factors and evidence. For example, an administrator noted that the evidence
often did not reach the appropriate provincial authority in a timely manner. It
was also observed that when experts make recommendations, they should
consider the repercussions on policy and the context in which decisions are
made. It was also suggested that research follow a direction indicated by
decision-makers according to their priorities instead of bringing new
information that obliges them to make changes not necessarily planned in
advance.
This study concluded that the best available evidence was considered as
essential for decision-making in Canada. However, decision-makers also
considered economic, political, and geographical aspects of the evidence.
The National Consensus Conference and the existence of national policy for
measles allowed each jurisdiction to receive relevant information. A strong
30
best available evidence. One recommendation of this report was that the
federai government and provincial health ministers establish groups or
systems that collate, analyze, interpret, diffuse and ensure continuity of
documentation relevant to heaith care. This could facilitate integration cf
data into complete, accessible databases and therefore improve the
availability of information to decision-makers. In addition, it was
recommended the integration cf evidence into the decision-making process
must be the resuit of an organized planning process including ail parties
involved. Finaiiy, a quality assurance process shouid evaluate decisions
(Tranmer et aI., 1998).
This study confirms observations and information from other sources of the
need for improved knowledge management and planning processes for
immunization in Canada. In the next sections, we wiII propose an integratïve
theoreticai framework to appiy to the case of immunization, and the bases
for such a model in the literature on knowledge transfer, research utilization,
the diffusion of innovations, and organizational studies.
CHAPTER Il: LITERATURE REVIEW
introduction- I ntegration of multi pie perspectives
Ihe theoretical framework adopted in this intervention and analysis is the
model proposed by Kemmis and McTaggart (2000), which ïntegrates
different research traditions and different knowledge constitutive interests,
and proposes a framework to reach a reflexive / dialectical view and
integrate these perspectives and connect them to major groups of theories
and research approaches. (Figure 2). This aims to avoid many of the
polarities that afflict much of social science, such as quality vs. quantity,
structure vs. meaning, and macro vs. micro ( stley & Van de Ven, 1983;
Silverman, 1993).
Figure 2: General Relationships Among Different Research Traditions and Different
Knowledge-Constitutive Interests (Kemmis & McTaggart, 2000)
Traditions in the study of practice
Knowledge-consfitutive
interests
Perspective: focus: View ofpractice
Objective Individual (1) Practice as individual behavior Technicul
Social (2) Practice as social behavior — i.e.ritual, system
structured
Subjective
Individuat (3) Practice as intentional action, shaped by values
Practical
Social (4) Practice as socially-stwctured, shaped by
discourses and tradition
Reflexive/dialeciical view oJ (5) Practice as socially, historically, and Critical-emancipatory
relaiionships belween subjective- discursively constituted by human agency and
objective and individual-social social action
The model proposed by Kemmis and Mclaggart is a combination of two
existing models. One component integrates an existing framework for
32
classification of sociological theones originally proposed by Burreil and
Morgan (1979), which includes a two-dimensional system with
subjectïve/objective and individ ual/sociai divisions. A ‘reflexive-dialectical’
perspective is proposed which integrates the various perspectives within
these two poies. Building on Habermas’ critique about the lack of
connections among different streams of social theory (Habermas, 1987),
they integrate his three types of knowledge-constitutive interests which
frame and justify the search for knowledge through research, nameiy
technical (instrumental) reason, practical reason, and criticai or
emancipatory reason (Habermas, 1974; 1972). Kemmis & McTaggart
propose an adaptation of the four-category table to relate these different
types 0f approaches to the study of practice to the three types of
knowledge-constitutive interests proposed by Habermas. it is also proposed
that action research is a method that can integrate various approaches to
the study of practice (Kemmis & McTaggart, 2000).
First of ail, justifications for this integrative model from the iiterature on
research utilization, and the diffusion of innovations will be considered. In
addition, current knowledge transfer theories will be classified and examïned
in comparison to this model to illustrate their limitations in integrating
perspectives to give a comprehensive view of knowledge transfer. This
model is based on various similar integrative frameworks in the knowledge
management literature that oppose subjective and objective levels and
individual and social levels. This will be examined in the section discussing
organizational studies and knowiedge management literature.
The second element of this framework is the relationship to the three
categories of knowiedge-constitutive rnterests proposed by Habermas
(1972, 1974), which have seen some limited discussion in the knowledge
transfer literature. The three types of knowledge constitutive interests differ
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in scope. The technical level is concerned with theoretical efficacy, whereas
the practical level is more concerned with real-life decisions or problems in
context. The critïcal-emancipatory perspective is even larger in scope, and
questions current social arrangements. Finally, this model will be modified
for this project to develop a new integrative theoretical framework in which to
consider knowledge transfer initiatives in various perspectives.
These authors consider action research as a way to integrate these
perspectives, combining the subjective ‘insider’ perspective on a given
context with the objective external context. Whïle this alternation of
perspectives may be a negative factor for certain research methodologists, it
is argued that this permits a more encompassing perspective (Meyer, 2001,
Wateman et al., 2001). The importance of integration of evidence and
context is being increasingly recognized (Dobrow et al., 2004; forthcoming),
which also supports the choice of an action research approach for this
project.
Three knowledge-constitutive interests as proposed by Habermas
Three different kinds of knowledge interests were expressed by Habermas
(1974, 1972): instrumentaI or technical reason, practical reason, and critical
reason. Varjous adaptations of these three types have been mentioned in
recent knowledge management (Schultze, 1999; Varey et al., 2003; Ulrich,
2001) and qualitative literature (Burton et al., 1998; Kemmis & Mclaggart,
2000).
Technical reason dates back to the Greek philosopher Aristotie, and
is concerned with improving efficiency, and is close to an objective or
physical science perspective in its approach.
Practical reason is more concerned with the application of science to
reality, and admits the contribution of various conditions in the context
of actors. This can consider complex situations and conflicting values,
or simply day-to-day problems. Actors can be educated to understand
the nature and consequences of their actions.
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Cntical reason is claimed to encompass and extend both practical
and technical reason. It goes beyond the perspective of the individual
actor and considers how a situation is a resuit of past occurrences
and present arrangements, and also questions how the current
situation may be changed for improvement.
This categorization has inspired reœnt literature on knowledge
management, mentioning three corresponding categories of
objectivisUpositivist (technical), interpretivist (practical), and critical
approaches (Schultze, 1999; Varey et al., 2003). It has also been proposed
that each knowledge category is broader than and inclusive of the previous
one (Varey et. aI, 2003; Ulrich, 2001, Kemmis & McTaggart, 2000),
ïllustrated in Figure 3.
This vision 0f the relationship between these three categories agrees with
that presented in Figure 2. This vision is useful in that it can help to more
clearly define the scope and potential impact of individual knowledge
transfer initiatives according to individual contexts.
Knowledge Transfer: the need for an integratïve model
The study of knowledge transfer and the Iinks between theory/research and
practice/policy has been especially popular in recent years, experiencing
Figure 3: The relationship between three facets of knowledge proposed by Habermas
Source : Adapted from Varey et al., 2003
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exponential growth (Dunn & Holzner, 1988). An immense, growing body of
literature exists, more than 10 000 publications according to the estimate of
Backer (1991). Numerous domains of research contribute to the study cf
the use 0f scientific knowledge, such as the study 0f technology transfer,
dissemination and use 0f information, research utilization, diffusion 0f
innovations, the sociology of knowledge, organizational change, research on
policy-making and interpersonal and mass communications studies (Roy et
aI., 1995).
The spheres 0f research and policy-making are often described as ‘two
solitudes’. lndeed, while evidence is important, it is but one factor in the very
complex process 0f decision-making (Woodward et al., 1997). Consider also
that there are many types 0f knowledge such as tacit and explicit
knowledge, which add to the complexity 0f this field (Nonaka, 1994). In
recent years, more attention has been paid to the context 0f application of
certain types 0f research. There has been a growth of research outside of
the traditional objective science domain, and a shift towards interdisciplinary
research. Knowledge production that is policy-oriented is interdisciplinary,
referred to as ‘domain-based’ (Trist, 1972) or as ‘Mode 2’ knowledge
(Gibbons et al., 1994). This change in perspective has been accompanied
by an increasing interest in the process of research utilization and
knowledge transfer and underlying associated theories. In addition, the
original tendency to consider optimizing diffusion has evolved into a more
complete, context-sensitive perspective (Dobrow et al., 2004; forthcoming),
of ‘contextualizing knowledge’ (Denis et al., 2003). This evolution and the
need for more integrative models is logical if we consider the complexities of
research utilization and the diffusion 0f innovations as presented in the
literature.
Originally, the conception of research utilization perhaps did not adequately
address the complexities of utilization in a given context. This lead to
t
assertions in the literature such as’ Research is not used as a can opener Is
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used.’ (Huberman, 1987), referring to the complexity of research utilization.
Indeed, the term ‘utilization’ of information is flot clear, and can mean many
things in reality, depending on the context, the type of information and many
other factors Machlup (1993). We can also divide the research utilization
process into major stages, such as introduction, interpretation and
application (Oh, 1996; Rich 1997), or reception, cognition, reference, effort,
adoption, implementation, and impact (Knott & Wildavsky (1980). In reality,
there is a spectrum of possibilities of increasing utilization between simply
‘getting information’ and actually using it in a meaningful manner. An
example of this is presented in Figure 4.
Figure 4: Degrees of ‘Utilization’ of Research
Progressive tevels ofresearch ‘Utitization’ Exampte ofstages of utilization
Receiving information.., introduction
... and reading information
... and understanding information... inteipretation
. . . and appreciating information
..
. and using information in a decision...
... and using information in a decision that application
follows from the information
Adapted from Machlup, 1993; Oh, 1996; Rich, 1997
Therefore, there are many degrees of ‘use’ of research, which involve both
subjective and objective and individual and social concerns. We must also
consider that there are many types of use of research (Astley & Zammuto,
1992; Dunn et al., 1997; Lavis et al., 2002; Weiss, 1998). For example, use
can be instrumental in that it is directly used in policy formulation. Research
can also be used conceptually as a form of enlightenment or deepening of
C
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understanding. Symbolic or tactical use can occur when research is used to
support an existing position or decision. Ihere are many components which
must be considered when analyzing research transfer process (Lavis et al.,
2003; NCDDR, 1996). For example, the content or message is important, as
welI as the users (target audience), the source of information (messenger),
and the medium of dissemination. Again, uniquely subjective I objective or
individual I social perspectives do not fully address these varlous types of
research utilization.
We can also consider the stream of research that studies patterns of
diffusion and adoption of innovations, as there are many parallels with
knowledge transfer. One definition of an innovation is ‘the elaboration,
acceptance, and implementation of new ideas, prncesses, products and
services’ (Thompson, 1965). Diffusion is described as the process by which
an innovation is communicated over time among the members of a social
system (Rogers, 1995). As with research utilization, adoption of innovations
was originally simply considered as the straightforward replication of
innovations (Nutley et al., 2002). However, innovations may be changed by
a user in the process of their adoption or implementation, due to multiple
factors (Rogers, 1995). For example, users may lack full knowledge about
the innovation, or complex innovations may be simplified. An abstract tool
with many possible applications may often be simplified, and changes may
also be made so that users may have pride of ownership of their innovation,
or so that they can integrate the innovation with their pre-existing tacit and
explicit knowledge bases (Rogers, 1995). Like research utilization,
innovation is therefore seen as a multistep process, which includes multiple
steps such as awareness, conceptualizatïon, elaboration of an idea,
evaluation, persuasion, resource acquisition, initiation, testing, adoption,
implementation, routinization, confirmation, institutionalization, a nU
continuation. (Rogers, 1995; Collerette & Delisle, 1993; Milo, 1971;
Shepard, 1967; Hage & Aiken 1970; Wilson, 1966; Ihompson, 1965; Pierce
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r & Delbecq, 1970, Zaitman et ai.,J 973). Therefore, the question of whether
an innovation has been ‘adopted’ or flot is a complex one, and depends on
how exactiy this term is defined. Partial adoption, modification, and other
influences are possible: therefore one must consider the diverse range of
possibilities, which adds to the compiexity cf analysis in this area. These
examples from the literature on research utilization and the adoption of
innovations indicate that many different factors are at piay when research is
used or innovations are adopted. We can also consider the literature that
indicates factors that increase impact of research on decision-making.
Empirical research has indicated many factors that can increase the impact
of research on decision-making (Beyer & Trice, 1982; Buxton, 1996; Davies
et aI., 1994; Hanney et ai, 2003; innvaer et ai., 2002; Jan, 1998; JRF, 2000;
Lavis et ai, 2003a; Lyles et ai., 1977; NCDDR,1996; Stamm, 1999; Trostie
et al., 1999; Weiss & Bucuvalas 1980; Wood, 1998). These observations
included a variety of contextual factors that highlight the incompleteness cf
models that concentrate soleiy on the methodological quality cf research as
a determinant cf its impact on decision-making. These observations also
indicate the complexity and importance of individuai decision-making
contexts. Consider some examples cf these factors that have been
observed to increase the impact cf research on decision-making, presented
in Table IV.
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Table IV: Examples from the literature of factors which optimize the impact of research on
decîson-making
Factors Which Optimize Impact of Research on Decision-Making
Personal contact between researchers and policy-makers
Perception that researcli is ofhigh quality
> Trusted source of info
> Timeliness ofresearch
User participation
> Relevance to the current policy agenda
> Manipulability of data
> Expanding the scope ofresearch to include political, social, ethical and legal factors
> Commissioning ofresearch reviews to synthesize data
> Publication in user-friendlyjoumals
> Target the material to needs of audience
> Extract the policy and practice implications ofresearch
> Combine dissemination methods
> Senior management support
> Encourage focus on local ideas, practices and attitudes
Clear summaries, actionable messages from a body ofresearch rather than a single study
Sources Beyer & Trice, 1982; Buxton, 1996; Davies et al., 1994; Hanney et ai, 2003; Innvaer et al., 2002; Jan,.
199$: JRF, 2000; Lavis et ai, 2003a; Lyles et aL, 1977; NCDDR,1996; Stamm, 1999; Trostte et aL, 1999: Weiss
& Bucuvalas 1980; Wood, 199$.
It is interesfing to note the wide range of factors observed in the literature,
and to consider to what extent these generally context-based observations
relate to traditional objective scientific approaches and the various theories
of knowledge transfer presented in following sections. Overali they indicate
a complex process that depends on many factors in a given situation. This
further supports the need for a broad framework that can integrate these
various perspectives and account for the whole picture of reality.
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C Categories of models for knowledge transfer
Modeis for knowledge transfer are often divided into three or more
categories in recent literature (Denis et ai., 2003, Capian et al., 1975;
Fourez, 2002; Habermas,1973; Wingens, 1990; Weiss 1977; Weiss 1979).
The literature consistently refers to two typicai approaches to knowiedge
transfer, the ‘push’ or knowiedge-driven model and the 1pulI or probiem
solving’ model. Despite somewhat differing terminologies in the literature,
these two models are reiatively well-defined and similar in the literature.
Many authors refer to a third category of modeis, often termed as exchange
or interactive models (Landry, 1999; Lavis 2003; Denis et al., 2003;
Habermas,1973; Yin & Moore, 1998). These models emphasize the
interactions or exchanges between various actors, often researchers and
decision-makers. Some authors also mention another type of model: the
diffusion or eniightenment model (Landry, 1999; Denis et aI., 2003;
Champagne 1999; Weiss 1979). Finally, other types of approaches are
often mentioned in the literature, such as the strategic, political, tacticai,
incrementaiist and ‘garbage can’ models (Denis et aI., 2003; Champagne
1999; Weiss 1979; Lindblom & Cohen, 1979; Cohen et ai, 1972; Janovsky &
Casseis, 1996). A comparison of some of these groupings commonly found
in the iiterature is presented in Tabie V.
C)
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Table V: Selected Groupings of knowledge transfer approaches in recent literature
*
‘diffusion’ is used in the literature to refer to both tne ‘push’ mode! and the enhightenment modei
We will now consider the general characteristics of each of these categories
of models, and some other approaches and models that are perhaps not
specifically addressed in these categories of models. Denis et aI. (2003)
presented a useful review of key characteristics of each of the five types of
models. Using this review as a starting point, we can combine the five
categories named by these and other authors indicated in Table V with
some observations from the literature to identify some key points of these
grouped categories of knowledge transfer theories.
Groupings of knowÎedge transfer approaches/theories
‘Push’ ‘Pull’ Mode! Interactive Enlightenment Other
Authors Model (information-seeking Mode! Mode! types
(diffusiont problem-solvmg. •) (exchange, (diffusiont,
knowledge-
-
s deliberative) percolation)
specilie,...)
Habermas Technocratic Decisional Two
(1973) communities
or exchange
mode!
Lavis Producer- User-pull model Exchange
(2003b) push mode! mode!
Yin & Knowledge Problem-solving Social
Moore, Production interaction(1998)
Landry ‘Push’ ‘Pull’ Interaction Diffusion
(1999)
Denis et al. Knowledge- Prob!em-solving Deliberative Enlightenment Strategic
(2003) driven
Champagne Knowledge- Problem-driven, Interactive Enlightenment Political,
(1999); driven problem-so!ving, tactica!
Weiss (1979) decision-driven
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The classicallpuristlknowledge-driven ‘push’ model
This model corresponds to the traditional positivist approach in science
(Denis et al., 2003), and envisions a linear sequence in which research
generates knowledge that impels action. This model can also be called the
‘push’ model or the agricultural extension model. It reflects a rational, linear
conception of the process of knowledge utilization. It can be referred to as
technocratic in that experts are in the best position to decide, without
negotiation and neglecting politics and ethics (Habermas,1973). The
assumption is that good ideas wiIl be implemented by those who are made
awate of them (Rogers, 1988). This type of approach is similar to that of
‘functionalist’ thinkers such as Williamson (1975), which considers that
individual rational actors combine to produce rational decision-makïng in
organizations. A model that is similar in its approach to knowledge is the
enhightenment model, which places more emphasis on the diffusion of
knowledge. However, in recent years, understanding about knowledge use
has revealed that this vision neglects many aspects of a process that is
extremely, complex, transactional, and dependent on characteristics of
intended users (NCDDR, 1996).
The information-seekingl policy-driven! problem-solving ‘pull’ model
In contrast to the knowledge-driven model, whïch is centered on the
researcher, the problem-solving model focuses on the decisïon-maker
(Weiss, 1979; Denis et al., 2003). This can also be termed as a decisional
model in which users determine the ends, and experts determine the means
(Habermas, 1973). This follows a sequence that begins with the
identification of a problem by a customer who requests the researcher to
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identify and assess alternative solutions. It is assumed that polïcy-makers
identify probiems, then gather and review ail data about alternative possible
solutions and their consequences, and then select the solution that best
matches their goals.
According to this model, knowledge utilization can be increased by
improving the ability of decision-makers to frame problems and the ability of
scientists to translate knowledge into local and practical applications (Denis
et al., 2003). This approach is similar to the evidence-based medicine
movement, which strives to improve decision-making by practitioners by
training them in methods to analyze and evaluate the quality of evidence in
the area of medicine. Evidence-based decision-making can be defined as
‘the conscientious, explicit and judicious use of the best avallable evidence
from health care, management and policy research in the care of individual
patients, the management of the health system, and health policy
formulation’ (HEALNet, 1998). This definition is a modification of the
definition of ‘evidence-based medicine’ (Sackeif et al., 1996; HEALNet,
1998) originally devised for clinical practice. In recent years when
examining knowledge transfer processes, researchers have begun to use
the term ‘receptor capacity’ to refer to the decision-makers capacity to
receive and process research. Therefore, improvement of problem-solving
skills of decision-makers is another potential target for improvement of
knowledge transfer and decision-making. Therefore, like the knowledge
driven model, the problem-based model addresses an important aspect of
knowledge transfer and decision-making processes, but does not address
other important factors in the overail decision-making process in health
organizations. The interaction model addresses some of these factors.
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The Iexchangelinteractivelsocial interaction model
This model considers a set of interactions and negotiations between
researchers and users rather than a linear move from research to decisions
(Habermas, 1973; Fourez, 2002; Landry et ai, 2001). These interactions
heip expose both groups to each other’s worids and needs, and increased
interactions shouid be sought throughout the knowledge production process
(Denis et al., 2003). A decision-relevant culture can be created among
researchers, and a research-aftuned culture can aiso be created among
decision makers (Lavis et ai., 2003; Roos & Shapiro 1999; Huberman,
1994). Such cuitural shifts can facilitate iong-term use of research in
decision-making.
A similar area given much attention in recent years is the study of networks
as an organizational form that can promote innovation. Whiie there are
many defïnitions of networks, one exampie considers a network to be a
grouping of individuals, organizations and agencies organized on a non
hierarchicai basis around common issues or concerns, which are pursued
proactively and systematicalIy, based on commitment and trust. There is
often an emphasis on knowledge, usefuiness, sharing and innovation
(Pedler, 2001). In addition to formai networks, it is important to recognize the
existence and importance of informai networks when analyzing the overaii
processes of knowiedge transfer and decision-making. The term ‘policy
communities’ is also used to refer to the powerfui, iong-term reiationships
between government officiais and interest groups (Rhodes & Marsh, 1992;
Kogan & Hanney, 2000; von Waiden Laing, 2001). Researcher invoivement
in ‘social networks’ ïs considered important for research utiiization (Yin &
Gwaitney, 1981), and groups of experts with a simiiar approach on a given
issue can influence policy (Haas, 1992). Deveiopment of ‘communities of
practice’ is important, as are opportunities for face-to-face interaction (Nutley
2003; Prusak & Lesser 1999).
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Enhightenmentlpercolationllimestone Idiffusion model
Like the knowledge-driven model, the enhightenment model considers
knowledge in itself to be valuable (Weiss, 1979; Denis et ai., 2003). This
model puts the accent on the need for a distribution mechanism for research
and considers that it is more iikeiy to be used through the graduai
sedimentation of insight, theories, concepts and perspectives. According to
the enhightenment model, increasing the diversity and circulation of
knowledge in society should improve decision and actions (Denis et ai.,
2003). This model has the advantage of extending the range of ways in
which research is seen to be utiiized. This modei seems to be a iogical
extension of the knowledge-driven model, as the ‘push’ name may impiy, in
that the process of diffusion of knowiedge is simpiy added to the
appreciation of the intrinsic value of knowiedge in decision-making and
C society.
Political and Strategic models
Politicai modeis consider that research findings become ammunition in an
adversariai system of poiicy-making (Weiss, 1979). Indeed, it has been
observed that as decision-making moves from the individual ievei to the
manageriai and poiicy-making level, the organizationai and poiiticai factors
with which research knowiedge must compete to influence the decision
making process become more apparent (Lavis et ai., 2003; Black 2001;
Waishe & Rundall, 2001). The poiiticai negotiation process in decision
making occurs between members with diverging interests. Poiiticai modeis
can also be applied to organizationai innovations, which can be regarded as
internai political processes (Eikin, 1983), which wiii succeed if support is
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received from actors who exercïse important controls on the organization
(Denis, 1988).
Tactical Model
An extension of the political or strategic model is the tactical model which
considers that reseatch can be manipulated to legitimize particular positions
or for gain in specific organizations. For example, research can be used
when there is pressure for action to be taken on an issue, when policy
makers respond by commissioning a research study on the matter, flot to
acquire knowledge but rather as a delaying tactïc (Weiss, 1979).
Other Models and Approaches
These major categories of models address different aspects cf knowledge
transfer, but do not integrate varlous perspectives. In addition, there are
other approaches in the literature which address issues flot specifically
addressed in these five models of knowledge transfer. We can consider in
particular incrementalist models, structural models, the ‘garbage can’ model,
bounded rationality, social learning theoiy, cognitive approaches, reflexive
learning and situated knowledge.
Incrementalist models recognize that policy-making is a complex process. It
can ïnvolve scientïfic knowledge and a range cf other factors including
interests, values, established positions within institutions, and personal
ambitïons. Evidence from research must compete with ‘ordinary knowledge’
(Lindblom & Cohen, 1979), which involves common sense, causal
empiricism, and thoughfful speculation and analysis. In this view, policy
making is not a clear movement towards predetermined goals, but rather a
series of small steps in a process of ‘muddling through’ (Lindblom, 1959).
lncrementalists allow for a greater role for interests in policy-making debates
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c and emphasize the many sources of information that impinge on policy
makers.
Structural models focus on organizations, and consider that it is important to
be aware of the impact of structural characteristics of an organization
(organizational ailributes, context, and nature of administrators) on
organizational change, and act by adjusting this structure to succeed in
implementing a structural change (Mintzberg, 1979). Consider also the
congruence mode! of organizational behaviour (Nadler & Tushman, 1997).
This model considers how components of an organization exist together in
various states of balance and consistency- which can be referred to as ‘fit’.
The higher the degree of ‘fit’ (or congruence) among the various
components, the more effective the organization. Analysis cf knowledge
transfer using these models would consider these processes in the larger
context and functioning of organizational structures.
C
The ‘garbage can’ is model suggests that solutions that might have been
discarded may remain in the policy-making system, and occasionally there
are problems to which they become aftached, highlighting to what extent
policy-making is an untidy process which does flot in reality have a neatly
defined series of phases (Cohen et aI, 1972; Janovsky & Cassels, 1996).
Bounded rationality is not specifically or clearly addressed in the various
theories on knowledge transfer in the previous section, to address practical
limits on rationality. Cyert & Match (1963) propose the term ‘Problemistic
Search’ in the situation whete limitations may cause actions to stem from
the immediate problem instead of following a long-term orderly process
addressing the overall situation. Similarly, the concept proposed by Simon
(1957) of ‘bounded rationality’ considers decision-making to have a rational
element which is bounded by contextual constraints, which limit the range of
r possible solutions to a given problem. Simon (1957) also made an important
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distinction between types of decisions: there are different types of decisions:
programmed decisions which are made frequentiy, and have an estabiished
procedure, and non-programmed decisions, which Iacks an established
procedure.
Bandura (1977) proposes a social learning theoiy to explain human
behaviour, which considers interaction between cognitive, behaviourai and
environmentai factors. Actors are neither totally controiled by the
environment nor free individuals capable of acting according to their wishes.
Learning occurs by direct experience and by observation of the behavior of
others by a process of reflexive thought of observers.
Cognitive approaches can be considered as an extension of problem-solving
models, which consider the perspective and sense-making processes of
individuals. individual cognitive styles may differ, ranging from analytical
(deductive, formai, convergent, rigorous) styles to synthetic (inductive,
informai, divergent, creative) styles (Allison & Haynes, 1996). Decision
makers have different knowiedge processing structures that may give more
importance to existing theories in the interpretation of information or
conversely may give more importance to information on the current situation
(Waish, 1995). While cognitive approaches were initially based on
psychology of cognition, more recent approaches take a more social
approach, considering cognitive aspects in relation to the context of
individuais (Farand & Arocha, 2003).
Schn’s theories on reflexive learning are useful in considering the
processes of knowiedge development and use (Schôn, 1983), and address
the issues of expert or tacit knowledge (Nonaka, 1994). it is maintained that
in practice, through a process of refiection in action, practitioners cope with
uncertainty by refiecting on what they are doing in a unique situation and
restructure their understanding as a resuit. Professional judgement is based
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on an interplay 0f personal, scientific, and experiental knowledge (Schôn,
1987). There is an emphasis on application of knowledge in a given
context.
A similar approach is that described as ‘situated knowledge’. This approach
gives ïncreasing importance to contextualization, arguing that heaith
professionals do not apply abstract knowledge, but collaborate in
discussions and engage in work practices that interpret the local validity and
value of scientific research. Evidence 15 a contested domain that is in a
constant state of ‘becoming’, and varies according to the context. Within
particular contexts, research is related to ‘situated knowledges’, structured
local ways of thinking and acting. Implementation involves reconnecting
research to practice (Wood et al., 1998).
Evaluatïon of models and other consideratîons
Given the variety of organizational situations and possible perspectives for
analysis of research utilization and knowledge transfer, it is evident that
each category of models can provide useful, but incomplete pictures of
reality. While recent analyses often take a position of exclusion or rejection
of certain types of models because of their limitations, this attitude ignores
the fact that certain models may be perfectly applicable in certain contexts.
Consider for example, the knowledge-driven model, which is aiso known as
the agricultural extension model (Rogers, 1988). This term refers to the
diffusion of agriculturai innovations in recent decades, in which the
technological advances were simply adopted as a result of research. Other
examples can surely be found to support ail of the other theories, therefore it
is more important to try to complete the gaps in existing theories and try to
combine them in an integrative approach. lndeed, some efforts have been
made to integrate the various approaches in recent literature. To reach a
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beffer understanding of knowledge transfer, it is necessary to go beyond
restricted theoretical approaches that address only one aspect of complex
realities.
Huberman (1989) considers that as the field of research utïlization has
grown and differentiated, there is a need for more integrative
conceptualization. Huberman presents two dominant models for knowledge
utilization, the instrumental (imperativist) model, which is similar to objective
or rational models and the constructivist (transactional, conflict-theoretic)
model which considers a more active role of users. This is similar to learning
or cognitive models. In their simplest form, instrumental approaches can be
referred to as the ‘RD & D perspective (Research, Development,
Dissemination), however more recent work is more socially interactive in
nature (Huberman, 1989). Constructivist approaches consider individual
frames of reference and information processing within the user’s mmd and
social setting, taking into account the reconstruction and transformation of
data, and also the more political, bargained, or strategic aspects of
information use.
Huberman stresses that findings on knowledge utilization in empirical
research are accounted for by a blend of both approaches, therefore
exclusive use of one approach leaves certain aspects of data unaccounted
for and overly simplifies the analysis (Huberman 1989, Huberman 1987). He
suggests using both models to understand research utilization, ‘looking
through both eyes’, and proposes that the field of research utilization would
benefit from integration of both approaches. The type of integration of
multiple perspectives proposed by Huberman can be examined by
considering the integrative framework proposed by Burrell & Morgan (1979).
51
The Burreli & Morgan framework for integration of theoretical
approaches
Overali the groups of models of knowledge utilization can be seen to be
incomplete, corresponding to certain individual schools of thought. To clarify
the underlying assumptions and contradictions in these approaches, it is
useful to situate these approaches relative to each other on a more global
level. Consider the fourfold schema proposed by Burreil & Morgan (1979)
and its various adaptations in recent literature applied to organizational
studies, sociological theories, and knowledge management approaches
(Figure 5). This framework was developed to classify social theories
according to their underlying philosophy of science and theory of society.
Figure 5: Burrell & Morgan schema for sociological theories
Radical Humanism Radical Structuralism
Presuppositions
Focus Subjectivity Objectivity
Sociology ofradical
change
$ociology ofregulatioit
Interpretivism Functionalism
Source: Burreli & Morgan (1979)
One set 0f poles concerns the objective approach (which considers that
reality is independent of human perception), versus the subjective stance f
which considers that reality is socially constructed as a resuit of actors
interactions and experience). The other poles oppose the sociology of
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regulation (representing a society which tends toward integration and order),
versus the sociology of radical change (representing a society where there
is conflict, change and coercion).
Much recent work, including the framework suggested by Kemmis &
Mclaggart (2000), has employed adaptations of this schema to discuss the
contradictions in sociologicai theories (Alexander, 1982; Waters, 1994),
organizational studies, (Astiey & Van de Ven, 1983), decision-making (Miller,
2000), knowledge transfer (Armistead and Meakins, 2002; Schultze, 1999),
or in qualitative and action research (Kemmis & Mclaggart, 2000). With the
exception of Schultze, these authors ail made some modifications to the
poies of the original Burreil and Morgan framework. For example, the poies
of subjectivity/objectivity were replaced by voluntaristic/deterministic,
political/problem-soiving, or empowered / imposed. Similarly, the original
poles of radical change! regulation were replaced by notions of
individual/social, action/order, or micro! macro leveis. These differences are
presented in Table VI.
Table VI: Modifications of poles in Burreli & Morgan model in subsequent adaptations
Publication Correspondence of poles between Burreit & Morgan model
and subsequent adaptations
Burreli & Subjective vs Objective Radical change vs Regulation
Morgan, 1979
Alexander, 1 9$2 Subjectivity Objectivity Action Order
Voluntarism Constraint
Astley & Van de Voluntaristic Deterministic Micro level Macro level
Ven, 1983
Waters, 1994 Subjective Objective Individualistic Holistic
Miller, 2000 Political Problem-solving Chaos Order
Armistead & Empowered Imposed Individual Organization
Meakins, 2002
Kemmis & Subjective Objective Individual Social
Mclaggart, 2000
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The various applications of this model indicate that it highlights reai
differences in theoreticai approaches and that it can be a useful tool in many
area. However, they also suggest some limitations of using simple
dichotomies. Similar to making changes in the poies of the models, many of
these authors have given different names to the four quadrants of the
original model (radical humanism, radical structuralism, interpretivism, and
functionalism), but there is littie correspondence among them.
The Burreli and Morgan framework has been criticized on many leveis
(Flynn, 2003). For example, the subjective-objective dichotomy is seen as
being too extreme, due to the fact that most individuals adopt positions that
are intermediate on this scale. The division of ail theories and approaches
into four mutually exclusive paradigms makes inclusion and acceptance of
ail theories impossible; therefore more categories may be needed. These
criticisms can be taken into account by going beyond dichotomies (i.e.
subjective/objective), for example by adding additional intermediate
categories between the poles. An open continuum between poles (rather
than separate compartments) can also be used, which allows individual
theorists or streams of theories to be situated in specific regions between
the various poles (Miller et al., 2000).
Despite its limitations, this framework can situate various debates and
contradictions of various approaches. For example, should we consider
organizations to be rational, technically constructed systems or rather
socially constructed entities reflecting vested interests and the power
structure of society (Astley & Van de Ven, 1983)? Are decision-makers
rational or subjective individuals and is their behavior guided by goals valued
by society or rather by political concerns and the acquisition of power? It
seems reasonable that most situations involve a blend of these various
opposites, depending on the situation. In this vein, from the perspective of
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organizational analysis, a flexible ‘contingency model’ has been proposed,
recognizing that the applicability of each model for the understanding a
change varies in terms of the organization in question (Denis & Champagne,
1990).
In the area of knowledge management, research has observed various
approaches and classified them using the fourfold framework of Burreil and
Morgan. Many different approaches wete used, however objective
approaches on the level of the individual or the organization (referred to
‘prescribed’ and ‘compliance’ approaches) were dominant (Armistead &
Meakins, 2002). It is difficuit to balance the four approaches in this
framework due to key trade-offs between imposed or empowered
approaches, focus on the individual or organization, concern with explicit or
tacit knowledge, or technological versus ‘people solutions’ (Armistead &
Meakins, 2002). Despite these challenges, and integrative approach is often
recommended in recent literature (i.e. Schultze, 1999; Nutley et al., 2003;
Hildebrand, 1999). Overall, this illustrates many different representations of
two useful poles in social research: the subjective versus the objective and
individual versus the system. It is important to consider these aspects as
non-exclusive and complementary to develop an appropriate framework for
this intervention.
Proposed Adaptation of Integrative Framework
The incompleteness of knowledge-driven, problem-solving, and other
theories and the need to integrate them must be recognized. It is therefore
useful to explore potential application of more comprehensive classification
systems proposed in the literature to encourage a more complete analysis of
this type 0f intervention. For this particular project, a compromise between
Miller’s (2000) open graph approach and the four quadrant approach
presented by other authors is proposed, which allows for intermediate
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categories between the poles cf subjective/voluntaristic and
objective/deterministic perspectives (Figure 6).
Figure 6: Proposed Revised Analytical Framework for Project
Adapted from Kemmis & McTaggart (2000)
Perspective I conception of actors
A total of four categories can be identified in this proposed model from the
objective to subjective poles: rational /objective, cognitive, situated, and
political. We can consider the rational/objective category to correspond to
objective scientific facts similar to positivist approaches. The cognitive
category considers the perspective cf the individual, their frames of
reference, and processing cf information. The situated perspective is similar
to the cognitive perspective but pays even more attention to the use cf
information and the relation of the user to a particular context. Finally, the
political model considers the factors of negotiation, power struggles, and
Knowledge- Criticat
Constitutive
Interests Practtcat
icaT1
DETERMINISTIC Intermediate
- Intermediate
- VOLUNTARISTIC
Level of - -
anal sis Imposed Cognitive, Situated Empowered
-‘ Objective evidence-based, knowledge, Subjective
Constraint problem-solving Situated potitical
rational approaches cognition,
Social leaming
approaches
Integrated
MACRO refle%vedwtecttcat
. viewholistic
order
coherence
MESO
intermediate
MICRO
Individual
Action
chaos
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other factors which form a background and influence the overali situation.
This model emerged from multiple comparisons of observations with theory
during this project.
The category ‘MESO’ was also added between macro (social ) and micro
(individual) categories to allow for intermediate categories between these
two poles. While this is only one possible structure and representation, this
particular framework is a starting point and should allow different types of
approaches and interventions to be positioned more clearly, and the
presence and importance of each category in the context of this project to
be evaiuated. The resulting adaptation results in an expanded 4x3 table.
For analysis of this project, various approaches in knowledge management
will fitst be situated in this classification system. Secondly, results of the
project on the development of the analytical framework and related activities
will be analyzed and classified using this system. This type of approach
should have the benefit of making the nature of a given knowledge
management approach more explicit and therefore promoting understanding
of similarities and differences between different interventions in knowledge
management.
Correspondence between framework and theoretîcal approaches to
research utilîzation
As an initial exercise, one can consider the groupings of research utilisation
approaches in recent literature and how they can be approximately situated
within this system of classification (Figure 7).
Figure 7: Interpretation of correspondence of Theories of Research Utilization to
Classification Framework
Perspective / conception of actors
Level of
analysis
DETERMINISTIC
Objective
Irnposed
Objective
Constraint
rational
Intermediate -
Cognitive
evidence-based,
problem-solving
approaches
Intermediate -
Situated
Situated knowledge,
Situated cognition,
Social learning
approaches
MACRO
Knowledge-drivenl
holistic ‘push’ model
order
coherence
MESO fnhightenment or Interactive 1’
intermediate diffusion model MoUds
Political/ Strategic
•• MoUds
- 1’
MICRO Problem-solving /
Individualistic ‘pull’ moUd
Action
Chaos
> the traditional knowledge-driven or ‘push’ model could be p!aced on the
deterministic and macro/holistic ends of the spectrum (Figure 6), due to
the fact that it ignores subjective, interactive and other factors.
> The problem-solving model, because of its consideration of a decision
maker who seeks information for resolution of problems, is more action
and process oriented, but stiil considers the decision-maker as being a
largely rational being in need of information to make decisions.
> Interactive models due to their consideration of exchange, action, and
different ‘cultures of groups, can be situated in a central position of the
grid. This position can be shifted towards any of the poles if different
varia nts of these theories are considered.
> The enlightenment model could perhaps be placed as an objective
approach at a meso level because of its consideration of the process of
diffusion of information. This tends towards an action perspective
perhaps more than the ‘push’ model.
Political and Strategic Models: because of the non-logical nature of
interactions in this model, they can be placed at the objective end of the
spectrum.
This placing of groups of theorïes on a classification is necessarily arbitrary,
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VOLUNTARISTIC
Political
Empowered
Subjective
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imprecise, and open to debate, especially because these classifications of
theories are also imprecise and open to debate. Some variants 0f these
theories may also cover a larger area rather than a given point. Detailed
discussion 0f the exact nature or position cf each group of theories is
beyond the scope cf this thesis. However, an important and useful
observation of this simple exercise is that the various theories are dispersed
along the spectrum, covering various areas. This indicates the potential
usefulness of this type cf approach in being able to integrate most
approaches, observations, and situations in research utilization and the
knowledge management area.
We will consider the results of the project in terms cf this classification
system to aftempt to understand the various elements 0f the intervention
and test the relevance of this type of classification system for interventions
in knowledge management. Given that the context of this intervention is in
the public health policy sector, specifically in the area of immunization, some
theoretical models specific to this area will also be considered in the
following sections.
The Public Health Policy Context
When considering decision-making in the context of public health, it is
important to recognize the importance cf factors other than scientific
knowledge from the outset. In addition to evidence, context must be
considered, and evidence-based pclicy-making is seen as a successful
balance between these two factors (Dobrow et al., 2004; fcrthcoming).
Another useful representation of various factors which combine in the
determination cf public health policy is proposed by Richmond and
Kotelchuck (1983), who contenU that the knowledge base interacts with
political will and a larger social strategy to produce public health policy
(Figure 8).
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Applying this model to the current situation in immunization program
planning in Canada produces the following corresponding elements:
> Knowledge Base: knowledge on vaccines and potential
immunization programs,
> Social Strategy. the National Immunization Strategy and various
provincial and territorial strategies including immunization,
> Political wiII: openness of politicians in various jurisdictions to
funding and support of immunization programs, and the willingness
of provinces and territories to engage fully in F/P/T collaboration,
> Public health policy. decisions regarding financing, timelines, scope
etc. of publicly funded immunization programs in Canada.
This type of systemic vision of public health policy aids to recognize the
limits of knowledge in determining public policy. However, it also illustrates
that the knowledge base can influence political will and social strategies,
which in turn can contribute to the elaboration cf public policies. Studies
which integrate the mechanisms of interaction cf knowledge, political will,
Figure 8: The Richmond and Kotelchuck Model for the Development of Public Health Policy
Source: Richmond & Kotelchuck, 1983
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Frameworks for Decision-Making
Many frameworks exist to assist planning in public health, which go beyond
the parameters of disease burden to address factors such as the social
context, and economic concerns. These tools vary in complexity and their
use. Consider the following two exampies:
• a comprehensive framework for technology assessment proposed
by BCOHTA (the Britïsh Columbia Office of Health Technology
Assessment) which includes 5 elements: population impact,
economic concerns, effectiveness evidence, social context,
and population at risk (BCOHTA,2000).
• the OVCD (Overview of Communicable Diseases) project in the
UK, which employs the criteria of burden of ilI-heaith,
socialleconomic impact, potential threat, health gain
opportunity, and public concern, and also asks users about
priorities for further research (PHLS, 1999). (see Appendix for
example)
These models are examples of efforts to include ail factors fràm the science
to the broader social context in the area of public health. There are also
some examples specific to immunization.
Models specific to immunization
When considering immunization programs, there are many factors to
consider. Firstly, there are factors that are ‘micro’ in nature, such as the
molecular biology of the disease and the vaccine. At the other end of the
scale are factors that are rather ‘macro’ in nature, such as politicai and
organizational aspects. This is represented in Figure 9.
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Figure 9: Decision-making in Immunization
Reductionism Holïsm
Molecular Microbïology Individual Epidemiology Health Sociocultural
Biology Ilinesses services and Political
Economics Aspects
Source: Duval, 2000
b be complete, examination of potential immunization programs must
address ail of these considerations, from the reductionist or micro Ievei to
the holistic or macro ievel. This distinction is important in situating theories
and interventions to improve decision-making in the area of immunization as
weil as in the area of knowledge transfer in general (this wilI be discussed in
foilowing sections of this document).
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General Framework for decîsion-making in the area of immunization
Harris (1975) stated that immunization programs should always be based on
« profit and loss» analysis, with profit being determined by the degree of
risk of the target disease, and loss being determined by the hazard of the
immunization itself combined with the failure to protect those who are
immunized. More generally, decision-making for a therapeutic intervention
aimed at a group has been described as containing the following elements
(Jenicek & Cleroux, 1985):
• the dîsease or health problem in question
• the proposed therapeutic intervention
• potential intervention strategies
• feasibilïty of possible strategies
• evaluation of the proposed intervention
This model is a simplified adaptation based on a normative scheme for the
planning and evaluation of immunization programs in Canada, devised by
White and Mathias (1982). White and Mathias’ model has the same five
criteria, but is much more detailed, having multiple questions to be
addressed within each criterion, and the addition of a sixth: Proposais for
Acquisition for Further Evidence. This section addresses whether further
evidence is needed from the preceding points before making a decision (see
Figure 10). Models of this type can be classified as Multiple Criteria
Decision Models (MCDM5), and have already been implemented in the
health care setting, for example for hospital resource allocation decisions
(Durand-Zaleski, et al., 1996). At the provincial level, similar multiple-criteria
models have also been examined informally in Quebec and British Columbia
for vaccination program planning (King & De Wals, 1999). This model will
provide a basis for development 0f the analytical framework in this project
and the criteria contained within wilI be combined with criteria identified from
data collection and consultation of key persons in the area of immunization
in Canada.
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Figure 10: Framework for Planning and Evaluation of Immunization Programs (White &
Mathias, 1982)
A. Definition of the Probiem
D. Assessment of Feasibility of
Strategy
1. What disease is to be prevented or
controlled?
2. What is the evidence concerning the
incidence of infection, disease, and
complications by age, sex, and
regional distribution?
3. What is the quality ofthat evidence?
4. What is the economic and social
impact ofthe disease?
B. Assessment of the Immunizing
Agent
What are the characteristics of the
immunizing agent? (e.g. live attenuated,
killed, absorbed/non-absorbed, viral or
bacteriai product, etc.
2. What is the evidence of short term and
long term efficacy?
3. What is the evidence of vaccine safety
? (e.g. in the laboratoty, in fleld trials,
under wide-spread use, short term,
long term, minor and major reactions,
etc.)
C. Identification of Strategies
1. What are the alternative objectives ?
(Options)
2. What are the alternative strategies
available for meeting alternative
objectives?
3. What are the alternative target groups
9
4. What is the evidence concerning the
short term and long term effectiveness
of alternative strategies?
5. What is the quality ofthat evidence?
6. What are the underiying assumptions
(e.g. probable life time immunity,
probable need for booster
immunizations, effect on duration of
maternai antibody, etc.)
1. How acceptable wiil the chosen
alternative be to the target group, and
to the population at large? What levels
ofcompliance are expected?
2. What would be the costs (vaccine and
administration) of impiementing and
maintaining each strategy at various
leveis ofcompliance?
3. What is the avaiiability ofthe vaccine,
or desired vaccine combinations, in
Canada?
4. What are the opportiInity costs of
alternative strategies?
5. What are the resuits of benefit: cost
analysis for each strategy, and how
rigorous were those analyses?
6. Are the resources available?
1. Is evaluation an important component
ofthe proposed program?
2. What tools are available for
monitoring incidence of infection,
disease and complications by age, sex,
and geographic distribution?
3. How reliable are those tools?
4. Is baseline data currently available,
and, if not, can it be developed?
5. If impiemented, cari a reiiable
evaluation component be built into the
F. Proposais for Acquisition for
Further Evidence
Is further evidence reiating to any of the
above planning components necessaiy prior
to making a decision?
D.feasibility
E.Evaluability
E. Evaiuability
program?
A. The Problem
B. The Vaccine
C. The Strategy
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Combining Theory and Practice via Participative Inquiry
Approaches
What types of research approaches can successfully combine multiple
theoretical perspectives in a single project? One proposed stream of
research is that of participative inquiry or action research. In contrast to
orthodox scientific method, participative inquiry involves working with and for
groups as co-researchers(Reason, 1994; Reason & Rowan, 1981). This
type of research method, also referred to as ‘action research’, is more cf a
style of research than a specific method, and can be traced back to work cf
Lewin (1951). Most definitions also mention its democratic nature, and its
simultaneous contribution to social science and social change (Carr &
Kemmis, 1986).
Due to the various definitions and forms of action research that exist, there
has been a recent affempt to develop embracing definitions of action
research. One such example the following definition proposed by Waterman
et al (2001):
“Action research is a period 0f inquiry, which describes,
interprets and explains social situations while executing a
change intervention aimed at improvement and involvement. It
is problem-focused, context-specific and future-oriented. Action
research is a group activity with an explicit critical value basis
and is founded on a partnership between action researchers
and participants, aIl of whom are involved in the change
process. The participatory process is educative and
empowering, involving a dynamic approach in which problem
identification, planning, action and evaluation are interlinked.
Knowledge may be advanced through reflection and research,
and qualitative and quantitative research methods may be
employed to collect data. Different types of knowledge may be
produced by action research, including practical and
propositional. Theory may be generated and refined, and its
general application explored through the cycles of the action
research process.” (Waterman et al., 2001).
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This definition does flot specify a particular philosophical perspective, in
order to encompass the variety of approaches in health care action
resea rch.
Action research can be classified according to whether it is more scientific or
empowering in nature (Hart & Bond, 1995). These types can also classified
into the three categories proposed by Habermas: scientific-technical,
practïcal-deliberative, and critïcal-emancipato,y action research (McKernan,
1991). The experimental end of the continuum (like Lewin’s approach) has
the researcher in the role of an external expert who designs the study
(Whyte, 1991), and research components generally dominate action,
improvement is considered as “socially engineered consensus” (Hart et al.,
1996). At the other end of the scale, action components dominate the study,
and there is a more pluralistic view of improvement (Rolfe, 1996; Hart et al.,
1996). A similar classification has been proposed which mentions technical,
practical and critical approaches
Action research is generally reflexive, involving a cycle of
developmentlplanning, implementation, reflection, observation and
evaluation/planning (Schon, 1983; Waterman et al., 2001). Consider for
example co-operative inquiry, a type of action research in which small
groups of professionals who wish to systematically explore and develop their
practice (Reason, 1994; Ebbutt, 1985). This method aftempts to break down
barriers between practitioner and researcher, allowing contribution to the
action that is the subject of the research (Reason, 1988; Rolfe, 1996). Like
in action research in general, there are four major phases in collaborative
inquiry (Reason, 1994):
1) Collaborative determination of study theme
2) Application of ideas and procedures in practice
3) Immersion and new awareness of practice
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It has been suggested that an advantage of this method is that each of
these phases builds different kinds of knowledge (respectively:
prepositional, practical, experiential, and preposïtional; Heron, 1981).
Research findings from action research have a tendency to be practical and
relevant in specific contexts rather than generalizable, but when combined
with other types of research methodology can produce more generalizable
resuits (Gibbings, 1993). Other challenges in this method include the
increased complexity and workload of combining the traditional research
tasks of data collection and analysis with the role of being a change
facilitator (Hart et aI., 1996). However, the overall goal of unraveling the
complex organizational, personal and professional changes required for
practice improvement to provide a map to practitioners of processes
involved and strategies to achieve desired changes (Titchen & Binnie, 1993)
is unquestionably a pertinent, and desirable goal of utmost importance in
today’s society.
Action research is increasingly being used in health seffings (Meyer, 2000)
particularly nursing (Rolfe, 1996), and is appropriate for development of
solutions to improve practice (Meyer, 2000; Hart & Bond, 1995) and close
the theory-practice gap (Webb, 1990), formalizing tacit, expert knowledge
(Schon, 1987), and allowing learning which can lead to long term changes
(Meyer & Bridges, 1998). In the U.K., there are multiple initiatives such as
the NHS Research and Development Strategy, the NHS Center for Reviews
and Dissemination, the Centers for Evidence Based Practice which
emphasize practitioner-based research approaches such as reflexive action
research (Meyer, 2000; Rolfe 1998; Titchen & Binnie, 1993).
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Comparing Action Research to Case Study Research
There is some debate in the literature regarding to what extent these two
similar reseatch methodologies are related. There is no standard definition
of case study research, howevet the following definition compiled from
various sources highlights some key features 0f case study research:
‘A case study examines a phenomenon in its natural setting,
employing multiple methods of data collection to gather information
from one or a few entities (people, groups or organizations). The
boundaries of the phenomenon are not clearly evident at the outset of
the research and no experimental control or manipulation is used.’
(Stone, 1978; Benbasat, 1984; Yin, 1984; Bonoma, 1985; Kaplan,
1985; in Benbasat et al., 1987)
The key factot in this definition which differentiates action research from
case study research is the fact that no experimental control or manipulation
is used. Despite this difference, the research element of action research
projects is similar to a case study, and certain aspects of case study design
and methodology can be applicable to action research projects. However,
some consider that action research may contain ‘cases’ which may be
studied with a case study approach (Davison, 1998), while others consider
action research to be a subset of case study research (Benbasat et al.,
1987; Galiers, 1991). Despite, these differences in opinion, some
differences can be noted between case study research and action research
(Table VII).
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Table Vil: Case Studies Compared to Action Research
Case Studies Action Research
Researcher is observer Researcher is active
participant
Exploratory, explanatory or Prescriptive, intervening
descriptive
Focus on ‘how?’ and ‘why?’ Additional focus on ‘how to?’
May be positivist or interpretivist Usually interpretivist
Source: Davison,1998; adapted from De Vreede, 1995
Despite these various differences, action research can often be presented in
writing in a case study format (Meyer, 2001), and the case study strategy
can support action research in understanding the chain of events, despite
the fact that the research has been a participant and co-producer of these
events. This wilI be particularly important in the consideration of measures
to ensure the validity cf this study, in which some criteria specific to case
study research will be considered along with general criteria for qualitative
research and criteria specific to action research.
CHAPTER IN: METHODS
Research Questions
This project conducted and analyzed the development and implementation
of an innovation and a new organizational structure in the area of
immunization in Canada, using an action research methodology guided by
an integrative analytical framework for knowledge transfer. Firstly, this
aNowed desired changes to be identified, implemented and tested in this
area, which can serve as the basis of further change in the area 0f
immunization in Canada, and eventually guide improvement of coordination
and knowledge transfer in other areas of health care. Secondly, this allowed
examination of an action research methodology to implement innovations
and organizational change. Thirdly, this allowed the development and
testing of an integrative framework for knowledge transfer to guide further
work in this area. Specifically, the five following questions are central to this
thesis:
1. What are the major important criteria in decisions regard ing
immunization programs in Canada, and how can these be
developed into a practical analytical framework to aid knowledge
transfer and decision-making in this area across Canada?
2. Using an action research approach, to what extent can this
framework be tested and implemented in various contexts, and
what is the appreciation of users?
3. What organïzational changes are desirable and feasible in the
area of immunization program planning in Canada?
4. To what extent is the action research approach successful in
implementing changes, integrating various approaches and
generating ideas, and to what extent is the approach potentially
useful in other initiatives in the area of interjurisdictional
coordination and knowledge transfer in health care in Canada?
5. To what extent does the integrative analytical framework based on
work by Kemmis & Mclaggart and Habermas apply to observed
resuits, and to what extent is this theoretical framework potentially
useful in other knowledge transfer initiatives?
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The first three questions specific to immunization in Canada wiIl be
answered directly by data collected and interventions conducted in the
context cf this study, however this is not a final answer as implementation cf
the framework and organizational change are ongoing. The success and
future potential of the action research approach in the area of knowledge
transfer will be evaluated by examining the results obtained by this method
in this intervention. Finally, the integrative framework will be evaluated by
examining to what extent the various elements of this framework were
present in observed results. Overali, the responses te these questions
should be useful in generating practical and theoretical knowledge and
guiding future research and intervention in the area 0f knowledge transfer
and interjurisdictional coordination in health care in Canada.
Research strategy- action research
Overail, this project follows the pattern the form of action research, in which
the starting point is the lived experience of people, in which observation,
analysis, development of new tools and structures and their experimentation
mingle, with the aim to produce knowledge and action directly useful to the
group cf people and leading to empowerment (Reason, 1994). In the spirit
cf generative thinking, design and creation of positive changes (De Bono,
1995), action research goes beyond the traditional boundaries of description
and theory generation about ‘here and now’ to consider and realize,
potentially, ‘what ought to be’. (Waterman et al., 2001).
The intervention chosen for this project was the development cf an
analytical framework for decision-making and knowledge transfer in the area
cf immunization program planning in Canada. Considering that the goal is to
bridge theory and practice while generating useful research, a balance
between sound research and relevant action was sought. An updated
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version of the White & Mathias (1982) model for immunization program
planning was utilized as a starting point for construction of a multi-criteria
framework for systematic evaluation of vaccines for publicly funded
vaccination programs. This model was designed specifically for the
Canadian context and has a broad perspective, considering not only
characteristics of the disease and of the vaccine, but also strategies for
intervention, feasibility, and available evidence for decision-making. This
model is also has the advantage of having been developed in the Canadian
context. Data collection from key persons in immunization in Canada was
then collected to identify additional important criteria which were combined
to forma prototype framework for testing.
This type of research has been used successfully to operationalize a
conceptual framework to improve practice in the area of advanced nursing
(Manley, 1997), so therefore seems to be a logical choice for
implementation 0f this framework. More specifically, the project followed the
structure of co-operative inquiry, as this method is recommended for use
with small groups of professionals (Reason 1994). The use of partïcipatory
action research is proposed to enable study of the social world in a more
encompassing perspective including subjective and objective elements, on
the level of individuals (action) and organizations (structure) (Kemmis &
McTaggart, 2000). This intervention represented an exploratory effort to
integrate these different perspectives, and to contribute to development 0f
more balanced methods of inquiry and intervention. The three levels of
knowledge-constitutive interests proposed by Habermas (1972, 1974)-
technical, practical and critical were also examined in this study to see to
what extent they were related and also to examine their relationship to one
another.
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Elements of a case study approach
This project also has some elements similar to a single case study approach
with embedded units of analysis (Yin, 1994). Strictly speaking, action
research should flot be considered a case study due to the fact that the
researcher has some control over observed events (Yin, 1994), however the
research component of this action-research project can be considered to be
a type of case study. The case examined inciudes ail interventions related to
this project from August 1999 to December 2003, starting from, but not
limited to the development, introduction, testing and impiementation of an
analytical framework for program planning in immunization in Canada. A
major part of the projectlcase is the development of an innovation, as
expected in the original research proposai. However, after developing the
project in collaboration with stakeholders, much of the process involved a
larger examination, discussion, questioning and proposed reform of
C organizationai structures and processes in this area. Therefore, the
appropriate level of analysis (considering the group dynamics involved and
the overall research questions) is the ensemble of activities related to this
project (Yin, 1994). The timeframe for analysis is from the beginning of the
project in August 1999 to include events for which information was availabie
until writing in December of 2003. Multiple levels of analysis were used,
specifically considering interventions on the national and provincial (Québec
) levels. The 12 other provinces and territories can in the long term be
considered as other units of analysis, however they did not receive direct
intervention as in Québec. The indirect exposure to the project from the
federal level was however considered in this analysis.
o
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Selection of context for study and intervention
The context of immunization planning in Canada was selected for many
reasons. Previous experience in this area as well as contact with key
persons in other research projects facilitated identification of current
developments and needs in this area. The increasing demand for timely
evidence to support policy making and the realization that the current
situation is suboptimal were also important in making this an appropriate
context of intervention. The possibility to intervene and study on two major
levels, in Québec and on the federal level with the Iimited resources
available to conduct this study was also an important factor. The challenges
in knowledge transfer and coordination in this area similar to those in other
areas of health care in Canada, such as technology assessment. Finally, the
choice of intervention for this study was also appropriate and timely as it
was chosen for grant support by the NHRDP/CIHR Training Awards
C Program and also by Health Canada in the development of the NationalImmunization Strategy.
Mode! of intervention
The project model as originally conceived had one cycle 0f research and
action, and involved the following major steps (Figure 11):
A: Startup, Preparation, and Formation of Partnerships
B: Development of Prototype Framework
C: Revision and Consensus-Building Process
D: Diffusion of Framework
E: Testing of Framework
o
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Figure 1f: Original Model of Intervention
A B C D E
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Startup: Development Revision Diffusion Testing
Preparation of consensus- of of
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of
partnerships (Delphi Method)
‘I. V
ADOPTION! UTILIZATION
EFFECTS 0f INTCRVENTION
In Phase A, an effort would be made to enroli a maximum of stakeholders in
this project, in the spirit of encouraging ‘sustained interactivity’ as mentioned
by Huberman (1989) and increasing impact of this project. In the spirit of
action research, efforts in this phase changed the nature of the planned
project, had some unexpected results in terms of impact on the decision
making context, and ultimately increased the complexity and interactive
nature of this project and its impacts.
Phase B, which involved the development of the analytical framework,
would use identify criteria from multi-criteria decisional models in the area of
immunization from the literature (White & Mathias, 1981), expert opinion (De
Wals, 1999), and a Canada-wide questionnaire that identified important
criteria in decision-making in immunization. AIl criteria identified would be
grouped into one comprehensive list organized around broad categories,
which would be submiffed to experts for validation.
Phase C would involve revision 0f the developed framework, and a
consensus-building process, preferably in face-to-face meetings. The
proposed approach was the Delphi method (Adler & Ziglio, 1996; Duffield,
1993; Duffleld, 1989; Nadeau, 1988; Sackman, 1975; Weaver, 1971).
Experts would express their opinions on the inclusion of each point, followed
by feedback of resuits until reaching a pre-defïned level of consensus. This
wouJd produce the ‘final’ framework, which would have a structure and
content agreed upon by the group of experts from across Canada.
Phase D would involve diffusion of the framework across Canada via key
persons, presentations in conferences, and an eventual publication.
Phase E would involve testing of the framework wïth vaccines currently
being evaluated, according to the available opportunities.
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r— Because of the action research approach and the formation 0f partnerships
in Phase A, a certain flexibility and iterative approach was expected in the
project. For example, after testing of the framework in Phase E, information
collected could be used to initiate another revision process followed by
diffusion of the revised version of the framework. The flexibility of this
approach allowed the project to benefit from opportunities in the context of
application, and increased the scope and impact 0f the intervention, as will
be seen in later sections. Overall, the five phases of the research project
aimed to contribute to adoption and utilization of the framework and f0
improve the efficiency and quality of planning decisions regarding
immunization planning and ultimately, to increase the effectiveness cf
immunization programs in Canada.
Data Sources
The overali strategy was to collect data from multiple sources over the
C period 0f the study, with feedback to participants in multiple iterations to
validate, update and revise this data. This contributes to the richness and
validity 0f this study (Yin, 1994; Waterman et al., 2001; Silverman, 1993;
Contandriopoulos et al., 1990; Janesick, 2000; Miles & Huberman, 1994;
Meyer, 2001; Guba & Lincoln, 1989; Lessard-Hébert et al., 1994; Murphy et
al.,1998). Data collection occurred from August of 1999 to December of
2003.
Federal/National Level
Multiple sources of data were used in the national component cf this project,
as presented in Table VIII. The fact that this project was part of a much
larger initiative of Health Canada, namely the National lmmunization
Strategy, had an impact on the data collection process. For example, the
data collection was associated with the ongoing consultations between the
federal government and the provincial and territorial jurisdicticns regarding
C possible mechanisms to increase collaboration, a very political prccess.
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Table VIII: Data Sources for Project- Federal Level
Data Source Detaîts
1. List ofChiefMedical Officers of Obtained from the Immunization Subcommittee, Public
Health (CMOH) in 14 Canadian Health
provinces and tenitories Used for questionnaire mailout to identify key persons in
immunization in each jurisdiction Working Group
2. Questionnaire #1: to CMOHs to Sent by e-mail, follow-up by fax if no response.
identii’ key persons
3. Questionnaire #2: to key persons Sent by e-mail, foltotv-up by fax if no response.
identifled in Questionnaire # 1
4. first Consultation with members of Preliminary report was circulated before ISC meeting, Nov
ISC to validate and revise 2000, discussed at meeting, participants were asked to
questionnaire results circulate in their respective jurisdictions for comments and
retum these comments
5. Written Record ofDecisions When available- vas available for November 2000, meeting
following ISC meeting
6. Request for additional information Representatives from eachjurisdiction in the ISC were
on decision-making structures and required to comment on the decision-making process as
processes in eachjurisdiction described in theirjurisdiction in report
7. Second Consultation with members Draft report was circulated before ISC meeting, April 2001,
ofISC to validate and revise discussed at meeting, participants were asked to circulate in
questionnaire 1 results their respective jurisdictions for comments and retum these
comments
8. Questionnaire #3: Goals and Sent out by Health Canada to each jurisdiction via
objectives for immunization representatives ofthe Immunization Subcommittee,
programs
9. Consultation regarding Goals and Preliminary report tvas circulated before ISC meeting, April
Objectives for Immunization 2001, discussed at meeting, participants were asked to
circulate in their respective jurisdictions for commenta and
retum these comments
10. Worksheet to compare candidate Utilized in ISC meeting, feb 2002 to compare expert
immunization programs- federal level evaluations of candidate programs. Administered as part of
the meeting to test the framework and new national
immunization committee
11. Questionnaire 44: follow-up on use Questionnaire to examine awareness and use offramework in
offramework aIl jurisdictions.
12. General: notes ftom meetings and Various informaI notes for verbal or otherwise undocumented
telephone conferences data.
The elements 0f the data collection process indicated in Table —5 can now
be considered individually (resuits wilI be presented in later sections 0f this
report):
1) ListofChiefMedical Officers ofHealth: Item #1 was simply a Iist 0f
the Chief Medical Officers of Health from each jurisdiction to identify
individuals who would receive the first questionnaire. The names and
addresses 0f the Chief Medical Officers of Health were obtained for
Canada’s 13 provinces and territories from the Subcommiffee on
lmmunizatïon of the Public Health Working Group.
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2) Questionnaire #1 to identify key persons: This initial
questionnaire (#1) was administered to CMOHs of individual jurisdictions
to identify key persons in immunization in their jurisdiction. CMOHs
identified in (1) were then contacted by e-mail with a cover leffer inviting
them to complete a short questionnaire requesting that they identify key
persons having an advisory role to their government in decisions
regarding publicly funded immunization programs (see Questionnaire #1,
Appendix 1). If no tesponse was received withïn a week, the
questionnaire was sent by fax. If no response was received after another
week, individuals were contacted by telephone. The list of key persons
identified was distributed to members of the Immunization
Subcommittee, and certain changes and additions were made in terms
of persons to be contacted. The resulting Iist of key persons in
immunization across Canada would be used in the next steps of data
collection (Appendix 3)
3) Questionnaire #2 for key persons in immunization:
This questionnaire was sent out to the key scientific and public health
experts involved in the planning of immunization programs across
Canada identified in (2), using the same process for mailout and follow
up of non-responders as in (2). This questionnaire (Appendix 3) collected
a wide range of information from key persons on immunization planning
in their jurisdiction. Firstly, key persons were asked to identify goals and
objectives for immunization programs in their jurisdiction, structures and
processes for decision-making in immunization, and whether a
framework was used for decision-making in their jurisdiction. They were
also asked to identify their general role in immunization program
planning, and their specific role in immunization program planning for
recent programs (such as measles 2’ dose, varicella, pneumococcal
C polysaccharide programs, pneumococcal conjugate vaccine or other
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programs). The names of other key persons in their jurisdiction were also
requested. Responders were asked to identify important criteria in recent
decisions to identify appropriate criteria for the analytical framework.
Finally, key persons were asked what criteria should be included in an
analytical framework, what type of framework would be most helpful,
what the major needs and problems in immunization program planning
were in their jurisdiction, and finally what decision-making structures and
processes should be in place to facilitate immunization program planning
in Canada. Preliminary resuits of this questionnaire would be presented
in a report and summarized in a presentation to members of the
Immunization Subcommittee in November, 2000 for validation and
following revision.
4) First consultation with ISC members to validate questionnaire
results: This first consultation with members of the ISC was another
data source, as the preliminary report was circulated to each jurisdiction
for corrections, revisions and comments, and then returned to the
researchers for integration in the report. Some comments were given in
person at the meeting, and additional comments were sent to the
researchers by e-mail or fax.
5) Wriften Record of Decisions, November 2000 ISC meeting:
The written record of decisions document for this meeting simply was
a record of details of this meeting (Append ix 14). This type of document
was rarely available for meetings conducted during this project.
6) Additional Data Collection on decision-making structures and
processes: lt was agreed in the ISC meeting that the
researchers should contact individuals from each jurisdiction to collect
more information on decision-making structures and processes in their
jurisdiction. Therefore, the information on each jurisdiction was sent to a
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representative from the ISC for each jurisdiction, who either responded
personally to add more detail to the information, referred the request to
another individual in their jurisdiction, or completed the information in
collaboration with colleagues in their jurisdiction. This information was
used to add more detail and revise the information on this section
(Appendix 4).
7) Second consultation with ISC members to validate and revise
questionnaire resuits and report: After completion of the
report, the updated version was presented to the ISC in April 2001 for
another round of consultations, using the same process as in (4). This
allowed further completion, updating and revision of data in the report.
8) Questionnaire #3 on Goals and Objectives for immunization
programs: At the request of Health Canada, and additional
C questionnaire was developed to collect detailed information on goals and
objectives for aIl publicly funded immunization programs in Canadian
jurisdictions. This questionnaire (Appendix 5) was developed and pre
tested with two experts in immunization. It was sent out by Health
Canada to representatives designated by the ISC. Health Canada also
ensured follow-up and that ail jurisdictions responded.
9) Consultation with ISC regarding Goals and Objectives Report:
A preliminary report was circulated to ISC members before the April
2001 meeting, in which a summary of resuits was presented. As in (3),
(4) and (7), this consultation allowed the collection of additional data, and
the updating and revision of the report.
10) Worksheet to compare candidate programs- federal level:
This worksheet (Appendix 6) was used to structure an activity on
(j evaluation and discussion of potentiai new programs with the ISC in
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present at the meeting after presentations by experts on the three
potential programs (meningococcal conjugate, pneumococcal conjugate,
and varicella) structured around the 8 categories of the analytical
framework. They were asked to indicate a response on a five-level Likert
scale as to their appreciation of the desirability of each candidate
program. Resuits of this exercise were summarized and presented to
participants the next day of the meeting for discussion. Participants then
divided into two breakout groups, and discussed the potentiai usefulness
and applications of the framework, and aiso recommendations regarding
structures and processes for immunization program planning in Canada
to submit to the Advisory Commiffee on Population Health.
11) Questionnaire #4- Foliow-up on use of framework: A follow
up questionnaire was sent out nationally to re-examine knowledge and
use of the framework (Appendix 9). The SARS crisis occurred at the
same time as the questionnaire, which interfered with data collection.
However it was decided to distribute the questionnaire despite this major
factor that was expected to reduce the response rate.
12) General- notes from meetings and teiephone conferences
Finaliy, several informai notes were used to compiete data which was
not necessarily noted in wriffen materials from meetings. This could
involve the conclusions of discussions, proposais, etc, and served to
validate the other formai data collection sources. The variety of notes
and informai observation from participation in meetings, telephone
conferences which were used are not ail summarized in this thesis, and
serve to confirm certain details of the various discussions on key issues
during this process. They confirm certain events that do not have a
written record elsewhere. One exampie was the proposai to use the
framework in a National Consensus Conference on Pertussis heid in
May 2002 (NACI, 2003). Another exampie is the reaction of the National
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Advisory Commiffee on Immunization to a presentation on potentiai uses
of the framework in October- 2003. Verbaily in this meeting, the
members agreed to consider an expanded role for NACI in considering
program considerations and working with the new Canadian
Immunization Commiffee (CIC), testing the analytical framework for
evaluation of potentiai new immunization programs. However, this did
not imply any officiai changes in the mandate of NACI (yet), and these
comments were expressed in anticipation of resuits of a meeting of
experts to brainstorm options for NAÇI and the CIC in October 2003,
followed by the inaugural meeting of the CIC in November 2003.
The structure of the contract with Health Canada facilitated the verification
and validation of data collected in an iterative process which involved
submission of preliminary reports, followed by distribution to ail members 0f
the ISC representing the 13 Canadian jurisdictions. Multiple face-to-face
meetings of the ISC were preceded by distribution of reports. During the
meetings, presentations were given to summarize resuits. 1SC members
were then invited to in turn circulate the results in their own jurisdictions, and
return comments afterwards. This iterative, consensus-building process
encouraged input from ail jurisdictions and multiple occasions to validate,
update, correct and revise data, legitimizing and greatly facilitating the data
collection for this project.
Members of the Immunization Subcommiffee were also involved in
completing ànd validating additional information on decision-making
structures and processes in their jurisdiction for submission in the report
submitted in April 2001. In addition, they were responsible for completing or
coordinating the responses to the additional questionnaire on goals and
objectives for immunization programs for their respective jurisdictions.
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Provincial Level- Quebec
Like the intervention on the federal level, multiple sources and types 0f
information were used during the interventions in the province of Quebec
related to this project. While the steps of the intervention were less
systematic than in the research contract with Health Canada, similar
instruments were used, and in addition, two working group reports have
been published, providing concrete examples of adoption of the analytical
framework. These various sources are présented in Table IX.
Table IX: Data Sources for Project- Province of Quebec
1. Worksheet to compare Utilized in CIQ meeting, March 2003 to compare expert
candidate immunization evaluations of candidate programs
programs- provincial level- Administered as part ofthe meeting to test the framework
Quebec for use in the CIQ to ail meeting participants. Similar to
federal worksheet
2. Follow-up questionnaire to Utilized in CIQ meeting, March 2003 to compare expert
evaluate framework and evaluations of candidate programs
related activities
3. Publication: report on Framework was used to structure report Published on
meningococcal conjugate website ofthe 1NSPQ
vaccine
4. Participation in meetings Presentation of framework to group followed by discussions
ofPneumococcal conjugate ofpotential use in report.
vaccine working group
5. Publication: report on Framework was used to structure report. Published on
pneumococcal conjugate website ofthe JNSPQ
vaccine
6. General: notes from
meetings and telephone
conferences
(1) Worksheet on vaccine evaluation
As on the federal level, this sheet involved an pilot exercise to test the
framework in Match 2003. This instrument had been tested in the federal
context, and revised to include 13 instead of 8 categories following
comments, and was also translated into French. At the request of the CIQ,
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a fourth potential program was added to the actïvity (acellular pertussis
vaccïne for adults and adolescents). The worksheet was pre-tested for the
adequacy of the translation and readability with an expert (PDW). The
worksheet and questionnaire used in the Quebec meeting is presented in
Appendix 12 and Appendix 15.
As in the activity in the federal meeting, this unvalïdated, subjective
instrument was administered primarily an educational activity to demonstrate
potential uses of the framework and stimulate discussion among experts.
This was followed by a questionnaire, which aimed to evaluate the activity,
and guide further uses of this framework with the CIQ and elsewhere.
(2) Follow-up questionnaire on use of framework
This tool (Appendix 13) was administered to gauge the appreciation of
members of the CIQ of the activity with the framework in the meeting and
their opinions on potential future uses. Like the activity, this information was
collected to allow participants to voice their opinions about the specific
activity and about methods for immunization program planning in general in
Québec, and therefore have an impact on future uses of the framework.
(3), (4),(5) Publications and participation in vaccine-specific working
groups
The reports published by the INSPQ on the pertinence of immunization
programs in Québec using the meningococcal conjugate vaccine (De WaIs
et al., 2003) the pneumococcal conjugate vaccine (Guay et al., 2003), and
the acellular pertussis vaccine (De Serres et al., in press) are important
sources of data as they represent a concrete result of use of the framework
resulting from multiple presentations to the CIQ and sometimes to individual
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working groups to promote use of the framework. The concrete result is
seen in the structure of these reports. For the meningococcal and pertussis
working groups, approval to use the framework was obtained by proposing
this use in general CIQ meetings. For the pneumococcal conjugate vaccine
working group, a presentation was given during one of their meetings
followed by discussion of use of the framework to structure the report of this
working group. -
6. General: notes from telephone conferences and meetings
Notes from various meetings during this process were used to complete
informàtion on pertinent events in the project in Quebec. For example, in
November, 2003, a meeting was held at AETMIS to discuss possible
partnerships for evaluation of potential hepatitis A and B programs in
Quebec between AETMIS, the INSPQ, and the CIQ. It was also proposed to
examine the possibility of a national coordinated effort (for example in the
economic evaluation of potential programs) with the Canadian lmmunization
Committee, NACI and Health Canada in 2004.
Sampling Strategy- Quebec
The sampling strategy included those present at meetings of the CIQ during
the multiple presentations and the activity using the framework. This ïs an
appropriate sample in Quebec as the CIQ is the expert group mandated to
examine scientific issues and make policy recommendations related to
immunization in this province. The framework was applied to three
irnmunization programs for which working groups made reports: the
pneumococcal conjugate vaccine group, the meningococcal conjugate
vaccine working group, and the pertussis vaccine workïng group.
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Strategies for Data Collection: Sampling, Validation, Revision and -
Triangulation of Data
Federal Level
Wfthin available time and resources, every effort was made to ensure that
data collected was accurate, and that it represented the community of
scientific experts across Canada having a roie in the policy process for
publicly funded immunization programs. The iterative and systematic
process in which data was collected,. summarized and presented to
representatives from ail jurisdictions allowed for the accurateness of factual
data to be verifled, and for data to be updated if necessary. This extensive
feedback to stakehoiders was a definite strength 0f data collection in thïs
part of the study. This was a form 0f trianguiation in that data coiiected from
a jurisdiction was presented to iSC members who couid then confirm this
data in their jurisdiction. This also helped to compiete missing data because
of non-response or poor response rates. For exampie, the ISC mem ber from
the Yukon was abie to provide information on decision-making structures
and processes in that jurisdiction foiiowing this request at an ISC meeting.
For data collection and identification of key persons, it was deemed
appropriate to follow the hierarchy or ‘chain 0f command’ in identifying key
persons for the questionnaire. This was firstly to increase awareness 0f the
project and involvement by CMOHs 0f provinces and territories, and
secondiy to avoid potential problems if experts in a given region participated
in the project by compieting the questionnaire wïthout the knowiedge of the
CMOH. This was admiftedly subjective and produced a variety of responses
according to each region. There is potentialiy a bias according to the length
of time that a CMOH has been in their jurisdiction, with newer CMOHs
having less experience perhaps. In the Yukon, the identified CMOH was
absent initiaiiy, and there was question of a change of staff for this position,
therefore, key persons couid not be identified for this jurisdiction, causing
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therefore, key persons could flot be identified for this jurisdiction, causing
resuits for this step to be incomplete.
After key persons were contacted, some regions had a coordinated
response, however there were no details on the nature or extent of this
coordination. Therefore, we can assume that each jurisdiction used its own
method in compiling the responses. Also, in some regions, large groups of
individuals on provincial advisory commiffees on communicable diseases
(flot necessarily experts in immunization) were contacted, with only few
responding, before a coordinated response was given (Alberta and Ontario,
for example). When regions had one responder to the questionnaire, it was
unclear to what extent responses accurately represented a summary of the
responses for that jurisdiction.
Overail, the impacts of the subjectivity of the choices of responders for this
C questionnaire and the non-response rate are minimized by two factors:
Firstly, the multiple opportunities to validate, revise, and update the
information in the questionnaire by multiple steps of presentation of the
resuits to the ISC followed by circulation and comments on revisions, which
allowed for the information in the questionnaire to be completed, and
revised where necessary.
The second factor which minimizes the impact of this potentially biased
group of responders is the nature of the data collected. Much of the data
was qualitative in nature, and served to explore the diversity of possible
responses, such as the section on criteria for decision-making. Other
sections asked for factual information on each jurisdiction, which was later
verified. Finally, other sections asked for personal opinions on mechanisms
to improve immunization program planning. While more responders would
provide potentially more diversity of ideas, in general the amount of
questionnaires received was adequate in generating a large variety of
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considering to what extent they were validated and revised, and aiso the
potential impacts in sampling or other biases. These points will be examined
in the discussion section 0f thïs report.
Finally, when Questionnaire #4 was to be administered, the SARS crisis was
occurring across Canada. This caused public health authorities involved with
infectious disease to be very busy with either outbreak management or
preventive measures. Despite this problem, the questionnaires were
distributed with the hopes of obtaining at Ieast partial responses, considering
that the additional, while incomplete, information obtained in this manner
would be preferable to no information at ail. Taking into account the
previous response rates to other questionnaires, contributions by
participation the ISC from each jurisdiction, and the success of grouped
responses, the individuai from each jurisdiction considered as being most
likely to be able to respond for was selected each jurisdiction to receive this
questionnaire.
Meeting Notes, informaI observation, participation in meetings,
discussions
The validity of these observations is not a problem if they are interpreted
appropriately. This is often limited to the reporting of events, opinions or
concerns at a specific meeting or data. This type of informai observation
increases the validity 0f the project by adding additionai data sources,
enabling triangulation with othet data sources, and enabling relevant events
to be included which are not necessarily documented elsewhere. InformaI
events are often important in the political arena, however, much discussion
is of a sensitive nature and is flot diffused in the public arena. This often
leaves the analyst with a ‘black box’ in terms of processes of decision
making, in which only some of the inputs and outputs are known. An
example is the functioning of the ACPH and its submissions to the
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Conference of Deputy Ministers, which lead to the approval of $45 million for
the Natïonal Immunization Strategy over the next five years. This is a very
important decision which had much impact on the establishment of the CIC
and the advancement of the project, but no information on how this decision
was taken is available for further analysis.
Project in Quebec
For data collection in Quebec, one major event was the activity using the
analytical framework to examine four potential programs. The goal of this
activity was to test the framework and to examine methods for the CIQ to
arrive at a consensus on the order of introduction of new immunization
programs in Quebec in the next few years. Part of this data collection was
designed to compare the degree of consensus and divergence among CIQ
members regarding various potential programs. However, this data involved
evaluation of vaccines according to subjective criteria. Therefore, members
could interpret each question differently, which could add artificially to
observed variation. However, despite the difference in the amount of time
reserved for this activity, and the number of vaccines considered. (4 in
Quebec versus 3 in the federal meeting), similar response distributions were
observed. The importance in blases due to interpretation of questions is
reduced by the fact that responses were simply used in an exploratory
nature and as a starting point to guide discussion. Should further exercises
be desired, with more formai outputs, they should be accompanied by a
more formalized process followed by ample time for clarification, revision
and discussion both of the tools used derived from the framework and the
resulting recommendations regardïng priorities for individual immunization
programs. Repetition of similar exercises with the framework would enable
this process to be further refined and evaluated.
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Concerning the foliow-up questionnaire, the goal was simply to examine the
appreciation cf CIQ members for the activity using the framework and to
collect their opinions regarding future uses cf this tool and other
improvements to the process cf evaluation and planning cf immunization
programs in Quebec. A summary cf general responses was returned to the
CIQ for further discussion, therefore this instrument also served to furiher
discussion and reflection regarding improvement cf existing decision-making
structures and processes in the CIQ. Potential biases couid occur if a single
member of the CIQ having a radically different opinion than other members
was absent, or if members gave ‘politically desirable’ responses due te their
knowledge that the president of the CIQ was a promoter cf use of the
framework. Despite these concerns, comments from this questionnaire were
combined with comments from other uses cf the framework in the CIQ
working groups te examine similarities and differences. The reports
published to date for meningococcal conjugate vaccine and pneumococcal
conjugate vaccine programs in Quebec represent concrete examples cf
adaptation cf the framework (as seen by the sections used to structure
these reports), Therefore validity or triangulation are not concerns for these
concrete, verifiable events.
This study can be considered to be exploratory in that it aims to examine the
process of deveiopment and implementation cf an innovation, and develop
new ways of conceiving knowledge transfer approaches, combining existing
theories, and developing new ones. There is aise a certain expianatory
element in that the contribution cf an action-research approach te adoption
of an innovation, and the applicability of the integrative model based on the
adaptation cf work by Burreli & Morgan (1979) and Habermas (1972;1974)
by Kemmis & McTaggart (2000) are examined. The model for policy-making
in public health proposed by Richmond & Kctelchuck (1983) is also
examined in this context.
CHAPTER IV: ACTUAL INTERVENTION & RESULTS
In the presentation of the results of this study, we must consider the specific
context of action research, which includes flot only observation but planning
and implementation of concrete changes over the course of a study, in
partnership wïth participants. Some elements 0f the methods, data collection
and intervention can be specified in advance, however they must be
modified to respond to constraints and opportunities during the project in a
sequence of events which is not known in advance, and is only under partial
control of the researcher.
Phase A: Preparation and formatïon of partnershïps
In September, 1999, letters were written to authorities at Health Canada and
in the Quebec Ministry of Health to seek partnerships and support for this
project. This Ied to collaborative project with a formai contract on the
national level with Health Canada, and an informai agreement to work with
the comité dimmunisation du Québec on the level of the province of Quebec
(Figure 12).
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Figure 12: Actual Phase A- Project Startup and Formation of Partnerships
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Provincial Level- Québec
In Québec, a letter was addressed to Dr Richard Massé, the Associate
Deputy Minister of Heaith and Social Services to propose the development
of an analytical framework for systematic evaluation cf vaccines in Québec.
A favorable response was received in a letter written in November 1999
which mentioned a possible collaboration with the Institut national de santé
publique du Québec (INSPQ) and the Agence d’évaluation des technologies
et des modes d’intervention en santé du Québec (AETMIS). Despite this
favorable response, no formai contract or project was established, however
several activities were conducted on an ad hoc basis with the Comité
d’immunisation du Québec (CIQ). This commiffee was established in 1990
to give scientific advice on the use of vaccines and implementation of
immunization programs to the Québec Ministry of Heaith and heaith
professionals. This committee served as an experimental ground for testing
the framework, starting in 1999. Severai presentations were given on the
framework and the possible prioritization excercises which couid be
conducted in the CIQ meetings in 2001-2002.
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Federal Level- Health Canada
On the federal level, Dr Arlene King, Director of the Division of Immunization
of Health Canada was contacted by letter proposing the development of an
analytical framework for immunization program planning in Canada. After
several telephone conferences, discussions, and meetings, an iterative
project was proposed to develop the analytica) framework. The proposed
project for developing the framework was grouped into the following phases:
Phase I: Formation of partnerships with Health Canada and
provincial authorities to obtain approval and facilitate the project
(already begun). In collaboration with provincial and territorial
governmental authorities responsible for immunization program
policy, identification of scientific experts having an advisory role in the
policy-making process.
Q Phase Il: study of the vaccine evaluation process by scientific expertsin Canadian provinces & territories to identify criteria important in this
process and variation between provinces/territories and individuals.
Phase III: Consensus-building process to adapt the important
factors identified in part (2) into a prototype framework for Canadian
immunization program planning.
Phase IV: Completion of the framework developed in step (3)
followed by distribution to potential users in Canadian provinces and
territories for use in planning programs for this vaccine.
Phase V: Testing of the framework developed in step (3) in a
national context. Revision.
These proposed phases, following the structure of action research, are
illustrated in Figure 13.
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Figure 13: Research Strategy as presented to Health Canada
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information regarding lll:Adaptaon and updatir9 of
useomevork, existing framevork
V: Ilemeation & te1 M Appliœtion offmeto
offtamerkin
candidaievaccfre&immunïfion prcram distiibution to pontial usersplanning
Specific Research Questions for Contract
1. Who are the scientific experts who give advice to provincial poiicy makers
in the area of immunization programs?
2. According a sampie cf identified scientific experts involved in the
decision-making process for Canadian immunization programs (at the
provincial and territorial leveis):
a) What were the major events and considerations in the policy
making process for recent immunization programs?
b) How do these criteria compare to those presented in the White
and Mathias model and what are ail of the important criteria
identified?
c) What is the usefulness of this framework, and in generai, what
should be done to faciiitate evaiuation of candidate vaccines for
pubiiciy funded immunization programs in Canada? How can the
framework be improved and how should it best be used?
3. What is the usefuiness of this analyticai framework, and to what extent
has it been diffused and used across Canada? What is the appreciation
cf this approach?
4. What iessons can we Iearn from this exercise about deveioping and
impiementing anaiyticai frameworks for decision-making?
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Additional Questions (added to contract):
In addition, another aspect was added foliowing negotiations with Heaith
Canada and members 0f the Subcommiftee on Immunization. This invoived
adding study and evaluation 0f structures and processes for decision
making in immunization in Canada to the project, and would have a major
impact on further developments and impact of the project, as will be
illustrated in the following sections.
5. What are the formai and informai structures for evaluating vaccines for
potential pubiicly funded vaccination programs in Canadian provinces and
territories?
6. What other changes in structures and processes would be feasible and
beneficiai to improve immunization program planning in Canada?
Details of Contract with Health Canada
After several discussions, meetings and telephone conferences, an officiai
contract was agreed upon, with the following objectives:
a) ‘Describe the decision-making structures, processes and
frameworks perlaining to publiciy funded immunization programs
in Canada; and
b) recommend a prototype framework, structures(s) and
process(es) to improve the coordination /harmonization of
publicly funded federal/provincial/ territorial immunization
programs.
This project was to be conducted in collaboration with the Subcommittee on
Immunization of the National Advisory Commiffee on Population Heaith, co
chaired by Dr. Arlene King of Heaith Canada, and Dr André Corriveau,
Ministry of Heaith, Northwest Territories. Project deliverabies were interim
and final research reports as weii as presentations at meetings of the
National Subcommittee on Immunization of the Public Heaith Working
Group, (which responds to the Advisory Commiffee on Population Health).
The contract followed the five proposed phases in the project (Table X)
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Table X: Phases in Project With Health Canada, (JuIy 2000)
Project Deliverable Date
Phase
Development of Project Outiine Description Match 2000
Detailed research protocol development April 2000
30 page report
iii i. interview study participants September 2000
ii. prepate 1st draft of report on curtent
ftameworks and decision making
structures and processes in place in
Canada, identification of similarities
and differences in these and
recommendations
iii. submit 1st draft reportto co-chairs for October 31, 2000
comments
iv. Subrnit 2 draft report and present to November 14, 2000
Immunization Sub-Committee fISC)
meeting in Toronto
y. Submit 3rd draft report (which includes November 24 2000
input from ISC)
IV i. Distribute 3td draft report to study November 2000
participants to obtain input
ii. Prepare 4th draft report which includes December 15, 2000
input from study participants
iii. Distribute 4th draft report to study December 20, 2000
participants to obtain views on others
comments
iv. Prepare and submit 5th draft report to January 31, 2001
co-chairs
y. Submit 6th draft (which includes co
chairs and ISC input)
V i. Prepare and submit final draft report to Match 2001
co-chairs on testing of prototype
framework
ii. Prepare and submit final report to co- End April 2001
chairs
iii. Presentation to ISC of final report
This formai contract was important to the success of the project as it gave
structure and legitimacy to the project and integrated it into federai efforts
related to the development of the National immunization Strategy. An
additional contract was added iater to examine goais and objective for
immunization in Canada, another of the five components of the Nationai
immunization Strategy (Table Xi). This component of the project addresses
many of the same issues of structures and processes for national
coordination of immunization programs.
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Table Xl: Phases in 2nd contract with Health Canada- Goals and Objectives for lmmunzation
Programs
Project Deliverable Date
Phase
i î. Report of current information on goals September 2001
and objectives for immunization
programs in Canada
ii. Development of a questionnaire on October 2001
goals and objectives for Canadian
provinces and territories
Il I. Distribution of questionnaire
ii. Analysis of resuits
iii. Submission 0f report to NIS directors November 22. 2001
iv. Revision of report
y. Submission of final report December 2001
Other phases of Actual Intervention- National Level
Overali, the aCtual intervention on the national level can be summarized in
the following figure (Figure 14).
Figure 14: Actual Intervention on National Level
Winter 2000 Summer- Nov 2000, Summer / Feb 2002 FaII-Winter 2004
______________
Fait 2000 April 2001 faIt 2001 2003 projected
Confract with
Heaith Canada:
Structures & Proposai
Processes 0f new
for Presentation —> Structure —* Adoption Potential co
immunization Data 0f New national Pilot testing offramework ordinated
Program collection Resuits, inununization of by NACI, interventions
Planning via Report, committee framework Emergence of with new
in Canada questionnaire Prototype and new potential
fiumework (- new committee programs:
(Additiona]
________________
national (CIC),
Data Discussion inununization first meeting, i.e. Hepatitis
Development of collection) Revision Proposai commiflee development A & B
Matytical — — To use —* of
framework frametvork terms
of
reference,
etc...
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Data Collection
The next phase was conducted with the intention of collecting data on real
decisions for publicly funded immunization programs directly from key
persons involved in the 13 Canadian jurisdictions. However, after discussion
with collaborators at Health Canada from the outset, it was stated in the
questionnaire that in addition to the analytical framework, the aim was to
create structures and processes to facilitate immunization program planning
in Canada, a significant broadening of the goals of the project. Participants
were aware that this project was being conducted as part of the
development of the National lmmunization Strategy. In addition to the
sections of the questionnaire designed to collect data for development of the
framework, other information was collected on structures and processes for
decision-making in each jurisdiction, goals and objectives for immunization
programs, needs and problems in immunization program planning, and
proposed frameworks, decision-making structures and processes should be
in place. This data collection step was identified as the first step of an
iterative process, including a consensus-building process.
Resu Its
As described in the section on data sources, key individuals were identified
in each jurisdiction by the CMOH of that region in Questionnaire #1. A total
of 75 individuals were identified (Table XII). Response rate for this step was
13/14 jurisdictions. In the Yukon, there was originally no response due to the
absence of the CMOH, afterwards there seemed to be some uncertainty
about a personnel change in this jurisdiction. Therefore no information on
scientific experts was obtained for the Yukon. However, participants in the
Immunization Subcommiftee from the Yukon at a later date would receive
the preliminary reports at multiple steps and had an opportunity to complete
and validate the data.
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Table XII: Number of Scientific Experts in Immunization identified by Chïef Medical Officers in
Canadian Jurisdictions
Jurisdictïon # of scientific experts comments
identified by CMOHs
Newfoundland (NF) $
Nova Scotia (NS) 2
New Brunswick (NE) 5
Prince Edward Island 2
(PE1)
Quebec (QC) 6
Ontario (ON) 19 The entfre Advisory Committee on
Communicable Disease was
designated
Manitoba (MN) 1 One expert designated to respond to
questionnaire
Saskatchewan (SK) 7
Alberta (AB) 13
British Columbia (BC) 6
Ynkon YT) O No response due to absence ofCMOH
Northwest Territories 5
(NWT)
Nunavut (NV) 1 The CMOH was the only expert
identifled
TOTAL 75
It is already evident that there is a large degree of diversity between
jurisdictions in terms of the number of scientific experts available to
influence policy decisions on publicly funded immunization programs. This
diversity was illustrated further in responses to the second questionnaire,
addressed to the key persons identified in these jurisdictions. The key
individuals identified by CMOHs in Questionnaire #1 were then sent a
detailed questionnaire (#2, Appendix 3) to collect data on varlous aspects of
immunïzation program planning in their jurisdiction. The responses from
various jurisdïctions are summarized in Table XIII.
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Table XIII: Summary of Response Pafterns to Questionnaire #2 by Jurisdiction
Jurisdiction Number Number Response rate Coordinated comments
originally sent responding response?
questionnaire
Nf 8 4 4/8 No Mailout included
regional CMOHs
NS 4 2 NIa Some Questionnaire vas
directed to 3 experts not
mentioned in
_______________
guestionnaire#1.
NB 5 1 NIA Yes One person designated
to respond for NB
PEI 1 1 N/A Yes CMOH responded
QC 6 3 3/6 No
ON 19 7 N/A Yes, afier mass Aller partial response,
mailout to ACCD chair ofACCD gave co
.
members ordinated response
MN 1 1 N/A Yes One person designated
to respond for MN
SK 7 2 2/7
AB 12 1 N/a Yes One person designated
to respond for AB
BC 6 1 N/a Yes One person designated
to respond for BC
YT O O No response from
CMOH
NWT 5 1 1/5
NV 1 (1) N/A e-mail response from
CMOH
Total 75 24 including 10/26 individuais, 8/8 grouped
6 group responses per jurisdiction
responses
A total of 24 questionnaires were received. Ail provinces and territories
except for the Yukon were represented. As the questionnaire was sent out
by e-mail to the entire group of experts identified in each jurisdiction, there
was some discussion and exchange foilowing the original e-mail between
the experts regarding who should respond. Some individuais asked for
clarification of the origin and goals of the project before responding. Some
provinces ciearly designated an individual to combine responses for key
persons in their region (Manitoba, New Brunswick, Alberta, British
Columbia). Some non-responders commented that they did not feel qualified
to respond and therefore would let other experts in their jurisdiction
complete the questionnaire. Overall there was awareness of the potentially
100
political nature of this questionnaire, originating from a project with Health
Canada and aiming to promote national coordination, which seemed to be a
factor in discussions within jurisdictions regarding who should respond.
Therefore the response rate reflects the decision of several jurisdictions to
group their responses. While this left the method of aggregating responses
for each jurisdiction beyond control of researchers (and thus subject to
variation), it facilitated responses from these jurisdictions. Responses were
also partial when questionnaires were sent ‘at large’ to ail key persons or
communicable disease committee members identified in a given jurisdiction.
There was a certain ‘self-seiection’ in which individuals replied that they did
not feei quaiified to respond to the questionnaire (or certain sections).
Fortunately, this questionnaire was only the first step in a long iterative
process of data collection and consultation which served to validate, update
and refine the information collected.
C
Summary of Responses to Questionnaire #2
The following sections summarize responses to sections of this
questionnaire which was administered to key persons in immunization
across Canada.
1. Goals and objectives for immunization programs in Canada
The responses indicated that there was much diversity on goals and
objectives for immunization programs in the various jurisdictions (Figure 19).
C
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Figure 15: Examples of Goals and Objectives for Immunization programs in Canada ldentified
in Questionnaire #1
Nova Scotia and Ontario have detailed goals for immunization. These include many
diseases (tetanus, measles, rubella, Hib, diplitheria,
...) and various objectives regarding
continuing absence ofindigenous diseases, elimination of certain diseases by specific dates,
and increase of vaccine coverage in target groups.
In Ontario, annual targets have been developed for some vaccines (i.e. influenza).
Nova Scotia mentioned that in 1996 these goals were developed for each publïcly funded
vaccine developed based on national targets.
New Brunswick: coverage goals for routine childhood immunizations were 95% coverage at
2 years, 99.5% coverage at school entry, 100% at school leaving. The target value for
influenza vaccine uptake is 80% in identified target groups.
Alberta : The following targets are mentioned in the Alberta provincial Business Plan. 4.
Percentage of 2 year old children who have received the recommended immunizations:
Target (2002): 97% (diphtheria, pertussis, tetanus, haemophulus influenza b, polio)
Target (2002): 98% (measles, mumps, and rubella).
Saskatchewan: none in Saskatchewan Immunization Manual. However, immunization group
within Public Health Services Project is working on possible goals.
Newfoundland: Strategy 5 to provide immunization programs to generat public vas
mentioned, but does not appear to include specific coverage targets.
Québec: Coverage objectives exist in the Priorities Nationales de Santé Publique, and there
are specific objectives for certain programs such as hepatitis B vaccination in schools and
influenza programs.
While there was some impact of federal goals introduced in 1995, most
jurisdictions had few resources to monitor attainment of goals, or to develop
new ones. Due to the tact that goals and objectives for immunization
programs was one important component of the National Immunization
Strategy, this data collection in Questionnaire #2 was followed up by a
specific questionnaire on Goals & Objectives (Questionnaire #3, Appendix
5).
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2. Structures and Processes for Planning of Publicly Funded
Immunization Programs
Overail, we can note three major elements in structures and processes for
immunization program planning in Canada (Figure 16). There is a scientific
advisory element, which transfers information to a public health authority.
Thïs public health authority advises in turn the Ministry of Health on the
potential program.
Figure 16: Common Overali Structure and Process far Immunization Program Planning in
Canadian Jurisdictions
Scientific Advjce /recommendation Public Advice /recommendation Ministry of
Advisory Health Health
Body authority
i.e:
Immunization i.e.:
Committee CMOH
Despite these common overail elements, there is significant variation in the
structures and processes for immunization planning in different Canadian
provinces and territories. The degree of formalization of the scientific
advisory bodies and the processes by which they advise the public health
authorities are quite variable. Some jurisdictions have formaI lmmunization
Committees (such as Quebec), and working groups on specific
immunïzation programs, whereas others have only Communicable Disease
Commiffees, which are responsible for much more than simply
immunization. Understandably, certain jurisdictions have much smaller
populations and fewer resources and personnel for this planning process.
Consider for example Prince Edward Island, where process can be limited to
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the Communicable Disease Nurse and the CMOH examining available
literature and discussïng options to be submifted to the Ministry of Health.
The type of advisory given can vary from written reports to simply informai
discussions according to the individual jurisdiction. Considering the vast
differences in population and resources available to each province and
territory, it is flot surprising that these structures and processes vary. Some
examples are presented in Figure 17.
Figure 17: Examples of Structures and Processes for Immunization Program Planning in
Canadian Jurisdictions from Questionnaire #2
Ontario:
-
Mînistry ofhealth staff receives advice regarding publicly-funded vaccine programs ftom the Advisoiy Committee
on Communicable Diseases (ACCD), the Canadian pediatric society, NACI, working groups with Ministry. The ACCD has an
Immunization Working Group.. Sometimes working group or subcommittee is created for a vaccine to make recommendations
(i.e regarding target groups), or to plan impiementation or evaluation. Recommendations made by the Working Group will be
considered in the elaboration of a proposai by ministry staff that considers cost, cost-effectiveness, and implementation issues.
Québec:
Comité d’immunisation du Québec (CJQ), (affiuiated with the Institut national de santé publique du Québec
(INSPQ) committees on specific vaccines (varicelia and pneumococcai conjugale vaccines), implementation working groups,
comité de l’acte vaccinaL
Saskatchewan:
Standing Committee on Immunization made up of representatives from Saskatchewan Health, representatives ftom
the Medical Health Officers Council ofSaskatchewan and the Nurse Managers Group. Committeees for specific vaccines:
i.e.pneumococcal vaccine
Alberta:
Advisory Committee on Communicable Diseases receives input from the Council ofMedicai Officers ofHealth,
the Communicable Disease Nurses Working Group, the Pediatric Society and other sources and advises Alberta Health and
Wellness.
NfLD:
Advisory committee on Infectious diseases, and Medical officers ofHealth Committee . Regional MORs meet
quarterly and make recommendations in consultation with provincial MOH. In addition to Medical Officers ofHealth,
Communicable Disease Nurses and nursing managers may provide recommendations regarding new programs.
NS:
Committee with wide representation. Subcommiftee usually formed to provide a discussion paper regarding
feasibility of introduction ofa ne’,’ publicly ftinded vaccine. Paper is then revicwed by provincial CDC committee, and
recommended option is submifted to public health working committee for approval. If approved by PHWC, submitted to
senior staff in Dept. ofHealth for approval.
PlI:
ChiefHealth Officer and Communicable Disease public health nurse review available information on particular
vaccines and make recommendations.
NU:
CMOR and project manager review scientific literature, NACI recommendations, discussions with regional MOH
and consultation of infectious disease experts. Proposai to recommend new program is submitted to senior management for
consideration and budgetaiy approval
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In recent years there has been a tendency towards more formai and
specific committees. For example, in addition to communicable disease
committees, many regions have immunization commiffees and also specific
working groups for new potential programs (i.e: varicella,’ pneumococcal
conjugate, influenza). 0f note is the fact that these commiftees in different
regions have littie contact with each other despite dealing with common
issues. The foilowing table summarizes the similarities and differences
between regions (Table XIV).
Table XIV: Summary of ProvinciallTerritorial Structures and Processes for Immunization
Program Planning
QC BC ON AB MN SK NS Nf NWf PEI NVT N Y
B T
informai
.7 .7 .7
framework for
vaccine V’
evaluation —
program
planning — — — — —
formai q’
framework for
vaccine V V
cvaluation and
program
planning — — —
Infectious/ V’ q’ .7 V’
Communic- I
abie disease vi’ 1
committee
Immunization 7 .7 q’ .7
committee 7 V q’ q’
Working
.7 q’
groups for
.7 q’ q’ 7
specific V’
vaccines:
varicelia q’ .7
V
pneumococcai V’
conjugate
influenza V q’(regular q’ 7
program)
Notes: 1. In BC there is a Communicable Disease Policy Commiftee
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More detailed descriptions by province/territory are presented in Appendix 4.
This confirms the wide degree of variation in structures and processes for
immunization program planning between different Canadian jurisdictions.
This aiso identifies that there is a large degree of duplication between
different jurisdictions. For example, four provinces indicated having working
groups for variceiia. Whiie experts in this area undoubtedly have some
informai exchanges, there is no formai forum in which these groups can
address the same evaluation questions for a particuiar vaccine.
Coordination of these working groupswas seen as desirable, but would
require additionai resources to support exchanges between these groups or
organizational change in the area of immunization in Canada. These
concerns were voiced in other sections of the questionnaire and wouid be
important in many foiiowing phases 0f this project.
3. Existîng frameworks for new pubiiciy funded immunization
prog rams
Nova Scotia, Saskatchewan, and Ontario mentioned using a type 0f
framework or structured approach for immunization program planning. Nova
Scotia and Saskatchewan have a stepwise framework which identifies
prerequisite criteria, absolute criteria (which are both necessary for a
publiciy funded program) and aiso relative criteria which are desirable but
not essentiai for the program to be approved. This tool is presented in
Figure 18.
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Figure 18: Framework for the Introduction of a new publicly funded vaccine use in Nova Scotia
and Saskatchewan
The following framework is developed as a guide to facilitate decision-maldng for the introduction of
a new vaccine in the Publicly Funded Vaccine Program.
This framework lias three basic levels of consideration:
1. Pre requisites ofprimaryfactors- resuit of vaccine studies/research that indicate:
1.1. vaccine is licensed by the Health Protection Brinch (determined to be safe and effective)
1.2. vaccine is beneficial to the individual
1.3. burden ofdiseasejustifies-the introduction ofthe vaccine (mortality and rnorbidity,
incidence/prevalence, cost-benefit analysis)
2. Absottttefactors- factors that must be in place within the province in order to consider a vaccine
for inclusion in the immunization schedule
2.1 NACI recommends the vaccine
2.2 Equitable and effective ways to deliver the vaccine to over 90% ofthe intended group are
established
2.3 adequate funding is secured
2.4 adequate human resources available to deliver the program
2.5 Regional Health Services were consulted
2.6 resources available to provide educationlinformation to those implementing the program
2.7 the provincial medical society was consulted
2.8 delivery options/models were examined.
3. Retailvefactors- factors that are ‘nice’ to have, or considered but flot necessary.
3.1 WHO and national goals established
3.2 impact on the current immunization schedule
3.3 political impact of action or inaction (public fear)
3.4 accessibility to 100% oftarget population
3.5 cost of the vaccine is comparable to other vaccines in the current schedule
3.6 material resources required for the vaccine are similar to those vaccines currently in the schedute
3.7 vaccine may be delivered during one ofthe regular visits or on the current immunization schedule
Non Publicly funded vaccines- these are vaccines that the Department of Health will support but not
fund. To support a vaccine, prerequisite factors identified above must be met.
Ontario mentioned having an informai Iist of about 10 issues for
consideration, which is in some ways similar to crïteria for considering
whether a disease should be made reportabie to public heaith authorities.
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(This includes criteria such as disease incidence, mortality and morbidity,
preventability by other measures, efficacy and effectiveness 0f the vaccine,
vaccine safety, implementation issues such as cold chain stability, method
0f administration, public versus private delivery, schedule and its integration
into existing immunization schedule, cost-effectiveness compared to other
preventive interventions, etc...). Despite the existence of and publication of
the White and Mathias framework in 1981, these were the only decision
making or planning frameworks that were identified to be in use in Canada.
4. Identified roles of key persons:
Responses of key persons indicated a diverse variety of roles in the
immunization planning process. This question produced an impressive
variety 0f roles. The following major categories were mentioned:
.educating, communicating and advocacy regarding programs
•scientific advisory role, literature reviews, assessing evidence
.membership in various committees and/ or working groups
•disease monitoring
.monitoring of vaccine adverse events
.monitoring and evaluating implementation
•determination of priorities
•consultation of other provinces
This diversity of roles suggests that many different situations may exist
across Canadian jurisdictions. It is also interesting to note that these
individuals may be involved in disease monitoring or other related public
health activities, which may limit the time and energy available for
immunization programs.
5,6. Major factors and criteria used in decisions regardïng
immunization program planning
Many crïteria from existing frameworks were mentioned, such as burden of
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disease, effectiveness of vaccine and vaccine cost. Many additional factors,
mostly broader context-related concetns, were also mentioned and
proposed for inclusion in the analytical framework such as the following:
• accessibility of target population
• antibiotic resistance
• requirement to be cost-neutral
• whether other provinces provide a vaccine
• if pressure is llkely to vaccinate
• international thrusts or targets
• impacts on other sectors (physicians, long term care facilities,
occupational seffings)
• ease of fit with. existing programs
• anticipation of public pressure for vaccine
• public perception of risks of disease
• public perception of risks of vaccine
• cost of vaccine similar to other vaccines on the current schedule
• material resources required for the vaccine similar to those
vaccines currently on the schedule
• avoided costs of outbreak control
• human resources
These criteria indicate that many factors beyond the basic scientific
evaluation of effectiveness are important in the consideration of
immunizatïon programs in Canada, and should be included in an analytical
framework which aims to be comprehensive and include aIl important criteria
in actual decisions in this area in Canada.
7. Type of framework which would be most helpful in immunization
program planning
This question aimed to collect opinions about the preferred type of analytical
framework. Some major comments concerned the need for long-term
planning considering ail aspects of immunization programs, from monitoring
to implementation:
Ç
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• provincial leadership/ national guidelines
• quick access to registration information /other studies
• invoivement of laboratories from the beginning to ensure data
standards and integrity, as these data will be used to judge needs
for a program and also to assess post vaccine program successes
• capture of scientific evidence, cost benefit analysis
• NACI guidelines
• should reestablish the Advisory Committee on Epidemiology
(ACE)
• use of objective/weighted criteria which can be scored, which can
allow comparison of an intervention to accepted and already
implemented interventions within and outside of the public health
sector.
• must address logistics of delivery, timing human resources 0f
vaccine administration which can often fait upon regions without
adequate planning for resources
• long range plan considering other potentiai new programs
It is interesting to note that many responses to this question did not seem to
concem specifically the analytical framework, but however addressed
broader concerns such as leadership, guidelines, and potential
organizational changes in Canada (i.e. reestablishing the Advisory
Committee on Epidemioiogy).
8. What elements should be included in IPP framework?
This question was added to complement questions 5 and 6 to identify
crïtetïa for inclusion in the analytical framework. Some notable responses
include the following:
• vaccine effectiveness, efficacy, cost, suppiy, safety, stability...
• valueformoney
• prioritization among availabie vaccines
• acceptability to health care system
• acceptability to parents
• additional resources required to deliver vaccine
• resoutce impact! savings
• communications
• documentation required and supported
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• information to consumers and providers
• time frame for introduction of new vaccines and what’s expected
in the next 5-10 years
• appropriate budgeting process for administration of vaccine as
weIl as purchase price
• very thoughfful health economics arguments as new vaccines
increasingly prevent morbidity more than mortality
Again, the expected factors of vaccine effectiveness and cost were
mentioned. However, a host of broader context-based factors were
identified, again confirming the importance that the analytical framework be
broad in scope to include these important factors.
9.Major needs and problems in immunization program planning:
This question aimed to explore the broader issues and needs in various
jurisdictions. Again, the responses touched a variety of areas:
• lack of personnel and fiscal resources (many responses)
• no specific operating budget for program evaluation and program
support, including public information
• concern about anti-vaccination movement
• workload issues where will staff corne from and how will they get
paid?
• how to prioritize vaccines, cornpetition for resources of catch-up
programs and new vaccines
• complicated delivery system (particulary physicians) with
unknown, uncontrollable delivery costs. Delivery by public health
could facilitate coldchain management and record-keeping
• lack of a vaccine registry makes it difficult to report on coverage
• lack of financing for resources to vaccinate given the current
pressure on the system
• operationalization of programs by regions without proper
planning/resources
• impression that we have reached saturation in terms of the
number of vaccines which can be given
• lack of harmony in provincial programs
• people who choose not to immunize
• need of funding for varicella vaccine
• streamlined schedules for infants and adolescents
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One response referred to information systems, noting the lack of a vaccine
registry. Another response mentioned the lack of a method for prioritization
of vaccines. The other responses revolved around issues of funding, and
practical aspects such as delivery, resources, personnel, public attitudes
and the growing number of vaccines in the immunization schedule. As in
the other questions, these responses indicate the importance of broader
factors in the planning of immunization programs.
1O.Frarneworks, structùres and processes which should be in place in
Canada:
This question aimed to examine ideas of key persons regarding optimal
structures and processes for immunization program planning in Canada,
and produced many proposais for major changes:
• continue to support NACI
• reestablish ACE (forum for planning and discussion at the
provincial epidemiologist level)
• a committee of provincial/territorial staff, perhaps reporting to the
PHWG, would be instrumental in developing such frameworks for
decision-making and assisting PIT programs in becoming more
uniform, which has been a tated goal of a number of supports for
many years (i.e. the immunization schedule, immunization
registries, etc.)
• consideration of which level of government should provide funding
for purchase of vaccines should also be considered, and there
may be a role for the federal government in this area.
• the Health Canada Population and Public Health Branch shouid
have funding to support the federal immunization program support
initiatives such as coverage surveys among 2-year olds, cold
chain surveys, active surveillance for vaccine preventable
diseases, and targeted studies required to elucidate policy
recommendations related to issues such as appropriate
immunization schedules and vaccine immunogenicity.
• criteria for introduction of new programs need to be developed
and approved at the minister of health level to facilitate decision
making following vaccine licensure.
• interprovincial commiffee to review and discuss new vaccines and
make recommendations for provincial consideration.
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• tactic to convince those with budget authority of the costslbeneflts
associated with recommended program changes
• standard approach across Canada to avoid inequities between
provinces, including standard resource base and standard array of
publicly funded vaccines.
• increased resources to accompany increased program activities
• independent scientific analyses (vaccine efficacy, international
experience, study 0f epidemiological impact, modeling, economic
evaluation)
• prioritization among available vaccines
• operational feasibility (i.e. frozen varicella vaccine)
• clear implementation and follow-up process
• need for a group to operationàlize NACI guidelines
• consensus meetings to standardize immunization programs
across Canada
• universal immunization program in Canada, with deviation only for
special circumstances (i.e high-risk communities)
• understanding of epidemiology in certain communities (Le. First
Nations, inuit)
• consideration of vaccines by conference of deputy ministers. Their
awareness of the importance of the vaccine wïll facilitate funding
for introduction at the provincial level.
• F/P/T decision-making process to facilitate standardized decision
making process across the provinces. Some agreement probably
required at the DM or ministerial level.
• NACI needs to be more than a yes/no body to support whether a
vaccine is indicated or not. Considerations mentioned in
consensus conferences such as program costs, population impact
and delivery problems need to be incorporated into decision
making.
These responses indicate a desire for increased federal funding of vaccines,
and support development of national committees to help evaluate and make
recommendations on potential programs. Broadening the role of NACI was
also mentioned. The development of standard approaches for evaluation of
programs and more standardized programs was also seen as important.
Overail, the responses indicate that there is much interest and support for
change.
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GIobaIly, these responses indicate many factors that are important other
than the basic science and costs of vaccines. A very clear paffern in the
responses ïs also the desire for more federal support in this area, with
increased coordination and funding, perhaps including a universal
immunization program in Canada. This proposed change is major in that it
would change the freedom of the provinces and territories with regard to
their health care system and spending. However, smalier provinces and
territories often were more enthusiastic in supporting this increased federal
role than the largest provinces.
Overali, the resuits of this questionnaire provided important information as
planned regarding criteria in decision-making as originally planned in the
project. Due to the inclusion of broader questions regarding organizational
structures and processes in this area in Canada, this questionnaire also
collected numerous proposais for major organizational changes. This
tepresented a major broadening of scope of the project and potential impact
weil beyond the simple deveiopment 0f the analytical framework for
decïsion-making. These responses were used to create the analytical
framework and a preliminary report and a presentation for the Immunization
Subcommiftee Meeting in November, 2000.
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Creation of the Analytical Framework
This step aimed to use ail avaiiabie sources to identïfy important criteria for
inclusion in the analytical framework. A total of 194 questionnaire
responses representing potential decision-making criteria were entered in to
an Excel database (Figure 19). For completeness, criteria inciuded in known
provïncial frameworks and the White and Mathias model (White & Mathias,
1982) were also added.
A clustering process was utilized to reduce the iist cf questionnaire
responses into unique criteria, using the dendrogram method to group
conceptually similar responses into criteria (described in Miles & Huberman,
1994) representing groups cf responses. Multiple mentions cf the same
criteria (i.e vaccine cost) were eliminated as were different wordings
representing the same concept (i.e. vaccine price and vaccine cost).
For clarity and inspired generally by categories mentioned in existing
provincial frameworks and the White and Mathias model, the list was
atbitrarily grouped into 8 sections to create the sections of the ternplate.
This produced a total of 55 criteria classified into 8 categories, including the
burden cf disease, vaccine characteristics, immunization strategy, cost
effectiveness, acceptability and feasibility, evaluability of program, research
questions, and other considerations (equity, ethical, iegal and political). The
framework was returned te participants for validation and tested in expert
committee meetings.
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Figure 19: Process for Creatïon of Analytical Framework
ê
Criteria organized into $ major categories
1
Proposed template with $ major categories and detailed
subcategories to be submitted for comments before
testing
The overali resuit is a comprehensive list that captures the variety of
different factors expressed from various sources regarding important criteria
in immunization program planning in Canada and makes a comprehensive
tool that including ail important factors to be addressed. The questionnaire
resuits and existing criteria generally show convergence in terms 0f overali
content. This analytical framework for Immunization Program Planning in
Canada, developed as a result 0f this questionnaire and the process 0f
grouping 0f identified criteria, is presented in Figure 20.
Questionnaire responses:
Total of 194 criteria mentioned in responses
Grouped into total of 55 different criteria
Combined with subcategories from existing frameworks
(White & Mathias, from various regions)
116
Figure 20: Analytical Framework for Immunization Program Planning in Canada
General Categories: (references wiII be included for each point)
1. Disease Characteristics and Burden
2. Vaccine Characteristics
3. Alternative Immunization Strategies and Programs
4. Social and Economic Costs and Benefits of Alternative Programs
5. Feasibility and Acceptability of Alternative Programs
6. Ability to Evaluate Programs
7. Research Questions
8. Other considerations
Detailed Points for Each Category:
1. Disease Characteristics and Burden
1.1 Nature and characteristics ofthe infective agents; including reservoirs, mode of transmission, and
pathogenic mechanisms.
1.2. Clinical manifestations and complications.
1.3. Epidemiology ofthe disease, including incidence, clustering, time trends, seasonal and
geographic variations, fatality rate, sequelae rate, and loss of life years.
1.4. Specific populations affected and risk factors.
1.5. Current disease treatment and preventability by measures other than immunization.
1.6. Social impact ofthe disease, including reduction of quality oflife ofaffected individuals, and
loss ofquality-adjusted life years, long-term disability, impact on families/ caregivers, fear ofdisease,
stress on communities.
1.7. Economic impact ofthe disease, including direct and indirect costs to patients and families,
productivity losses, health service utilization and costs to health system.
I)
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2. Vaccine Characteristics
2.1. Nature and characteristics of immunizing agent (i.e. live, attenuated, killed, absorbed/non
absorbed, viral or bacterial product).
2.2. Characteristics ofthe commercial products (i.e preparation, stabilizing agents and preservatives,
dosage, combination, conservation).
2.3. Storage, handiing, product format (frozen, etc).
2.4. Vaccine manufactures, production capacity, and supply to Canada.
2.5. Administration schedule, number of doses, combination with other vaccines.
2.6. Nature and characteristics of immune response.
2.7. Immunogenicity in different population groups.
2.8. Efficacy: short and long-term, including direct and indirect protection (herd immunity).
2.9. Effectiveness: expected impact on reduction ofburden ofdisease (morbidity, mortality, etc...).
2.10. Safety: rates and severity adverse events, contraindications, precautions.
2.11. Potential interaction with other vaccines.
2.12. Potential impacts on antibiotic resistance.
3. Alternative Immunization Strategies and Programs
3.1. Existing recommendations/guidelines for use ofthe vaccine (i.e. NACI, consensus conferences,
ACIP, AAP).
3.2. Objectives ofdisease control/eliminationleradication at international (i.e. PAHO, WHO etc..),
national, andlor provincial/territorial levels.
3.3. Alternative immunization strategies for meeting objectives (i.e. selective vs universal
imnmization programs, catch-up programs).
3.4. Specific objectives in terms ofreduction of incidence, complications, sequelae and mortality.
3.5. Specific objectives in terms of vaccination coverage for different target groups.
3.6. Delivery strategy/system: nurses versus physicians, different locations (i.e schools, private
clinics, public health clinics).
7-
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3.5. Specific objectives in ternis of vaccination coverage for different target groups.
3.6. Delivery strategy!system: nurses versus physicians, different locations (i.e schools, private
clinics, public health clinics).
4. Social and Economic Costs and Benefits of Alternative Programs
4.1. Total and opportun ity costs ofprogram in a societal perspective, including direct and indirect
costs for families and the health system.,
4.2. Evidence regarding the short and long-term effectiveness, including reduction in disease
incidence, complications, sequelae and mortality.
4.3. Evidence regarding social and economic benefits including reduction in health acre costs,
improvement in life expectancy, in quality of life for individuals, families, caregivers and
communities, productivity gains.
4.4. Other benefits (i.e reduced microbial resistance, reduced emergency room overcrowding).
4.5. Economic evaluation : Net present costs and cost-benefit ratios (from health care and societal
perspectives) of alternative strategies (per life saved, case prevented, life year gained, quality-adjusted
life year gained), discussion ofunderlying assumptions, evaluation ofrobustness ofeconomic model
using sensitivity analyses, comparison with other studies, pertinence for local settings, and
comparison to other vaccines and other health care interventions.
5. Acceptability and Feasibility of Program
5.1. Public perception of disease risk, severity, fear, need for disease control.
5.2. Demand for! acceptability of immunization program to target groups, population at large,
professionals (nurses, MDs, public health personnel) and political authorities.
5.3. Priority for new program with respect to other potentiallapproved programs.
5.4. Expected dates oflicensure or current use of vaccine (i.e. by the private sector).
5.5. Integration of new program with existing immunization programs and schedules.
5.6. Impacts of program (including catch-up) on existing immunization services and other health care
sectors (physicians, long-terni care facilities, hospitals, occupational settings...).
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5.7. Accessibility oftarget population, and expected levels of uptake/coverage for target groups.
5.8. Availability of vaccine supply.
5.9. Availability of funding for vaccine purchase.
5.10. Availability of human, technical and financial resources for distribution, conservation (cold
chain stability), and administration of vaccines, including implementation of the new program and
catch-up.
5.11. Availability of appropriate documentation!consent forms for the population and health care
providers.
5.12. Availability of system for recording/registering vaccine administration.
5.13. Availability of resources for marketing and communication to the public, information and
training ofhealth professionals.
5.14. Existence of operational planning and implementation committee.
6. Ability to Evaluate Programs
6.1. Desirability of evaluation to families, professionals (nurses, MDs, public health personnel) and
political authorities.
6.2. Availability of information systems to measure coverage (including immunization registries) and
vaccine utilization, quality of vaccination services.
6.3. Availability of information systems for monitoring reduction of disease incidence,
complications, sequelae, and mortality.
6.4. Availability of information systems for monitoring adverse events associated with vaccine
administration.
6.5. Availability of systems for Ïinking health outcomes databases, immunization registries and
population registries.
7. Research Questions
7.1. Ongoing and planned research projects in the fields of vaccine development, immunogenicity,
efficacy and safety.
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7.2. Identification ofareas in previous sections in which research is needed to assist evaluation,
planning and decision-making regarding this particular program and proposais to meet these needs in
a timeiy manner.
8. Other considerations
8.1. Equity ofnew program including universaiity, accessibility and gratuity ofservcices for the most
vuinerable population groups.
$ .2. Ethical considerations, inciuding informed consent, and protection of confidentiality ofmedicai
information.
8.3. Conformity of new program with pianned or existing programs in other jurisdictions and
countries
8.4. Possible poiiticai benefits and risks associated with implementation ofnew program.
Explanation of Categories in the Analytical Framework
We wiII now consider in detail some examples of important factors for each
of the categories of the framework identïfied from the questionnaire, the
scïentific literature in Canada, and consultation with experts:
1. Disease Characteristics and Burden
In a public health perspective, the burden of disease is an important factor
to set priorities. Vaccines were first developed to prevent frequent and
deadly diseases such as smallpox, diphtheria, tetanus, infant pertussis,
poliomyelitis, or measles, and the relevance of the programs implemented
during the 20th century cannot be questioned. However, new vaccines
developed during the last ten years are targeting Iess frequent or Iess
severe conditions, and investments for their prevention have to be weighted
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against other competing health priorfties. The need to justify new programs
led to epidemiologicai studies aiming to assess preciseiy the heatth and
economic impact of vaccine preventable diseases in Canada, including
varicella (Law et al. 1999a; Law et al. 1999b, Getsios et al. 2002),
pneumococcal infections in chiidren (Scheifele et al. 2000; Petit et ai., 2003
in press), meningococcal disease (Erickson & De Wals, 1998), and
adolescent pertussis (Senzilet et al. 2001, Skowronski et ai. 2002, De
Serres et ai. 2000). The high frequency of invasive and non-invasive
pneumococcai infections in children coupied with the increasing resistance
of the bacteria to antibiotics was determinant in assigning the 7-valent
conjugate vaccine as a top priority, whiie the rarity of severe complications
and absence of permanent sequeiae from whooping cough (pertussis) in
adolescents determined the iow priority given to an adolescent pertussis
program (De Wals P, personai communication).
2. Vaccine characteristics
Efficacy and safety of vaccines are the main criteria in the initial evaiuation
process. When the decision was made in Quebec to use the new serogroup
C meningococcat vaccine instead of the polysaccharide vaccine to control
an outbreak in 2001, the high effectiveness in young chiidren of the former
and ifs capacity to induce long-term memory were critical arguments (NACI,
2002). When aceilular pertussis vaccines were introduced in Canada,
safety above ail other considerations was decisive for their immediate
adoption (NAC1, 2000). The introduction of a refrigerator-stable variceila
vaccine was a definite improvement over the previous frozen vaccine, an
important factor encouraging the use of this new vaccine.
Alt immunization programs must be evaluated in terms of their safety and
population effectiveness. In addition, public heaith authorities must be
accountabie to taxpayers. In Quebec, there is a weil-estabiished tradition of
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including an evaluative component in ail new immunïzation programs. The
usefulness of this type of investment was demonstrated after the mass
serogroup C meningococcai immunization campaign in Quebec (using the
polysaccharide vaccine) in 1992-1993, in which post-implantation studies
alerted of the poot performance 0f this vaccine in young chiidren and the
short duration of protection (De Wals et aI., 2001).
3. Alternative Immunization Strategies and Programs
Sometimes, public héalth objectives can be attained via different
immunization strategiés, and the control of influenza is a good example. A
universal vaccination program was implemented in Ontarlo, in 2000, while a
< high-risk» approach is still used in the other provinces (Schabas 2001).
UnfortunateIy, the relative cost-effectiveness of the two strategies has not
yet been evaluated. Another example is the new meningococcal conjugate
vaccine, which can be given in a one-dose universal program (as in
Quebec), or in a three-dose universal program (as in Alberta).
4. Social and Economic Costs and Benefits of Programs
With the increasing cost of vaccine products, cost-effectiveness analyses
are needed to justify new programs, especially because Iong-term, recurrent
expenditures are involved (BCG and smallpox being ‘exceptions). In
Canada, the first economic analysis was performed for the influenza
vaccination of health care workers in 1991 (Yassi et al., 1991). Presently,
this type of information is systematically. requested and cost-effectiveness
analyses have been produced for the two-dose measles program (Pelletier
et al. 1998), the adult pneumococcal program (CETS, 1998), the varicella
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program (Brisson et al., 2002; Getsios et aI. 2002), the infant pneumococcal
(Lebel et aL, 2003; De Wals et al., 2003) and serogroup C meningococcal
programs (CIQ 2002; De Wals et al., 2003, in press). Although not aiways
cost-saving, immunization programs generally compare well with other
health interventions (Tengs et al. 1995; Stone et aI. 2000). It seems,
however, that the absolute cost of a program is perceived to be more
important than the predicted marginal cost-effectiveness ratios in the short
term perspective of some decision-makers. In addition, lift le is known about
the actual impact of economic evaluation on decision-making
(Contandriopoulos, 1999) and this issue warrants further study.
5. Feasibility and Acceptability of Alternative Programs
The best immunization strategies have no value if they are impossible to
carry out in practice. Past experience has shown that it is aiways easier to
implement a new vaccine if it is combined with an existing vaccine or if it
may be administered in the same visit as another vaccine. This was indeed
the case for the replacement of the live oral polio vaccine with the
inactivated combined injectable polio vaccine. In certain cases, practical
aspects require vaccine doses to be given which are not strictly necessary.
An example is the second dose of the mumps vaccine at the same time as
the indispensable second dose of measles vaccine and the less
indispensable second dose of rubella vaccine.
The demand for a new program is a very powerful argument for decision
makers at the political level. Consider for example the case of serogroup C
meningococcal disease, which generates a lot of anxiety in the population
and affracts enormous media attention, due to the unpredictable, rapid
onset of this disease and its serious consequences (Erickson et al., 1998).
A survey in Quebec in 2002 found that 86% of respondents felt that the
conjugate vaccine should be included in the routine childhood immunization
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series. Support for a vaccine against (pneumococcal) pneumonia was 60%,
and only 41% for a vaccine against chickenpox (De Wals et al.,2002).
Despite the fact that the varicella program is the most favorable program
from an economic point of view (Brisson et al. 2002; Getsios et al. 2002),
and also that the greatest disease reduction can be achieved from a
program using the 7-valent pneumococcal conjugate vaccine (De Wals et al.
2003), a routine one-dose meningococcal program was introduced in
Quebec in 2002. No decision has yet been made for the other two vaccines.
While Canadians may be generally favorable towards immunization, general
lack of knowledge by the public about vaccines may hamper the feasibility of
new prôgrams (Ritvo et al., 2003)
6. Ability to Evaluate Programs
This section involves the availability of resources and information systems to
evaluate immunization programs. Often there are no resources devoted to
measuring immunization coverage, therefore making evaluation of impact of
the program difficult. This was the case for the universal immunization
program for influenza in Ontario, where liffle information was available to
determine vaccine uptake and coverage. This also involves planned
research projects, and implementation 0f immunization registries.
7. Research Questions
New immunization programs are often implemented before important
research questions can be resolved. A current example is the fact that the
duration 0f protection given by the type C meningococcal conjugate vaccine
given at 12 months of age is not yet known (Richmond et al., 2002), while
this program aims to prevent invasive meningococcal infections until
adulthood. In contrast, for certain programs uncertainty about certain
scientific questions may block adoption of the program. For example,
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uncertainty about the impact of a varicella immunization program and impact
on the incidence of zona in the adult population (Brisson et al. 2002) are
factors which have delayed implementation of this program in several
provinces.
8. Other Consîderations
Applying principles of equity’ applied torimmunization in Canada should
mean that vaccines are freely accessible to populations that can benefit
from them. The supposedly universal nature of Canadian health care 15
often cited as an example to follow for other countries.
Problems of access to vaccines occurred with the origïnal varicella vaccine
in Canada which had to be stored frozen. This caused several problems for
the distribution network, particularly in outlying regions. During the Canadian
Varïcella Consensus Conference in 1999, availability of a refrigerator-stable
vaccine was considered as a sine qua non criterion for adoption of a
universal program (LCDC, 1999). Fortunately, the pharmaceutical
companies involved rapidly met this challenge and refrigerator-stable
varicella vaccines were quickly developed and commercialized in Canada.
In Canada, there are no mandatory immunizations, and regulations
regarding immunization in schools or workplaces allow exemptions in certain
cases, or are challenged if no exemptions are allowed. Important measures
have been taken by public health authorities to supply the best possible
information on vaccine products and to ensure informed choices by the
populations, via publications, Internet sites, or information sheets given
during visits for vaccinations. A practice guide for vaccinators has also been
distributed. Multiple efforts are thus undertaken to avoid any ethical or
deontologïcal problems in the area of vaccination.
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In the practice of curative medicine, certain medications are often used in a
manner different than that originally recommended by the manufacturer and
defined in the original licensure of the product. The principie of freedom of
practice in treatment is harder to apply in the areas 0f prevention and
publicly funded immunization programs than in other areas. For example,
mounting evidence indicates that a single dose 0f the hepatitis A vaccine
gives good long-term protection and that the marginal effectiveness of the
second dose is quite low. Therefore, implementation of a one-dose hepatitis
A vaccination program for haif the cost of the original two-dose program
(following the manufacturer’s recommendations) can be considered for
evaluation as a program option. With resources saved by this program, it
would theoretically be possible to invest in other programs to maximize
health benefits for the population. However, this type of approach has the
potential problem of legal action in the case of vaccine failures.
Also, it is important to consider political aspects of immunization programs
which can involve political benefits or risks. Mass meningococcal
immunization programs had political benefit in Quebec as they responded to
demands from the public and also affenuated much negative media
coverage of disease outbreaks (De Wals et al., 2002). Political risks and
problems are present in the case of pre-exposure smallpox vaccination in
the United States for certain workers, which has caused much disagreement
and debate, while in Canada discussions in this area are quite laborious,
especialiy given our political structure.
Transformation of the analytical framework into a practical tool
Overall, the effort to identify ail criteria which are important in planning
decisions for immunization programs in Canada has identified an impressÏve
list of factors which may be important. However, questionnaire resuits and
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recent examples of decisions have indicated that different criteria are
important in each case. Even non-experts recognize the differences
between for example varicella and meningococcal programs. Ihis variation
was important to consider in the design of the framework to be adopted for
testing in the next stages 0f the project. Because of these factors and the
research-action approach of the project, a flexible tempIat& approach was
adopted for the framework. A template is defined as a gauge, paffern or
mold used as a guide to the form of another object being created (Collins,
1988). Similarly this ‘template’ was considered to be a guide to be
transformed by users for various applications 0f the analytical framework.
The decision was made to include the maximum number of potentially
pertinent subpoints in each section as the template should be modified to ‘fiV
each particular case. For example, more or less detail can be used in
specific categories depending on pertinence to each potential program and
application of the framework. This tool was presented to the Immunization
Subcornmittee in the next step 0f the project for consultation, discussion and
revision.
Testing of the Analytical Framework
Meeting of PHWG ISC, Toronto, November, 2000
This meeting of the Immunization Subcommittee of the Public Health
Working Group had representatives from Canadian provinces and territories
and was held to update efforts on the National Immunization Strategy. The
presentation and following discussion by participants is summarized in the
Draft Record of Decisions summarizing this meeting (PHWG, 2001),
presented in Appendix 14.
The resuits of the questionnaire and preliminary consultation process were
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presented in two forms, a 22-page report entitled ‘Development of an
Analytical Framework for Immunization Program planning in Canada:
Preiiminary Resu Its, Phases I & il’ (circulated prior to the meeting) and also
a presentation whïch summarized resuits of the questionnaire and gave
preliminary recommendations, foliowed by a discussion. The presentation
summarized questionnaire results and the development of the framework,
as well as presenting existing frameworks in certain jurisdictions such as
Nova Scotia and Saskatchewan. (Figure 18). The desire of various
jurisdictions (expressed in the questionnaire responses) that mechanisms
be deveioped to address implementation concerns, human resources, public
perception and cost-benefit issues was highlighted. Members agreed that a
systematic framework is required at a national level to effectively evaluate
immunization program planning, which addresses social and political
considerations.
As indicated in the contract with Heaith Canada, the project went beyond the
simple development of the analyticai framework, considering also
organizational structures and processes in this area in Canada and making
proposais for change. In addition to supporting the framework, members
indicated that it was necessary to look at structures and processes for
immunization program planning in Canada, particuiarly those which ‘can
withstand political change’. it was noted that whiie the National Advisory
Committee on Immunization (NACI) provides recommendations to the
federal government on the optimal use of vaccines:
‘it does not effectively address the issues of ïmmunization programs
and the delivery of vaccines so some additional mechanism is
required to take the scientific recommendations to an implementation
phase’ (PHWG, 2001)
The members agreed to a stepwise, collaborative approach to deveiopment
of a national £framework, structure and process’. This was a confirmation of
a key development in the project to broaden its scope. It was suggested to
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use a current potential program as a concrete pilot project for testing the
framework, such as the pneumococcal conjugate vaccine. A potential role
for the framework in an expected national consensus conference on the
pneumococcal conjugate vaccine was also discussed, as members agreed
upon the significant value of this type of conference in the immunization
planning process in Canada.
The following actions were agreed upon as the next steps in the project,
now referred to as Vrogram Planning in Immunization in Canada (PPIC):
Validation and circulation of repot
Completion of draft analytical framework in Match 2001 for
presentation to ISC and approvai
> Discussion cf NACI statement on pneumococcal conjugate
vaccine in February/ Match 2001.
> Testing cf framework and development cf recommendations
for pneumococcal conjugate vaccine at April 2001 ISC
mbeting.
These actions were indeed compieted, except for the last one regarding the
pneumococcal conjugate vaccine. While there was indeed some wotk
conducted with the pneumococcai conjugate vaccine working group in
Quebec, thete was no formai work done in this specific area on the federal
level. There would simply be an informai discussion at the next ISC meeting
in April 2001.
April 2001 Meeting ofthe immunization Subcommiftee cf the Public
Heaith Working Group
This meeting was a continuation of from the November 2000 meeting. In a
similar manner, a 34-page report entitled Program Planning in Immunization
in Canada was submiffed to participants before the meeting, and a
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presentation was given summarizing the resuits, and proposed continuation
of the process. This was followed by a plenary discussion to ratify the report.
The 34-page report gave detailed summaries of questionnaire responses
and was divided into the following 5 sections:
1. Goals and objectives for immunization in Canadian provinces
& territories (presented ïn previous section)
2. Detailed structures and procèsses for decision-making in
Canadian provinces & territories (Append ix 4)
3. Presentatibn of the analytical framework for evaluation of
candidate programs (presented in previous section)
4. International examples of structures and processes for
immunization planning and proposed structures for Canada
(part of which was presented earlier in this report-section in
immunization)
5. Conclusion.
The report and presentation differed from those presented at the November
2000 ISC meeting in that the results were more complete. In addition,
structures for national coordination of health care planning in Canada were
presented, such as the Canadian Coordinating Office for Health Technology
Assessment (CCOHTA), the National Transplantation Strategy, and the
Social Union Framework, to help examine the pertinence of such models for
immunization. Testïng of the framework was proposed with the
pneumococcal conjugate, meningococcal conjugate and influenza
vaccination programs in various national activities. For example, an activity
with the framework was proposed for a national influenza conference to be
held in May of 2001. This finally did not occur because the planning
process for this meeting was already too far advanced for this meeting to
include activities with the framework. Finally, in addition to proposing testing
of the framework with varlous potential programs, the presentation
concluded by recommending the establishment of a new national commiftee
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for immunization program planning to complement the current activities of
NACI.
The subcommiffee ratified the analytical framework and agreed that it be
tested in current cases. In addition, they discussed the possibility of a
national commiffee on immunization programs, which could be an expansion
of NACI or a stand-alone commiffee. The function and mandate of this
committee would be to address immunization program issues that are flot
currently addressed by NACI. This would support and complement the work
that is curréntly carried out by provincial/territorial commiffees, consensus
conferènces, and ad hoc committées and avoid duplication of efforts. This
would also promote beller coordination between regions. National
representation in the commiffee would be expected, and the Iink to federal/
provincial and territorial governments could be similar to some of the
examples mentioned previously in this report.
This meeting also included some work in smaller breakout groups which was
to establish key messages to be given to the PHWG and the ACPH in a
meeting in May 2001 as part of a preparation of submissions to the Deputy
Ministers meeting in June 2001. The messages developed in these
breakout sessions included the following:
> Immunization is a very cost-effective intervention, saving lives and
avoiding much illness and suffering.
Inter-jurisdictional differences are causing inequitable access to
vaccines in Canada
> Immunization is an essential foundation of the system of public
health in Canada
The status of immunization in Canada is threatened by the Iack of
coordination which exists and the lack of a National Immunization
Strategy.
The primary recommendation was that inter-governmental partnerships are
needed to support a consistent national immunization strategy, as is a re
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investment in the immunization program as part of a commitment to the
renewal of the public health system in Canada. These statements express
recognition of these key persons in immunization of the need for change in
this area in Canada.
While this meeting continued the process of development of the framework
and discussion of its potential use, the larger questions of possible
organizational changes in the area of immunization were also being further
discussed. As previously mentioned one potential change involved the
establishment of a new immunization planning commiffee, for which there
was a large degree of consensus. A more controversial proposai, which was
simply discussed at the informai level, was that the federal government fund
the purchase of certain vaccines on a national level. Representatives from
certain provinces and territories (especially the Iess populated ones) were
very supportive of such a plan to allow them to fund some of the new
candidate programs with vaccines which are much more expensive per dose
than traditional vaccines.
However, the affitude from some of the other jurisdictions, particularly the
larger and more populous ones, were less open to what was considered as
federal infringement on the provincial I territorial jurisdiction of health care
spending. Some individual provinces would wish to opt out of such a
program and request simply that the federal government transfer the funds
to the province or territory so that it could decide on how to spend it in their
particular jurisdiction. This situation has occurred often in the past with
provinces, especially Quebec, wishing to opt out of federal initiatives. An
example is the establishment of Canadian Blood Services, in which the
province of Quebec decided to establish its own agency, Hema-Quebec.
This illustrates some of the uniquely Canadian and very complex issues
involved in any efforts of national coordination in the area of health care.
Despite the support of members of the ISC for organizational changes, a
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long process of federai I provincial I territorial consultation would be required
to offïciaiiy approve and implement such changes.
Meeting with Heaith Canada officiais, June 1st 2001
The purpose of this meeting was to present the proposed components cf the
National Immunization Strategy to senior officiais at Heaith Canada,
including the Deputy Minister of Health, and heip to develop a federai
position on proposed organizationai changes. The meeting inciuded a
presentation foiiowed by a discussion. The Deputy Minister was
unfortunately unabie to attend the meeting, however, other key officiais from
the office of the Deputy Minister and Heaith Canada were present. Whiie the
discussion was useful, iittie formai written agreements or other
documentation were produced from the meeting, and its impact is difficuit to
measure. However, this meeting was certainly an important step in the
poiiticai negotiation process, and helped to deveiop the proposais which
wouid be submitted to the conference of the provincial and territorial Deputy
Ministers of Heaith in summer 2001. A submission was made at this
meeting regarding the National immunization Strategy, but no
documentation ïs available regarding the precise nature of this submission,
and the reiated specific discussion and decisions at this meeting.
National Immunization Strategy Meeting, Feb 2002
This meetïng was a cuimination of the research contracts conducted in
collaboration with the Subcommittee on Immunization of the Public Heaith
Working Group of the Advisory Committee on Population Health. Originaiiy,
work was conducted on two components of the National Immunization
Strategy, nameiy:
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> Goals, objectives and monitoring of immunization programs
> Mechanisms to ensure that vaccines are available and used in a
cost-effective man ner across Canada
However, this work also included examination of immunization planning
structures and processes in Canada and concluded that a new national
commiffee to study immunization programs would be desirable to support
the individual provinces and territories in planning their immunization
programs. The analytical framework was proposed as a tool to support work
of this commiffee. This meeting 0f representatives from the 13 Canadian
jurisdictions was conducted on a pilot basis to test this tool and the possible
functioning of such a commiftee on three real candiate programs in Canada.
There was a systematic effort involved in planning the meeting with Dr
Philippe De Wals, the co-chairs of the Subcommiffee on lrnmunization,
Arlene King (Director, Division 0f Immunization, Health Canada) and Greg
Hammond (Director, Department of Communicable Disease, Manitoba
Ministry of Health). Given the fact that many jurisdictions were considering
new programs with the conjugate pneumococcal vaccine, the conjugate
meningococcal vaccine and the varicella vaccine, it was deemed pertinent to
discuss these programs in particular, using the analytical framework as a
tool to structure these activities. The meeting was conducted as follows:
1) Experts were invited to give short presentations on each potential
program: varicella, meningococcal conjugate, and pneumococcal
conjugate. They were alloffed 20 minutes to give a presentation on
each potential program. In addition, they were required to structure
their presentations around the 8 categories of the analytical
framework (of which they were given a copy in advance). They were
not required to address each cf the sub-points of each category, but
rather to give an overview in their expert opinion on each category.
2) Experts present at the meeting were requested to rank the candidate
vaccines in terms of their relative desirability for a publicly funded
program in Canada. This worksheet was based on the 8 major
categories of the analytical framework, and asked experts to rank the
desirability of each potential program on a Likert scale from 1 (flot
desirable) to 5 (most desirable). This worksheet is presented in
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Appendix 6.
3) This was foiiowed by presentation of the response profiles to experts,
and discussion.
4) Finally, there was an informai discussion evaluating this activity and
the piiot commiffee.
This exercise allowed examination of the degree of consensus or
divergence among experts in terms of their evaluation of each candidate
program. For exampie, by tabulating the frequency of responses in each
category, and the distribution of responses in the various categories, points
in which there is a need for more discussion or explanations of divergent
opinions can be identified. Table XV presents the frequency of responses of
experts present at the National immunization Meeting on the worksheet in
Appendix 6.
136
Table XV: Number of Responses per Category, Worksheet for Vaccine Comparison, February
2002 National Immunization Meeting
Type C Meningococcal Varicella Heptavalent
Pneumococcal Conjugate
Ra,iking scateJorder: (Not desirabte) 1 2 3 4 5 (Verv desirabte)
Disease Characteristics 1 3 0 10 7 0 0 1 $ 10 0 0 0 5 13 (cxi)
and Burden
Vaccine Characteristics 0 1 1 3 4 2 0 4 8 6 0 0 3 7 8
Immunization Strategies O 0 2 8 9 0 0 5 8 6 0 0 8 3 5
Social and Economic 0 4 6 5 4 (ex 2) 1 1 2 10 6 0 2 3 8 6
Costs and Benefits
Feasibihty and 0 0 1 6 H 0 3 5 8 3 (ex 3) 0 0 2 9 7
Acceptablility
AbilitytoEvaluate 0 0 5 6 O O 7 4 0 1 6 6 4
Programs
Research Questions 0 2 8 5 4 1 2 5 9 2 0 2 6 7 3
Other Considerations 0 1 5 7 4 0 1 8 6 1 0 0 5 6 3
Overali-this vaccine 0 1 4 6 4 0 0 1 7 7 0 0 1 7 6
should be publicly fiinded
Comparisons across 0 6 7 5 1 6 5 8 0
vaccine_types-_ranking
Rauking scate /order jst 2’Q’ 3rd
Each number represents the number of tesponses per categoiy. The mode (most frequent rcsponse) is underlined in each
categoly, examples are in bold figures
We can consider some examples of response distributions of experts to
individual questions on the worksheet for this activity:
> Example 1: We see for example that there is strong consensus
among Canadian experts as to the important burden of
pneumococcal disease (column 3, row 1 of Table XV), with 13
experts checking box #5 on the Likert scale (most desirable),
and 5 checking box #4 (the second to most desirable of the 5
response options), and no experts choosing the other choices.
This strong consensus indicates that there is no need to debate
or further study this area to examine current consenus among
Canadian experts. Identification of this type of consensus has
the advantage of conserving time to address the more
contentious issues where there is more divergence among
experts about potential programs.
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> Example 2: consider social and economic costs and benefits for
potential programs with meningococcal conjugate vaccine
(column 1, row 4 of Table XV). Here in contrast, responses of
experts are almost equally distributed among four response
categories, reflecting a great deal of divergence of opinion. This
differing assessment of costs and benefits of meningococcal
immunization programs probably reflects dïfferent opinions by
experts on the value of calmïng the media and the public in the
context of a meningitis outbreak.
> Example 3: regarding feasibility and acceptability of potential
varicella programs (column 2, row 5 of Table XV), the response
distribution is an intermediate between strong consensus and
strong divergence. The identified factors here were a balance
between the advantages of this program requiring only 1-2
doses versus the perception of certain parents and caregivers
that varicella (‘chicken pox’) is a normal, innocuous part of
childhood which will reduce uptake of varicella vaccine in
potential programs.
While the overali profile of responses can present certain advantages in
giving a detailed presentation of individual responses of experts in this
activity, it makes global interpretation more difficult. For this reason,
responses were also converted to a single index score which represented
the percentage of a maximal (most favorable) score possible obtained for
each section (Table XVI).
138
Table XVI: lndexed Responses from Activity using Analytical Framework, Immunization
Subcommiftee Meeting, February 2002
Type C Varicella Pneumococcal
Meningo Conjugate
1. Disease Characteristics and Burden 73% 87% 93%
2. Vaccine Characteristics 78% 70% 82%
3. Immunization Strategies 84% 76% 66%
4. Social and Economic Costs and Benefits 61% 74% 74%
5. Feasibility and Acceptablility 90% 51% 82%
6. Ability to Evaluate Programs 79% 71% 69%
7. Research Questions 64% 62% 65%
8. Other Considerations 68% 61% 71%
Overail-this vaccine should be publicly 72% 85% 84%
funded
Comparisons across vaccine types- rankinq
. ..
3rd I 2nd j lst
These resuits were presented to experts at the February meeting to guide a
follow-up discussion. The first part of this discussion involved examination of
areas in which there was littie consensus among experts, and helped to
clarify which areas regarding each potential program were clear versus other
areas which required more discussion and/or targeted research to guide
decisions.
*Conversion method : % of maximal score=
[fOx # of response 1 +lx # of response 2+ 2x # of response 3, +3x # of response 4+ 4x # of response
5)! 4x # of responders] x 100%.
Example: The response profile for row 1, column 2 in Appendix — was the following:
Response: 1 2 3 4 5
Points: 0 1 2 3 4
#of 1 3 0 10 7
responses:
% of maximal score= (Oxl)+(1x3)+(2x0)+(3x 10)+(4x 7)/(4x21) 61/84 = 73%
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Participants were in agreement to the usefulness of such an approach, but
also identified the lack cf a Canadian forum in which ta have this type of
discussion. The meeting concluded with the recommendation that Canada
establish a body ta coordinate national immunization planning, using
exercises such as this one with the analytical framework ta support
Canadian jurisdictions in vaccine evaluation. While coordination and
harmonization of immunization programs is a stated goal of the National
Immunization Strategy, the jurisdiction of the provinces and territories in
health care was not brought into question. However, the possibility of
eventual federal programs ta purchase vaccines for new provincial/territorial
programs was considered as desirable by most participants.
This exercise, developed in collaboration with organizers of the meeting and
some expert participants, illustrates another use of the framework. After
C considering comments of participants, the framework was revised and its
structure of categories was modified. The changes involved dividing the
categories of Feasibility and Acceptability into twa separate categories of
Feasibility and Acceptability. In addition, the original category 8, ‘Other
Considerations’ was divided into 5 categories: equity/accessibility, ethical
considerations, legal considerations, conformity of program, and political
considerations. This gave a total of 13 categories in the revised framework
(Table XVII). This revised framework was tested in a similar experience with
the CIQ in Québec in March of 2003.
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Table XVII: Revisions to Categorïes of Analytical Framework
Original Categories Revised Categories
1 Burden of Disease 1. Burden of Disease
2. Vaccine Characteristics 2. Vaccine Characteristics
3. Alternative Immunization 3. Alternative Immunization Strategies and
Strategies and Programs Programs
4. Social and Economic Costs and 4. Social and Economic Costs and Benefits
Benefits
5. Feasibility and Acceptability 5. Feasibility
6. Acceptability
6. Ability to Evaluate Programs 7. Ability to Evaluate Programs
7. Research Questions 8. Research Questions
8. Other considerations 9. Equity/ accessibility
10. Ethical considerations
11. Legal considerations
12. Conformity cf program
13. Political considerations
Questionnaire #4: FoIIow-up on Use ofFramework
In February 2003, a follow-up questionnaire (Appendix 9) was sent to key
persons in Canadian provinces and territories (eXcept Quebec). The goal of
the questionnaire was to collect additional information to examine to what
extent the framework was known across the country, to what extent it had
been used, and it what manner, to what extent key persons in immunization
found it to be useful and in which manners and contexts. In addition, the
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questionnaire collected information about recent and expected changes in
immunization planning in each jurisdiction.
Considering responses to previous questionnaires and participation in ISC
meetings, one key person was contacted from each jurisdiction to respond
to the questionnaire or refer it to other persons in their jurisdiction qualified
to respond (Appendix 10). As expected, considering that this was the fourth
questionnaire to be administered in this project and that it was distributed
during the SARS crisis, response to the questionnaire was quite limited.
However, information was obtained from five jurisdictions. This was valuable
due to the fact that hile new information had been received about use of the
framework in jurisdictions other than Quebec.
Summary of Responses to Questionnaire #4 by province/territory
Britïsh Columbia
One key person responded to the questionnaire after consultation with
colleagues. The analytical framewotk was noted ta be similar to that used in
Ontario and B.C. for the preparation of budget submissions, treasury board
submissions, or briefing notes related to obtaining new funding for vaccine
programs. While the framework had not yet been used, it was seen as
providing a good structure for future submissions. It was also mentioned
that the framework must be individuahized for specific vaccines with some
parameters carrying more weight than others depending on the context. The
framework was seen as potentially useful in providing a template for funding
requests for new programs, serving as a reminder of key issues ta be
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included. In Canada in general, it was proposed that the framework could be
used by Health Canada, or a working group under the new National
Immunïzation Sttategy, to ‘f111 in the blanks’, assisting many provinces and
territories in this process in completing the identical or similar components of
their submissions to their respective governments. The framework was
considered to be a good approach to detailing the considerations
undertaken in preparing a justification for a new vaccine program for policy
makers and politicians. Standardized pharmacoeconomic analyses were
seen to be of increasing importance as vaccines become generally more
expensive (and less cost-effective). A major challenge in B.C. was stated as
having insufficient resources to deal with current challenges /competing
priorities such as West Nue Virus, SARS, and new vaccine programs.
However, a process underway to deVelop ‘cote programs’ for public health
was seen as a potential solution in articulating clear goals/objectives for
immunization programs. Challenges in obtaining funding for new
immunization programs include convincing decision-makers that diseases
are worth preventing, and that programs wiIl actually be as cost-effective as
predicted. Varicella was an example of a program with these two concerns,
as weIl as concerns about potential harm from insufficient coverage.
In terms of solutions to deal wïth these challenges, more resources from the
NIS for example, could help. In addition, standardized approaches to
pharmacoeconomic analyses and Canadian-based research into the
determinants and deterrents of immunization uptake or acceptance
including at the political level. In the future, it was considered Iikely that a
wider variety of participants would be involved in the planning process for
new vaccines, and that more information would be collected on various
aspects of pre-marketing of vaccines such as acceptability to health care
providers and the public.
While in British Columbia not enough time has passed since introduction of
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the framework for it to be used in planning activities, this response
corresponds with many themes previously identifled in the project, such as
the desire for support from Health Canada, the approval of the framework as
a useful tool, the desire for coordinated planning, and the need to broaden
the research base to include factors such as acceptability of programs.
Saskatchewan
A verbal response by telephone indicated that in Saskatchewan there had
flot been sufficient immunization planning activities to test the framework.
The framework and immunization planning issues were to be discussed with
the Saskatchewan Immunization Committee.
Man ito ba
Two responders were designated for Manitoba. While several of the
components of the framework had been used in planning decisions, there
was and interest in using the framework as a checklist for funding proposais
for new vaccines. The framework was also seen as being useful in planning
decisions, should the federai government eventually fund immunization
programs. Another unanticipated use of the framework was in educating
health care professionals and the public about the various important aspects
of immunization programs. This framework was seen as beneficial in
addressing ail areas of concern for health care providers, the public, and
politicians. It was seen as a tool that could avoid duplication of efforts
between provinces and territories for evaluation of potential programs.
Another advantage of the framework was to make specific differences
between programs and key ‘stumbling blocks’ to funding or impiementation
more explicit, aiding understanding of ail relevant issues. This could also
increase transparency in justifying the basis for public spending decisions by
Ministries of Health and governments.
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In terms of desired changes to immunization planning in Canada, targeted
research on questions of national intetest (i.e. efficacy of acellular pertussis
vaccines in adolescents) was mentioned as welI as cost-effectiveness
studies which could be included in NACI recommendations. An increased
interest in cost-effectiveness analyses, as well as coordinated planning was
mentioned. The Manitoba immunization commiffee requested additional
information on the framework, to study possibilities for integration into their
planning process. Finally, this type of effort was seen as potentially assisting
immunization and other areas of prevention in allaining a higher profile and
a justified increase in funding in Canada.
Nova Scotia
A response was given by telephone, which indicated that appropriate
persons were aware of the framework in Nova Scotia, and apprecïated its
usefulness. However, it was mentioned that they did not have current
programs under consideration and therefore had not tested the framework.
Northwest Territories:
It was indicated that the framework had been used in discussion of
pneumococcal and meningococcal vaccine position statements in the NWT.
The framework was seen as being useful in bringing more variables for
consideration and broadening the scope of the evaluation process for new
programs, helping the planner organize a logical argument and providing
guidelines for putting forward policy options. Major challenges in NWT
mentioned were vaccination coverage, funding for new programs, and
education of health care personnel.
f
The framework was seen as an ‘excellent tool’, which was adopted in the
NWT. In fact, an article on the framework and criteria for evaluating
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immunization programs was published in the issue of Epi-North a publication
on public health by the NWT Department of Health and Social Services
(BelI, 2002). The author of this article was the representative for the NWT at
meetings of the Immunization Subcommiffee.
While these responses from several jurisdictions were partial and did flot
represent ail jurisdictions, they confirmed data collected in other steps of the
project. The challenges facing various jurisdictions in terms of funding for
new programs, and the interest in cost-effectiveness analysis were
confirmed, as were the desire to avoid duplication of efforts and for beffer
coordination of planning. Despite the relatively short time frame in terms of
observable impacts on public health planning decisions, the framework was
welcomed as a useful tool and part of eventual, broader changes in this
area. Multiple examples of unexpected adoption or use of the framework
(educational uses, journal article, ongoing discussions) suggest that this tool
was useful to those involved in immunization planning. These general
tendencies are encouraging in that they are quite similar to data collected in
numerous other steps of the project in various jurisdictions. Ongoing and
future events in 2004 and beyond will certainly provide more occasions to
further examine the adoption and potential impacts of this project.
National Advisory Commiftee on Immunization Meeting (October 2003)
As a key organization in the area of immunization in Canada, The National
Advisory Committee on Immunization (NACI) is an important player in any
proposed organizational changes in this area. NACI was asked to consider
the use of this framework in an expanded role for current programs under
consideration by Health Canada. In October 2003 a presentation was given
at the NACI meeting explaining how the framework has been used to date,
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and commentïng on how it could be potential used by NACI to coordinate
national immunization program planning. This demand came in the context
of organizational changes in immunization program planning in Canada,
such as the emergence of a new national immunization commiffee the
‘Canadian Immunization Committee’, made up of Chief Medicai Officers of
Health from the 13 Canadian jurisdictions. This commïttee’s first meeting
occurred in November 2003.
Canadian Immunization Committee Meeting (November 2003)
Following presentation of the framework to NACI in October 2003, and a
meeting of key persons on possible structures and processes for
immunization program planning in Canada (October, 2003), the analytical
framework was presented to the Canadian Immunization Committee at its
inaugural meeting in November 2003. While the exact functioning of this
group is under discussion, the framework is one potential tool to help this
group develop methods for harmonizing publicly funded immunization
programs in Canada. More officiai information on the functioning cf this
commiffee and their pianned use of the analytical framework is expected to
be published or otherwise made availabie in 2004.
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Provincial Level- Québec
In phase A, it was proposed that this project be conducted in collaboration
with the Institut national de santé publique du Québec (INSPQ) and lot the
Agence d’évaluation des technologies médicales et des interventions en
santé du Québec (AETMIS). Finally, it was decided that this project would
be conducted in collaboration with the CIQ on an ad hoc basis, (the details
of the collaboration were to be determined later). This collaboration was
greatly facilitated by the fact that one of the main researchers on our project
(Dr P De Wals) is also the president of the CIQ. Unlike the federal project,
the actual intervention was less well deflned in tetms of timing, steps and
scope. lnitially, two presentations were given to present the potential uses of
the framework and also to inform the CIQ of the advancement of the federal
p roject.
Once the prototype framework (or template) had been developed in the
federal project (as described in previous sections) the details of the
framework were presented to the CIQ. However, no immediate dates were
determined for such an exercise, therefore much time passed and this item
was often pushed back to later meetings of the CIQ. In spite of this, the
framework was integrated into vaccine specific workïng groups of the CIQ at
an early stage, for programs such as meningococcal conjugate vaccine and
pneumococcal conjugate vaccine. The overali structure of the Quebec
intervention and results to date is presented in Figure 21.
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Figure 21: Actual Project Interventions in Quebec (untfl December 2003)
Protope ftework developed in project wi Heal Canada
1’
Promotion of testing and use of framework by CIQ
4, 4,
Testing with evaluation
Testing with CIQ working groups on individual programs of multiple vaccines in
CIQ meeting (March
2003)
Meningococcal conjugate Pneumococcal conjugate vaccine Acellular
vaccine pertussis
vaccine
framework Economic Participation in Economic Framework follow-up questionnaire
uscd to evaluation working group evaluation project used to and evaluation
structure project meetings structure report
report
4, 4, 4, 4, 4, 4,
Development framework used to Development of
of computer structure report computer
Report interface interface finalization Continuation in 2004published 4, 4, 4, and (to be determined)
Diffusion and Report published Diffusion and publication
.
. . of reporttesting (sept 2003) tcsting (ongoing) (in progress)(ongoing)
2004 and beyond: Possible continuation wzth other vaccines, i.e. Hepatitis A & B
Testing with individual vaccine working groups
Menïngococcal Conjugate Vaccine Report
This report, completed by members of the CIQ, used the framework to as its
structure (CIQ, 2002). This can be seen by comparing the framework
categories to the table cf contents of this report (Table XVIII)
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Table XVIII: Comparison of sections of report on Meningococcal Conjugate Vaccine and the
Analytical Framework
Sections of Report Corresponding Categories of
Analytical Framework
Introduction -
Disease Characteristics Disease Characteristics
Vaccine Characteristics Vaccine Characteristics
Vaccination Strategy Vaccination Strategy
Cost-Effectiveness Indexes Social & Economic Costs and
Benefits
Acceptability of Program Feasibility & Acceptability cf
Feasibility cf Program Program
Evaluation of Program Evaluation cf Program
Research Questions Research Questions
Other Considerations Other Considerations
Conclusions
Recommendatïons
References
Pneumococcal Conjugate Vaccine Working Group (Québec)
In October 1999, the Comité d’immunisation du Québec (CIQ) created a
working group to study the pertinence cf introducing the new heptavalent
conjugate pneumococcal vaccine (known as Prevnar® or PCV-7) into the
regular infant immunïzation schedule in Quebec. This mandate included the
production of a report including consideration of the burden 0f
pneumococcal disease in chiidren, vaccine characteristics, costs and
benefits of a program, feasibility and acceptability of this potential
immunization program. This report would aim to assist public health
authorities in making an informed decision regarding the use of PCV-7 in
Québec.
Meetings of the PCV-7 wotking group were attended to discuss economic
evaluation cf the program and also to explain the potential use 0f the
analytical framework by this working group. Due to the strong concordance
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between the mandate 0f the PCV-7 working group and the elements of the
analytical framework, it was suggested that the working group use the
framework to structure their work and the final report. This was accepted,
and the sections of the analytical framework indeed correspond to the table
of contents of the group’s final report (Guay et al., 2003) as presented in
Table XIX.
Table XIX: Comparison of sections of report on Pneumococcal Conjugate Vaccine and the
Analytical Framework
Sections of Report Corresponding Categories of
Analytical Framework
Introduction
-
Disease Characteristics Disease Characteristics
Vaccine Characteristics Vaccine Characteristics
Potential Programs and Potential Programs and
Strateg les Strateg les
Social & Economic Costs Social & Economic Costs and
and Benefits Benefits
Feasibility & Acceptability of Feasibility & Acceptability of
Program Program
Evaluation of Program Evaluation of Program
Research Questions Research Questions
Other Considerations Other Considerations
Recommendations
-
References
-
This report was officially made public by the Institut de santé publique du
Québec (INSPQ) and posted on their website (www.inspq.qc.ca) in
September 2003. Like the meningococcal conjugate vaccine working group
report, this report followed very closely the categories of the framework. This
type of common structure between evaluation efforts for different programs
is a concrete example of adoption and impact of the analytical framework in
Quebec.
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Pertussis Vaccine Working Group (Québec)
The working group on pertussis is also in the process of writing a report on
the pertinence of potential immunization programs using the acellular
pertussis vaccine in Quebec for adolescents and aduits This committee is
also utilizing the framework to structure their report, which is currently beïng
written (De Serres G, personal communication). The framework was
proposed for use in a national consensus conference on pertussis in 2002.
initial planning discussions were heid but the proposed activity did flot occur
at thïs meeting. This could have been due to the fact that this proposai
arrived too late in the planning ptocess for the meeting, however the exact
reason is uncertain.
Hepatitis A and B programs
In addition, there is currently the possibility of using the framework with a
working group and a potential coordinated national effort regarding new
hepatitis A and B immunization programs in Canada. Discussions were held
in November 2003 with the 1NSPQ, the CIQ and AETM1S regarding potential
joint efforts in evaluation of these potentiai programs. As of December,
2003, A project submission to Health Canada as part of the National
immunization Strategy is being prepared. A second possibility is submission
to CCOHTA for funding as part of current technoiogy assessment initatives
of national importance in Canada. Concrete developments in this area are
expected in eariy 2004.
Testing with evaluation of multiple vaccines
At the CIQ meeting in March 2003, a prioritization exercise similar to that
conducted in Februrary 2002 was conducted using the framework to
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compare the following potentïal programs:
> Meningococcal conjugate vaccine
> Heptavalent pneumococcal vaccine
Varicella vaccine
> Acellular pertussis vaccine (for adolescents and adults)
A worksheet on the framework was circulated to participants in the meeting
(Figure 22). The worksheet used was based on that used in the February
2002 National Immunization Meeting except for the addition 0f the fourth
candidate program, acellular pertussis for adolescents and adults. Following
comments on revisïon of the framework from testing at the February 2002
meeting, the 8 categories were revised to 13 categories.
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As in the previous exercise, participants were asked to evaluate the
potential programs based on their current knowledge and taking into
account the expert presentations which had occurred in the CIQ meetings.
As in the federal exercise previously presented, these responses can be
indexed to facilitate comparison (Table XX).
Table XX: lndexed Responses from Activity using Analytical Framework, CIQ Meeting, Match
2003
% of maximal (most favorable) score for each category*
Type C Varicella -Pneumococcal Acellular Pertussis
Meningo Conjugate for
adolescents!adults
1. Disease Characteristics and 64% 59% 91% 50%
Burden
2. Vaccine Characteristics 82% 69% 78% 75%
3. Immunization Strategies 79% 72% 88% 75%
4. Social and Economic Costs 54% 56% 34% 38%
and_Benefits
5. Acceptability 93% 53% 79% 34%
6. Feasibility 79% 75% 64% 50%
7. Ability to Evaluate Programs 93% 88% 86% 63%
8. Research Questions 68% 56% 75% 81%
9. Eguity/Accessibility 79% 81% 79% 72%
10. Ethical Considerations 82% 71% 79% 68%
1 1. Legal Considerations 79% 66% 68% 72%
12. Conformity of Program 50% 59% 69% 38%
13. Political Considerations 96% 47% 66% 25%
Overail-this vaccine should be 79% 78% 94% 71%
publicly_funded
Comparisons across vaccine types- 3td 2nd 4th
ranking
*Conversion method was the same as for Table XVI)
Like the exercise on the federal level, certain pafferns emerge, such as the
recognition of the burden of pneumococcal disease, and the very political
nature of meningococcal programs. With the addition of the acellular
pertussis program, we see that it is flot supported as much as the other
potentiat programs by experts in Quebec. This exercise should be repeated
on the national level to verify agreement of responses. These responses
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provide many areas to target discussion to examine ateas of divergence and
consensus among Quebec experts regarding these immunization programs
Comparison of Vaccine Ranking Exercises: National Meeting versus
CIQ meeting.
The two similar activities using the framework worksheet to evaluate
programs and guide discussion among experts on federal and provincial
(Quebec) levels can be compared. There are several significant differences
between the National Immunization Program planning meeting in February
2002 and the Comité d’immunisation du Québec (CIQ) meeting in March
2003 in which the framework was formally tested. First of ail, an additional
vaccine was added to the worksheet, the aceilular pertussis vaccine for
adolescents and aduits. Secondly, the framework categories were expanded
from 8 to 13. However, for the categories which did not change, it is
interesting to compare response profiles in the two contexts. Consider for
exampie Category #1: disease burden and characteristics applied to the
heptavaient pneumococcal program (Table XXI, Figure 23). The response
profile at the CIQ meeting, like the Canadian meeting, had a reiatively strong
consensus as is seen in the concentration of tesponses in the iast two
categories of the Likert scale (on the favorable end of the response scale).
Table XXI: Comparison of Response Distributions on Provincial and Federal Levels: Burden of
Disease, Pnemococcal Conjugate Vaccine
Number of responders per category, evaluation ofBurden of
Disease
Response CIQ meeting, March 2003 ISC meeting, Feb 2002
Unfavorable O O
(1)
(2) 0 0
(3) 0 0
(4) 3 5
(5) 5 13
favorable
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Alternatively, these resuits can be presented graphically (Figure 23).
Figure 23: Comparison of Responses for Burden of Pneumococcal Disease
it is important to indicate that these comparïsons are made on a purely
exploratory basis. While the exercises were similar in nature in asking the
experts to make a certain judgment using the framework about the
candidate vaccines, there were important differences such as the context
(national versus provincial meeting), the framework used (8 vs. 13
categories), the timing (Feb 2002 vs. March 2003), and also the time given
to complete the responses. In the CIQ meeting, less time was available for
the activity, and expert presentations were only given on one of the potential
programs (acellular pertussis vaccine for adults and adolescents).
Another example is category 4, social and economic costs and benefits for
meningococcal conjugate vaccine (Table XXII). in the CIQ meeting, whïle
there was a smaller number of responders, the responses are fairly widely
ISC Meeting, Feb. 2002
CIQ Meeting, March 2003
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distributed, indicating a Iack of consensus, with most experts in the central
area of the scale.
Table XXII: Comparison of Responses on National and Provincial Levels: Meningococcal
Conjugate Vaccine
Number of responders per category, evaluation of Social and
Economic Benefits
Response CIQ meeting, March 2003 ISC meeting, Feb 2002
Unfavorable
(I) I O
(2) 1 4
(3) 2 6
(4) 2 5
(5)
favorable 1 4
As in the previous example, these responses can also be presented
graphically (Figure 24).
Figure 24: Comparison of Responses at National and Quebec meetings: Social and Economic
Costs and Benefits of Meningococcal Conjugate Vaccine
•
DCIQ Meeting,
March 2003
O ISC Meeting,
Feb. 2002
—r
unlavorable (1) r
ISC Meeting, Feb. 2002
CIQ Meeting, Match 2003
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This particular application 0f the framework with the CIQ differed from the
application at the national meeting in February 2002 in various ways, other
than the addition of another (fourth) candidate program to the exercise.
These differences are summarized in Table XXIII. Contrary to the previous
exercise on the federal level, planning for the CIQ meeting was aU hoc, at
the Iast minute, and poorly structured. When the activity was finally
per[ormed in March 2003, this was only following multiple and sometimes
repetitious presentations at the CIQ meetings, over the previous year, after
which the exercise was pushed off the agenda and delayed until the next
CIQ meeting. The fact that four potential programs were considered
increased the demands of this exercise considerably, especially considering
the fact that there was only a presentation on one of the candidate programs
during the meeting. The fact that the framework had expanded from 8 to 13
categories also increased the number cf responses required of participants
52 in the CIQ meeting versus 24 in the federal meeting. This produced
somewhat of a ‘cognitive overload’ for participants, who often commented
that the number of categories was too high, and the time was toc limited, a
comment which was absent from the federal meeting.
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Table XXIII: Differences in the exercise with the Analytical Framework Exercise with the CIQ
(Match 2003) and in the federal meeting (Feb 2002)
Aspect CIQ meeting Federal meeting comments
Planning ofactivity Ad hoc, ofien delayed, Systematic, multiple This could explain the
unstructured, role of meetings, and superior functioning
researcher unclear. telephone conferences, and evaluation ofthis
role ofresearcher clear activity at the federal
and defmed by formai level.
contract.
Number of 4: as in federal meeting 3: variceila vaccine, This was due to timing
vaccines with addtion ofacellular pneumococcal ofthe meeting and
considered pertussis for aduits and conjugate vaccine, advancement ofthe
adolescents meningococcat evaluation process for
conjugate vaccine. these vaccines
Number of 13: revised version 8 Nuber ofcategories
caterogies in the was increased after
framework comments at federai
meeting, however, this
does not seem to have
been an improvement.
lime for meeting Part of an aftemoon Most of a day There was flot enough
time availabie in the
CIQ meeting to
optimally perfonn the
activity.
Expert One given on same day, Presentations on ail For the other candidate
presentations following the framework three programs given programs, CIQ
categories at same meeting, members were asked to
stmctured with consider previous
framework presentatïons, flot
necessariiy structured
around the framework.
lime for discussion Limited Ample time given in Discussion in federal
meeting meeting aiso revolved
around possible
organizational changes.
Foilow-up or next Unclear- possibly for Discussions underway Possible in early 2004
actions hepatitis programs with NACI, and CIC,
possibly for hepatitis
programs
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Questionnaire on appreciation of framework
A questionnaire was circulated to members of the CIQ regarding their
appreciation and suggestions for use of the analytical framework,
specifically in this activity as well as in general. The full questionnaire and
responses (in French) are presented in Appendix 9. The questions and
variety of responses can be summarized as follows:
1. Appreciation of activity with framework:
The activity was generally seen as useful. However, participants noted that
there were too many categories in the framework, there was not enough
time to correctly complete the worksheet, and that criteria were not well
defined enough to evaluate for each potential program. It was also seen as
important to define the precise program strategy before evaluation.
Participants feit that not ail categories should have the same importance.
For example, one responder feit that too much emphasis was placed on
political, legal and ethical considerations and not enough on vaccine efficacy
and short and long term benefits of immunïzation. Overail, responses
indicate that while members of the CIQ appreciated this type of activity,
many improvements could be made. This would require time and effort to
plan a structured discussion by CIQ members to determine how they could
best use this framework.
2. Which tools or other processes should be used with the CIQ in the
future?
Members suggested having better structured meetings, with use cf the
framework with standardized criteria and responses, and evaluation of
specific immunization strategies. It was proposed to use the framework to
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structure future written documents produced by the CIQ.
3. Have you used the framework in other contexts?
Some members mentioned having used the framework on several
occasions with medical students or medical residents in community health to
inform them of the complexity of decision-making in immunization, and
prepare for their licensing examinations.
4. What other applications of this tool should be considered in the
future?
Members suggested using the framework to plan a pre-decision research
program, as a tool for directors of public health and other decision-makers,
to communicate between various actors in the health system (nurses, M.D.s,
CLSCs, etc.), and also for educating students in medicine and nursing. It
was also mentioned that this tool should be proposed to Health Canada and
NACI.
5. Considering expected changes in the next 10 years, what actions
should be taken to support immunization planning in Quebec?
Members had numerous suggestions for this question, including better Iinks
with the media and better promotional efforts for vaccination. The need to
address the notion of opportunity cost, increase research capacity in
economic evaluation and to have specialists in this area on a permanent
basis was highlighted. A general effort to inform decision-makers and the
public of important criteria for decisions in this area was also mentioned.
Finally, better monitoring systems for vaccine-preventable diseases, a
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vaccination registry, and a national immunization strategy were also noted.
2. Other comments:
Previous comments on the format of the framework were again mentioned
that there were too many categories and that there were possibilities of
different interpretations of sub-categories. However, it was mentioned that
this process was essential, and could have a positive impact on the public
health system at the provincial and federal level. Overall, this questionnaire
indicates that the CIQ members had many ideas of how to improve this
partïcular actïvity. More systematic planning of this activity, more time for the
ctual activity and more consultation of CIQ members beforehand to tailor
the activity to the needs of this committee would have perhaps avoided
these problems.
However, CIQ members appreciated the framework and had many ideas for
improving the immunization planning process in Quebec and in Canada.
Overail, their desire for increased coordination and more systematic
planning ïncluding resources for economic evaluation of potential programs
confirmed the comments collected in various other steps of the programs
from various key persons in other Canadian jurisdictions.
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Targeted intervention on one category of framework: Social and
Economic Costs and Benefits
In conjunction with the immunization program planning project with Health
Canada, the specific area of category 4 of the framework, ‘Social and
Economic Costs and Benefits’, was targeted for study and intervention. The
goal was to illustrate how specific categories of the framework could be
examïned to develop national coordinated efforts in research and planning.
This focused effort at national coordination on a specific area of the
analytical framework aimed to facilitate the development of other
coordinated efforts in other categories of the framework (i.e.: acceptability
and feasibility of programs).
Researchers in this project had previously been involved in numerous
economic evaluations in the area of immunization, for exampie the
meningococcal polysaccharide mass immunizatïon campaign (De Wals &
Erickson; 2002), meningococcal vaccination 0f college students in the U.S.
(Scott et aI, 2002), use of the pneumococcal conjugate vaccine in Canada
(De Wals et ai, 2003a), and the meningococcal conjugate vaccine (De Wals
et al., 2003b), and economic evaluations of influenza vaccination programs
(presentation at Influenza Conference, Montreal). This experience and
observation of the actual use (or non-use) of the results of these studies,
involvement with Heaith Canada in an effort to improve use of and
timeliness of economic evaiuations as weIl as the expressed demand for
beffer coordination of economic studies motivated this project, which aimed
to Ïmprove coordination of economic evaiuations of vaccines in Canada. The
original means chosen was to develop a flexible computer interface for
economic evaluation of programs which could be modified and updated by
users. Therefore, ail jurisdictions could adapt economic evaiuations of
potential programs easiiy to their jurisdiction by changing parameters such
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as population, epidemiology of disease, vaccine price and number of doses.
This program could also be used as an educational tool. Two economic
evaluations wete selected for intervention: the pneumococcal conjugate
vaccine and the meningococcal conjugate vaccine.
Pneumococcal Conjugate Vaccine
The vaccine manufacturer, Wyeth-Ayerst Canada, and Heaith Canada,
financed an economic evaluation under the direction of Dr De Wais. To
ensure impartiality, the project was conducted in collaboration with the
Agence dévaluation des technologies et des modes d1ntetvention en santé
du Québec (AETMIS). The output of this project was a report (AETMIS, in
press) and a journal article. However, in addition to this, a computer
interface was developed in collaboration with AETMIS. This computer
interface allows users to modify the assumptions of the economic model and
change parameters such as the population vaccinated, which is useful for
individual provinces and territories to estimate budgetary impact of a
potential program in their jurisdiction. This interface was presented at the
Quebec Journées annuelles de santé publique (JASP) in Quebec City in
November 2002, and also at the Canadian National Immunization
Conference in Victoria, British Columbia in December 2002. In addition, the
program is available for testing to representatives from ail Canadian
provinces and territories.
Meningococcal Conjugate Vaccine
The concept of a computer interface was taken further for the economic
evaluation of the conjugate type C meningococcai vaccine, in collaboration
with the population and public heaith branch of Heaith Canada. A more
user-friendly computer interface was developed, MeninGo Solution,
downloadabie in a CD-ROM format or from a website, with an information
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bookiet, protected by copyright. The MeninGo Solution CD is currently being
distributed to key persons in immunization program planning in Canada for
testïng. When outbreaks of meningococcal disease next occur, key persons
should have this computer program on hand, which can be readily modified
or updated to reflect the current epidemiological and vaccine cost data. This
should provide valuable information regarding the use of economic
evaluations by scientific experts and key decision-makers in Canada.
Data collected in thïs project have indicated an interest in the development
of coordinated and standardized methods in this area. Despite the fact that
there are many questions about the interpretation and use of economic
evaluations and their actual impact on decision-making (Contandriopoulos,
1999; Salkeld et al., 1995), factors such as the timing and the manipulability
of tesearch have been mentioned to increase impact (i.e.: Beyer and Trice,
1982), therefore this type of interactive form of economic evaluation should
be studied as a first step in beller understanding and improving this process.
It is important to examine, particularly for programs with intense political
pressures such as meningococcal vaccination, the actual role economic
considerations and specific research evidence play in program decisions.
This sector of the project is ongoing and hopefully will provide useful
information on use of economic evaluations and improvement in this area.
Other diffusion! communication efforts for project
In addition to the efforts previously mentïoned during this project, there were
numerous occasions in which the framework and lot the project including
proposed organizational changes in immunization in Canada was diffused
publicly. These events were important as they increased awareness of the
project with key persons in immunization in the Quebec and Canadian
contexts. Here are the key events in conferences, publications, and
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information on web sites:
Presentations at Conferences:
The framework and the project wete presented on numerous occasions at
confetences on the federal and provincial levels. This allowed experts in the
area to be aware of the project and to link it to other activity in the area of
immunization on the federal and provincial levels.
> National Immunization Conference, Halïfax, December 2000:
The development of the framework and the project on immunization
planning was presented at a plenary presentation on the National
Immunization Strategy (Arlene King, Joel Kefiner).
> 8e Colloque provincial en maladies infectieuses, Huli, Québec,
1f-12 mai 2000: The prolect on development of the framework
was presented in a plenary presentation (Philippe De Wals)
> Colloque provincial de maladies infectieuses, Québec City, f 18-
19 avril, 2002): The immunization planning and decision-making
processes in Quebec were presented as well as the framework and
compared to current work in technology assessment ( Philippe De
Wals, Lonny Erickson, Van Hung Nguyen).
> Journées Annuelles de santé publique (JASP), Québec City,
(Nov, 2002): The analytical framework was presented in a
seminar on technology assessment and immunization (Lonny
Erickson, Renaldo Baffista, Philippe De Wals). A computer interface
developed for the pneumococcal conjugate vaccine in collaboration
with AETMIS was also presented at their kiosk at this conference
(Lonny Erickson).
> Canadian National Immunization Conference, Victoria BC,
(December 2002): The project examining structures and
processes for immunization planning and the framework was
mentioned in a plenary presentation (Arlene King). The computer
interface developed for the meningococcal conjugate program was
ptesented at a kiosk at the conference (Lonny Erickson)
Réunion de la Direction Scientifique, AETMIS, (Feb., 2003):
The project on the development of the analytical framework was
presented wïth potentïal applications to health technology
assessment (Lonny Erickson).
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> Conférences-midi, DSPPÉ Montérégie (Jan 2004):
Presentation wiII be given on development and testing of the
analytical framework (Lonny Erickson).
Web Sites
> A COPY 0f the Power point presentation given at the Journées
Annuelles de Santé Publique (JASP) is available on the site of the
INSPQ. (www.inspg.gc.ca)
This presentation was posted on the site of AETMIS (
www.aetmis.qouv.gc.ca) in English and French in May, 2003.
> The reports on meningococcal and pneumococcal programs are
available in the publications section of the INSPQ site
(www.inspg.gc.ca)
Summary cf presentatïon given at the Canadian National
Immunization Conference, December, 2002 entitled ‘Working
Together Better: Program Planning and Equitable Access to
Immunization in Canada’ (http://www.hc-sc.qc.ca/pphb
dqspsp/publicatlccdr-rmtc/03vo129/29s4/29s4 2e. html ) on Health
Canada’s website (also published in CCDR)
The Canadian Institutes of Health Research (CIHR) Institute for
Infection and Immunity mentions the need for and advancement 0f
the National Immunization Strategy, including ‘collaborative program
planning for equitable access’ at: http://www.cihr
irsc.gc.ca/e/institutes/iii/1 7777.shtml?
The importance cf the internet as a means of diffusion of this project is hard
to quantify exactly, however some statistics are available concerning the
number of downloads of the presentations on the analytical framework from
the site of AETMIS since May, 2003 (Table XXIV):
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Table XXIV: Statistics on num ber of downloads of presentation on Analytical Framework from
AETMIS web site, May-September 2003
Month french version English Version
May 2003 6 2
June 2003 6 11
July 2003 2 7
August 2003 5 15
September 2003 18 19
Total 37 54
Source: Service des communications, AETMIS, November 2003
Combined with the INSPQ site, the posting of this information on the internet
is another effective diffusing information about the framework and this
project.
Publications
> The two reports from the CIQ working groups on the
meningococcal and pneumococcal conjugate vaccines.
An article on the development of the framework is being
prepared for submission to the Canadian Journal of Public
Health in early 2004.
> Summary of presentation given at the Canadian National
lmmunization Conference in December 2002 was published in
CCDR (Canada Communicable Disease Report, 2003)
CHAPTER V: DISCUSSION
Discussion of resufts must be conducted considering the action research
approach of this project. In anaiyzing the resuits, we see the representation
of certain types of phenomena mentioned in the literature. Objective,
cognitive, situated and political aspects are ail present. In addition using the
three types of knowiedge constitutive interests proposed by Habermas
(1972, 1974), what was originally a project invoiving oniy technical and
practical levels was expanded to inciude a critical element, due to the action
research approach.
Analysis: Looking with Several Eyes
Following a broad theoreticaiiy inclusive approach similar to that proposed
by many authors (Huberman, 1989; Astley & Van de Ven, 1983; Armistead
& Meakins, 2002; Nutley et ai, 2003, Hiidebrand, 1999; Kemmis &
Mclaggart, 2000; Schuitze, 1999) in an effort to more fuily understand the
various leveis of this intervention, a fou r-ievel theoretical modei was adopted
for analysis of this particular intervention. However, this modei was refined
as previously presented (Figure 6) to include four levels on the subjective to
objective poles:
Rational/Objective
Cognitive
> Situated
Political
After preiiminary analysis of resuits of this intervention, correspondences
between these four levels were found with various aspects of the
intervention. We can therefore add these components to our original model
of the intervention, applying them specifically to the creation of the anaiyticai
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framework (Figure 25). This allows us to consider the varlous steps of the
intervention in relation to their influence on the four levels of impact leading
to adoption/utilization of the framework and the ultimate effects cf the
intervention, and explore the suitability of this emergent model.
Figure 25: Emergent Modet of Intervention with 4-Level Theoretical Model for Analysïs
ftedbak
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Ihe presence of rational, cognitive, situated and political factors in this
project wiIl be considered in terms of specific aspects of the project.
However, it is important to first consider the broader scope of how the
overali intervention compared to the original planned project.
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Actual versus Planned Intervention
The resuits indicate that this project went beyond the simple development of
an analytical framework, examining organizational structures and proposing
organizational changes in Canada. The actual intervention did flot include ail
elements of the original pianned intervention. For exampie, the development
of a single, universal framework and its revision using the Delphi method did
not occur. This was in part due ta a Iack of interest in continuing the
refinement of the framework, instead using a flexible ‘template’ which could
be modified according to different uses. Anothet reason was the interest in
discussing and expioring possible organizational changes in Canada. The
fiexibility of the action research apptoach allowed the project to be
expanded in scope ta beffer respond ta needs af stakehoiders and
ultimately have braader impact. These changes in the project made it
diffïcult ta have a high methodological complexity in data collection in this
praject. However, this was compensated by a gain in relevance, adoption af
the innovation, and iong-term impact af the project. The first major events in
p!anning the actuai intervention will be considered in the next section.
Phase A: Startup ofproject
The project was developed in close collaboration with Dr De Wals, an expert
on immunization very active in research on the provincial, Canadian and
international leveis. This certainly provided much expert experience in
designing a tool and means of intervention flot available ta an outsider ta
this context, and promoting the innovation from within this context. This
corresponds ta the notion of the important raie and contribution of a
‘champion’ of an innovation noted in the literature (Schôn, 1963; Rogers
1995). Also, there was careful consideration of similar efforts in the area of
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immunization such as the Vaccines for the 21st Century project. The initiai
proposai was to perform the same type of exercise as in this project,
however adapted for Canada. After refiection and discussion, it was decided
to pursue another approach. This was in part due to knowiedge of the needs
cf the decision-making context in immunization in Canada, and also of the
limits of the approach of Vaccines for the 21st Century, which was based on
prioritizing new vaccines in the next 10 years based on cost-effectiveness
models. From the outset, the approach of the framework was based on a
more flexibie, interactive approach. in terms of Habermas, this project began
with a technical approach in the deveiopment of the framework, but was also
practical in that it sought învolvement of stakeholders and active testing cf
this tooi from the outset.
This fiexible, interactive approach allowed the project to be tailored to best
integrate with the two major contexts of application- the nationai ievel and
the provincial ievei in Quebec. The intervention on the two ieveis was quite
different, and depended on the individual agenda and timelines of partners
at each level. One major difference which existed between the two ievels of
intervention was the fact that there was a formai contract at the national
levei, whiie in Quebec, there was simply an informai agreement to examine
the potential uses of the framework (with no written contract). This
formaiization of the intervention on the national ievei had many advantages
such as clarifying and iegitimizing the role of the researcher and the project,
providing a clear and defined timeline for the project, and defining specific
deiiverables for each phase of the project. At the federai ievel, there were
systematic iterations of data coiiection, feedback, revision, reflection and
action in the true nature of action research. This helped increase the
richness of the data and confirmed its validity, and was a definite strength of
the project on this Ievei. In contrast, on the provincial level in Quebec, with
the absence of a defined project and contract, the deiays were much longer
and the proposed activities could be easily pushed back on the agenda to
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later meetings. Therefore there were fewer iterations and systematic
feedback on this level of the project, which Iimited the planning of certain
interventions and perhaps aiso the scope of the project.
OveraN, both levels of thïs project (federal and provincial), we note the
crucial importance cf forming partnerships in the startup phases of such a
project, and allowing structures and process of the context of application to
influence the ptoject to aid in adapting it to the particular seffing in a
process, which is more political than scientific in nature. This was an
essential step that assisted the project enormously and allowed many
opportunities, contexts, and interventions that would flot have been possible
otherwise.
Federal Level
On the federal level, submission of the original project proposai was crucial
to the success cf the project, as it began a process of discussion and
negotiation which led te the agreement of a formai contractuai collaboration
with Health Canada. Thïs allowed the development of the framework to play
a role in the larger effort of developing a National Immunization Strategy,
specifically one cf the five components, which was to help ensure that
vaccines in Canada are accessible and utilized in a cost-effective manner. A
second component, goals and objectives for immunization programs, was
added later to the project. The support and involvement cf Health Canada
gave legitimacy to the project and facilitated data collection by relating the
project to the National immunization Strategy. Consider simply the
considerable resources required te finance, schedule and organize multiple
face-to-face meetings wïth representatives from aIl 14 Canadian jurisdictions
in the area of immunization, a unique opportunity for the researcher te
present the project to key persons from across Canada, observe, interact,
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and actively participate in the discussion and consultation ptocess of
meetings of the Subcommiffee on Immunization.
These observations correspond with certain observations from the literature
on the political or contextual level regarding the importance of factors such
as personal contact between researchers and decision-makers, participation
cf users, and relevance to the policy agenda. This initial stage was indeed
very polïtical, involving a rich process of discussion and communication with
the Division of Immunization at Health Canada to explain the project and its
potential benefits, foliowed by more discussion and negotiation to establish
a very detailed and structured contract including deliverables and precise
deadlines (Table X). For Health Canada and the Immunization
Subcommittee, the framework was cf interest because it represented a
practical means to pursue an important component cf the National
immunization Strategy.
A very interesting and unexpected benefit of this initial negotiation process
with Health Canada was that some additional components were added to
the intervention, namely the study and evaluation of structures and
processes for immunization program planning in Canada. This key addition
allowed the project and its eventual impacts to be much larger in scope than
originaliy expected. The new analyticai framework was not only being
proposed as an innovative way to evaluate immunization programs, it was
part of a broader proposai to change structures and processes for this
evaluation and plannïng process in Canada. The resulting emergence of a
new Canadian Immunization Committee and an expanded role for the
National Advisory Committee on Immunization, with future possibilities of a
federal program for immunization, are ail new forums in which the
framework can be empioyed and have a significant impact.
The interactive nature of this project aiso heiped the project to affain its’
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action research orientation, in which researchers and participants work to
seek and enact solutions to problems of a current situation and bring a
concrete solution (Greenwood & Levin, 2000). This type of intensive
consultation at the beginning of a participatory research project is important
to success. Another factor is the existence of a detailed written agreement
that defines the roles, expectations, timeline and deliverables 0f the
researcher and the participants. Without this structure, there is less of a
clear mandate for the researcher to interact with participants, and this lack
of structure can cause delays and problems with data collection and
advancement of the project, as was seen in Quebec. Part of the approach of
the project, which included data collection on decision-making processes in
Canada in an effort to improve them, can be seen to be a rather functional,
technical or rational approach. However, there is a practical aspect in
examining the pilot testing of the new commiffee in February 2002 (as
described in the results section). This is contrasted however, with the
extremely politicat federal committee meetings and processes of
consultation, discussion, negotiation and consensus-building regarding
immunization program planning in Canada.
In the particular Canadian context of federal-provincial-territorial relations in
Canada, the interest of provinces and territories for federal support in areas
of public health is balanced by their resistance to federal infringement on
their jurisdiction of health spending. Therefore, these federal/ provincial!
territorial initiatives have a uniquely Canadian jurisdictional tension (similar
to meetings on the constitution) that affects their content and functioning.
Again, in terms of knowledge management, this component of the project is
in the reaim of negotiation, and political endeavors, and voluntaristic
(subjective) in terms of the collaborative nature of the consultation and
development process for the framework.
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Development and Testing of the Framework
The data collection regarding criteria for decision-making produced an
impressive array of criterïa that are important in decision-making in
immunization in Canada. However, a similar, yet less detailed list had been
existence and had been published over 20 years ago, but was not in use
(White & Mathias, 1982). The important question was therefore how this
framework could be used and how it should be modified for potential uses.
Whiie there was question initially of developing a more formai framework
with a scoring system, this idea was not practical for several reasons. Firstiy,
this would require enough interest in the deveIopment of such an instrument
nationally and also enough resources to compiete such an exercise.
Secondly, the growing awareness that the importance of various factors was
not constant between potential programs made the development of such a
rigid quantitative instrument Iess desirable and practical. Therefore an
approach in which the framework was distributed and used in various
activities was adopted. This had the advantages 0f enabling this tooi to be
adapted to various contexts and needs at the time of application. By
involving the target users and allowing them to have a role in the use of and
revision of the framework, they became active in the project, promoting
adoption and usefulness of this tool.
Use of the framework in a vaccine ranking exercise was a success. For
example the meeting in February 2002 including presentations by experts
followed by evaluation and discussion was an important learning exercise. In
addition, responses allowed identification of issues on which there was a
consensus among experts versus those for which responses were divergent.
This aliowed targeted discussions to examine further important points. This
type of activity is important in consensus building and can help to identify
research priorities and areas for further study at an early stage. Another
important benefit of this type of activity is to be more efficient among
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jurisdictions, avoiding the repetition of efforts that has occurred in recent
cases. Use of the framework on the national level allowed key persons from
various jurisdictions to distribute it in their jurisdiction, and use it in their
immunization planning activities, or have it ready for use when the next
potential programs are considered, as indicated in responses to
Questionnaire #4.
The spontaneous uptake 0f the framework to be used in educational
settings was an unexpected application of this tool, and added an area in
which this project can have an impact. If this new physicians and nurses are
exposed to this tool, there could be a positive impact on understanding of
the rationale for decisions regarding immunization programs. This is
especially important if these individuats receive documentation about
potential programs that follows the format of the framework, which will be
perceived differently if they have already been exposed to this tool. Finally,
an important event was that the exercise to develop the framework
highlighted the absence of a national forum in which to use it. This was part
of the justification for ptoposed organizational changes that are in the
process of implementation on the federal level. Overali it seems that the
specific details of the framework are less important than the process of
building awareness about current decision-making processes and
generating ideas about how to improve them with key stakeholders in
Canada.
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Examination of structures and processes for Immunization Planning in
Canada
The addition of this aspect of the project was a key element on the federai
level of the project, which had a certain synergy with the development of the
framework. Originaiiy, the object of studying these processes was simply to
beffer undetstand how to use the framework, but early in the project this
expanded to a critique of existing processes and proposais for change on
the federal level. This is a major shift, and adds a critical aspect (in the
sense proposed by Habermas) in questioning current arrangements.
The action research methodology began with reflection on the current
situation. This was supported by collection of detailed information in
questionnaire #2 which was then returned to key persons from ail
jurisdictions and distributed via ISC members. This raised awareness and
allowed various parties to identify problems in the current situation and
participate by proposing changes to the current situation. The recognition of
the duplication of efforts in various jurisdictions was highlighted, for example
workïng groups on individual programs which have little informai or formai
contact. This ied to the proposai of a national working group on a specific
program as a test case, which would require resources from Health Canada
to occur. This has not yet occurred, but is being proposed with Hepatitis A
and B programs (December, 2003), in the context of the National
Immunization Strategy, or in with CCOHTA.
A new national immunization planning commiffee that considers potential
new immunization programs was also formally proposed and tested. The
pilot testing exercise testing February 2002 examined how the analyticai
framework could be used and also how such a new commiftee would
function. This confirmed to parties from ail jurisdictions that a national
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commiftee evaluating immunization programs using the analytical framework
was a desirable and feasible change.
In fact, this activity led to officiai acceptance of these proposais, and major
changes are underway in Canada. This includes the emergence of the new
Canadian Immunization Commïttee (dc), which had its fïrst meeting in
November 2003. This committee wiII deal with issues regarding the
planning of immunization programs and will have the Chief Medical Officers
of Health or their delegates as members. The emergence of this committee
is of great importance and potential impact. Further changes have been
proposed recently in the broader national context. Over the course of this
project, the National Immunization Strategy received funding of $45 million
over several years to further development of this strategy. Many other new
structures have been proposed in Canada. The overali nature of the
pianned organizational changes are illustrated in Figure 26.
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in considering these resu Its, we note that the aspect cf the project invoMng
the framework produced concrete resuits and resuited in successfui
adoption cf this tool. in addition, the broadening cf the project started a
more profound process cf organizationai change, which leU to
impiementation of a new structure for federal /provincial /territorial
coordination in immunization planning in Canada. Whiie the advancement of
these organizational changes is relatively slow, their potential impact is
great. The fiexibility 0f the action research approach of this project aiiowed it
to capitalize on these opportunities and increase the long-term impact of this
p roject.
As is presented in Figure 26, the CIC is a new structure that aims te
facilitate coordination between Heaith Canadaand the 13 jurisdictions. This
is a major addition to NACI, which has been historically the most important
structure in this area in Canada. However, the role cf NAC1 is aiso changing,
as ït must determine to what extent it wiil officiaiiy address program issues
and recommend which new vaccines should be adopted. The extent and
impact cf these ongoing changes wili certainly be major and wili be observed
in the coming years in Canada. More profound changes are aise possible,
particuiariy foilowing the SARS crisis in Canada in 2002-3, and the following
report released in October, 2003 (National Advisory Committee on SARS,
2003), which proposed that the federal government provide $100 million in
funding for vaccine purchase cf ‘agreed upon vaccines’ in ail Canadian
jurisdictions. This confirms the desire for such a program expressed multiple
times throughout this project, and would increase the importance cf these
new structures and the analytical framework in reaching decisicns on which
vaccines and programs te fund naticnally.
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Provincial Component of Project- Quebec
As previously mentioned, intervention on the Quebec provincial level was
quite different from the federal project. Firstly, thete was no formai contract
defining the intervention and the various steps to foiiow. However, the roie of
one cf the co-researchers (Dr. De Wals) as the president cf the CIQ was
very important in identifying opportunities for intervention. Unhike the federai
project, there was hue broader questioning of the decision-making
processes in Quebec, other than potential uses of the framework and
suggestions collected from the follow-up questionnaire on use of the
framework. While the vaccine evaiuation exercise using the analytical
framework to evaluate severai vaccines was less successfui than in the
national meeting, this was perhaps due to Iack of planning and time for this
exercise, as indicated in the follow-up questionnaire. CIQ members are now
aware of the potentiai uses of this tool, and can easiiy integrate into future
activities invoiving the entire committee if desired.
However, the vaccine-specific working groups in Quebec were an important
seffing in which to appiy the framework. Three groups to date have used the
framework to structure their reports, and a fourth has been proposed for the
future. These exampies have been presented on the federal ievel, and may
Iead to similar types of groups being formed either on a piiot or on a
systematic basis. As on the federal levei, the flexible, action research
apptoach enabled this project to interact with key persons in the context and
adapt the project to harmonize it with other initiatives and aiso to respond to
user’s needs. However, the lack of a formai contract and systematic
discussion, feedback, and iterative steps made this interaction Iess intense
than on the federal ievei. This could be in resuit due to a iack of resources in
Quebec to specificaily support such a project.
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Potential blases and their impacts
We can now consider potential bisses in the data collection and their
possible impacts. When evaluating action research, care must be taken not
to appiy inappropriate arguments from a different paradigm of reseatch
(Meyer, 2001; Guba & Lincoln, 1989; Kemmis & McTaggart, 2000;
Waterman et ai., 2001). As in qualitative research in generai, the principles
of triangulation, reflexivity, and respondent validation (or member checks),
are seen as particuiarly important (Silverman, 1993; Guba & Lincoln, 1989;
Janesick, 2000; Yin, 1994). In general, we can also consider plausibility and
credibility of qualitative research (Hammersiey, 1990). Recently, the term
ciystallization has been proposed as a more complete alternative to
triangulation, which considers multiple dimensions and perspectives of a
single reality (Richardson, 1994). Taking into account these various general
factors which apply to qualitative research and specificaliy action research,
we can consider the potential biases in data collection in various stages of
this project and their potentiai impacts (Table XXV). More generai
considerations of validity and quality wili be discussed in later sections).
Consider first of ail the data collection on the federal level. As previousiy
mentioned, the choice of key persons was subjective and determined by
CMOHs of each jurisdiction. This was done in part because CMOHs were in
a good position to identify key persons having an impact on the policy
process in their jurisdiction, and also to foliow the hierarchy 0f power in each
area in terms of making the project known and building support. The
persons identified by CMOHs were validated by representatives from each
jurisdiction to the 1SC, and some changes were then made. Therefore
overali, whïle it cannot be considered that the totality of persons who may
have an impact on immunization programs in Canada responded to the
questionnaire, a significant amount of data from many key persons in neariy
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aIl 13 Canadian jurisdictions was collected and afterwards validated to begin
the research/action process.
Table XXV: Potential Impacts of sampling and other biases in Questionnaire #2
Category of Potentiatprobtems Actions to reducepotentiatprobtems Potential impact on resutts
iiformation
-
colteded
Qi: Goals and Lack ofdetail, lack Consultation, follow up. Minimal, due to follow-up with
Objectives for of information for Additional project with detailed Goals and Objectives Project
Immunization certain jurisdictions questionnaire on goals and objectives
Programs
Q2: Structures Lack ofdetail, lack Multiple consultations and submissions Minimal, as information vas
and Processes for of information for for revision. Additional data collection eventualiy obtained from ail
Immunization certain jurisdictions specifically on structures and processes for jurisdictions.
Planning decision-making in eachjurisdiction
conducted for each jurisdiction via ISC
representatives.
Q3: Use ofa Omission of framework tvas diffused as broadly as Minimal, as existing frameworks
framework for frameworks in use, possible in many channels as possible were identified.
immunization across Canada, however no other
planning frameworks were identified (other than
those mentioned in questionnaire
responses)
Q4, Q5: roles of Omission ofroles of Original questionnaire requested Some loss of information,
responder those flot responding identification ofkey persons with general probably of minimal impact on
to questionnaire and specific questions. project, as roles ofindividuals
were simply collected as
background information.
Q6-8: important Omission of Comprehensive list of criteria vas created Potentially some loss of
criteria in important criteria in ftom combination of questionnaire information if non-responders had
decisions, type of decisions or types of responses, literature and expert important points which were
framework useful frameworks consultation. omiffed. However, multiple
desided due to non- framework vas also revised afler broad consultations and opportunities
responders multiple consultations to add points were available to update the
considered relevant if requested by users. framework, minimizing the
chance ofthis occurring.
Mso, this vas designed as a
flexible tcmplate to be
transformed by users according to
desired use.
Q9-1 1: Major Omission ofuseful Multiple consultations, discussions, Potentialiy some loss of
needs, problems information due tu revision, follow-up. JSC members were information if non-responders had
in immunization non-responders. asked tu consult key persons from their important points which were
planning, jurisdictions at ail levels oftheir project. omittcd. However, multiple
solutions, general Responses This question vas included to start a forums allowed for and actively
commenta influenced by discussion that tvas continued at multiple sought out expression of major
political factors levels with the PHWG, ACPH, and the needs and problems in
conference of Deputy Ministers in the immunization planning, potential
development of the National solutions in a consensus-building
tmmunization Stratcgy and new process in the ISC and elsewhere,
organizationai structures for immunization therefore most important points
planning. should have been mentioned at
some point during the project.
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We can consider the Questionnaire #2 for key persons in particular in terms
of the nature of the data collected, efforts to reduce potential problems, and
potential impact on results of possible blases, considering this questionnaire
in the context of ongoing consultations and interventions to follow in this
project (Table XXV). A lower number of responders and incomplete
coverage may have impacted the data in terms of omission of some
responses which were not emifted elsewhere. However, due to the iterative
nature of the project and data collection and revision, and the minimal
nature of expected impacts on resuits, the impact on this collaborative
project is expected to be minimal. The nature 0f the multiple and sustained
contacts with stakeholders enables the data coflected to be validated and
very ‘grounded’ in the real-life context of immunization program planning in
Canada, over a long and recent time span.
Goals and Objectives Questionnaire
Regarding the following questionnaire on goals and objectives for
immunization programs in each jurisdiction, an enormous amount of data
was coliected, with responses being received from ail jurisdictions via the
ISC. As this data was more objective and simpiy aimed to describe these
officiai policies in each jurisdiction, there was no need for a larger
consultation, and there were few concerns about validity 0f this data. In
addition, the use of this data was simply to start a discussion on
mechanisms to develop and monitor goals and objectives for immunization
programs in the future in Canada, therefore consequences of minor
omissions or errors on certain programs in certain jurisdictions cannot
reasonably be imagined to have a major impact on the overall diversity in
this area in Canada nor on the resulting discussions.
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Worksheet on vaccine evaluation
This sheet involved a pilot exercise to test the framework, in which
categories of responses corresponded to those in expert presentations.
This was flot a validated scientific instrument, the categories were flot
specifically operationally defined, and the ranking methods were subjective,
therefore responses can be considered to be affected by potential
differences in interpretation. However, the goal of this exercise must be
considered, which was flot to produce a global score for each vaccine with
the diverse responses for each category, but rather to compare profiles of
responses of experts in terms of the degree of consensus or divergence.
This could guide further discussions into points for which there was much
divergence to explore the underlying issues and potentially provoke further
research or systematic study. The overail aim was to make the expert
knowledge of participants more explicit, as well as the important points in
the evaluation of particular candidate vaccines. Comments were collected
on this activity to make revisions before applying a similar wotksheet in the
provincial context in a similar activity.
Action research approach
By allowing the project to be transformed and revised in an iterative process,
the action research or co-operative inquiry approach allowed the project to
benefit from consideration of needs of stakeholders and be appropriately
adapted to needs in the context at the time of application. This allowed the
researcher and the project to be broadened in scope, going beyond the
objective area of scientific knowledge to explore the cognitive factors cf
decision-makers, situated in their specific context and influenced by political
factors. Therefore, action research has the benefits of bridging theory and
practice, being reflexive, and producing change relevant to participants in
187
the context.
However, this intense invoivement or ‘sustained ïnteractivity’ with the context
which is activeiy sought out to improve the links between research and
practice aise limits the methodological complexity and ‘objective’ scientific
rigor of the research aspect of the project. For exampie, there was no
formai coding cf some types 0f data for analysis. Factuai data (Le. on
immunization structures and processes) was systematicaliy compiled and
verified. Data on important criteria for decision-making for the analyticai
framework were systematically clustered to form the criteria for the
framework. However, data regarding OjflIOflS et key persons was not
formally coded, due to the fact that this data was to be summarized and
returned to key persons for discussion and debate. The method for
summarizing this type of data was simply to present the variety of responses
expressed to contribute to the collaborative intervention. No further formai
coding was seen as necessary after the intervention was completed.
In this intervention, the action research approach worked exceptionaiiy weII
to develop a decision-making toci and begin a process of organizational
change in a broad interjurisdictional setting, with objective, measurabie
events that occurred as an impact cf this intervention as tangible resuits.
Whiie the action research approach did permit an integration cf multiple
elements and perspectives of this phenomenon, it is unclear te what extent
these couId be studied in depth without having more resources for this
project. Iherefore, from a perspective of trying to bridge research and
practice, implement change or try to better understand methods to
strengthen this iink and/cr improve practice, the action research approach is
a definite success in this case. This approach enabled not oniy the creation
cf an anaiyticaI framework by key persons in the target context, but aise
began a wider process cf crganizaticnai change that is ccntinuing. Ihe
action research approach enabled not oniy the effective and broad
188
impiementation of this tool, but also a generative process of reflection,
expression of ideas, and consensus-building, leading to major changes in
this context.
This approach also enabled integration of objective and subjective
elements, at the individual and system level. Multiple, sustained, long term
interactions and collaborations with the context, particularly on the federal
level where there was a formai contract, allowed the project to be
responsive and pertinent to the context. Opposed to these benefits, the
action research approach presents some limitations. The generalizability of
these results, highiy influenced by the context, can be questioned, and must
be confirmed by other studies or cases. Due to the unpredictable nature of
the project and the intervention, which were at the mercy of the context,
there was liffle control over time frames and data collection by the
researcher. AIl planned interventions and data collected needed to be
C presented to partners in the context of application for approval. While this
resulted in several successful interventions (described in the results section)
and was in some aspects a strength of the project, it also resulted in delays
and some lost opportunities. Consider for example that the vaccine ranking
exercise with the CIQ was delayed for a year, perhaps making it less
pertinent as some programs were already being approved (i.e the
meningococcal conjugate program).
It must be considered that collaborative research is a two-sided coin with
advantages and corresponding disadvantages. The formai collaboration with
Health Canada allowed the project to be structured and connected to the
context, giving the researcher a clear mandate and opportunities to interact
with the context. However, priorities of the research partners were
sometimes not the same. For example, at one point in the project,
establishment of a pilot national working group on a specific vaccine such as
C pneumococcal conjugate vaccine was proposed, which would provide
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another opportunity for diffusion and testing of the framework and national
collaborative structures for immunization planning. However, at this time
there was a need for action on the element of the National Immunization
Strategy concerning goals and objectives for immunization programs.
Therefore a questionnaire (#3) and lengthy data collection was performed.
While resuits in this area confirmed results of questionnaire #2 in terms of
the need for national coordination and long-range planning, this did not
specifically advance research or action on the framework. In addition,
administration of this additional questionnaire may have reduced response
rates on the following questionnaire (#4).
The specific context of this research project as a PhD thesis must also be
mentioned. While the goal was to test existing theories, explore and develop
new ones, and test a mode of intervention to implement a change to
improve knowiedge transfer, this ail had to be done satisfying a certain
degree of methodological complexity and rigor of scientific research, beyond
the success or practicality of this particular intervention. The strength of
being grounded in the actual context and vaiidated by multiple iterations and
actual observable changes is balanced by the weaknesses of the iack of a
predetermined, objective, validated and structured data collection and
analysis method. These tradeoifs are central to many current debates on
action research and qualitative research. Further study should focus on how
these tradeoffs or potential shortcomings can be minimized.
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How do resuits compare to literature and theories of knowledge
transfer?
First of ail these resuits can be compared to the five categories of
knowledge transfer (i.e. knowledge-driven) commonly identified in the
literature. As expected, no single theory could account for the range of
observations in this project, and ‘knowledge’ or ‘evidence’ was but one
factor in a very complex process of decision-making (Woodward et al.,
1997). The introduction of an innovation was a complex, multistep process
as described in the literature (Rogers, 1995). In particular, this project was
conducted in a complex interjurisdictional setting in which much political
negotiation and discussion were present in addition to the knowledge or
science components. The innovation was designed to be flexible to
encourage appropriation and use by target users, and was indeed
transformed, reinvented and sometimes simplified according to the time and
context of application.
Many factors which have been seen to optimize impact on decision-making
in the literature were observed in this project. For example, personal contact
or ‘sustained interactivity’ between researchers and policy-makers helped
tailor the project to the current policy agenda, make it timely, encourage
user participation, and encourage focus on concerns of the specific context
(i.e. Beyer & Trice, 1982). This Ieads us to consider the observations of this
project as compared to various categories of models for knowledge transfer.
Firstly let us consider in turn the five groupings of knowledge transfer
approaches (previously presented in Table V) as applied to observations in
this project and context:
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1. Knowledge-drïven and 2. Enhightenment models:
It is flot surprising that these models cannot account for the complexity of
interactions and events observed. However, it would be an error to reject
this model, as much cf the base of public health and indeed vaccines and
immunization programs involves scientific knowledge with a rational
component. In terms cf the analytical framework, these components
correspond especially to the first four categories, namely burden of disease
and vaccine characteristics; and also to the third and fourth categories,
alternative immunization strategies and programs, and social and economic
costs and benefits. A recent example of scientific knowledge having an
impact on decisions was the high frequency of pneumococcal infections in
chïldren being determinant in assigning this vaccine as a top priority, while
the rarity 0f complications from pertussis contributed to its being assigned a
Iow priority (Erickson & De Wals, 2003).
Another observation during the development of the analytical framework
was the spontaneous uptake and use of the framework as an educational
tool in multiple seffings in Quebec and Manitoba. This was discovered in
questionnaire responses and also requests to obtain copies of the
framework, without any active promotion of this type cf use. Therefore, as in
the agricultural extension model (Rogers, 1988), innovations can simply be
adopted without any active effort at diffusion. However one must admit that
some sort of exposure (active or not) is required for users to learn of the
innovation. lndeed, knowledge does flot diffuse without mechanisms (such
as publications or conferences), and this can be passive as illustrated in the
cases mentioned. However, this ignores more active processes that were
observed and can be accounted for by other models.
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3. !nformation-seeking or ‘pull’ mode!
Certain aspects of this model can be observed in the context cf
immunization program planning in Canada. Corresponding to this model, the
identified need for which information is sought is a potential new
immunization program, which must be evaiuated. This can originate from
scientific experts, ministries of health, public demand or a combination of
these. When an advisory body in a given jurisdiction is given the mandate
to produce advice on a given program, they gather and review data about
this subject and present their assessment to the decision-makers (in this
case the Ministry of Heaith). Consider for example the working groups in the
province of Québec mandated by the CIQ to make recommendations on
potential new programs such as the pneumococcal conjugate vaccine. The
need for information about this potential program was sufficiently important
that specific research projects were funded (such as an economic evaluation
C of a routine immunization program with this vaccine). Therefore, like the
knowledge-driven model, the information-seeking model describes part of
the multiple and complex events in this case but oniy provides a partial or
incomplete view cf the overall situation.
4. Interactive mode!
This model applies to many observations in this project, which involved
numerous interactions between key persons in the development of the
analytical framework and the negotiation and approval of organizational
change. There are multiple interactions, formai and informai networks in the
area of immunization in Canada, which had an important role in the adoption
of the framework and the emergence of organizational change in Canada.
The emergence of a new Canadian Immunization Committee is an
opportunity to create new interactions in a new community of practice in this
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area that can influence policy. Therefore, this model seems to address one
aspect of knowledge transfer quite well. However, it is flot clear to what
extent this model includes considerations such as a problem-solving
approach or simple use of information as in the other two models.
5. Political models
These models are totally appropriate for the context of this intervention, in
particular the federal context in which constant negotiation between the
federal government and the 13 provinces and territories was present. Any
attempts at national coordination were made in the context of sometimes
divergent interests by provinces and territories. It has often been observed
that the larger provinces are more independent in terms of resources from
Ottawa and therefore aim to preserve and increase their power. Smaller
C provinces and territories on the other hand are in need of resources to assist
them in their planning activities and therefore have more to gain by
collaboration with the federal government and national coordination.
It must be noted that while decisions on immunization programs may have a
scientific base, a favourable decision regarding a new immunization
program has many political implications, such as negotiating and approving
new spending by the government, and having the resources and support cf
cf involved partners in the health system to implement the program.
The decision to provide mass immunization against meningococcal disease
in the province of Québec was highly political both times it occurred, with
public pressure and dramatic media coverage putting pressure on the
Ministry of Health to adopt a program. Other examples in which programs
have been implemented at least in part to political pressures have been
noted in Canada. For example, the province of Prince Edward Island
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implemented a variceila program at ieast in part due to pressure on
government officiais by a parent of a chiid with sequelae of varicelia. Some
have suggested that the decision of the province of Ontario to provide free
influenza vaccine to ail residents occurred as a resuit of a desire to reduce
emergency room overcrowding, which can be interpreted as a largeiy
political consideration.
Overail, observations in this project indicate that each model has something
to offer in terms of describing the observed events, however, no single
approach can account for the overail picture. We see particuiariy that the
frames of reference of the decision-maker are important, as is the
application of research or an innovation to their particuiar context.
Therefore, cognitive, situated iearning and refiexive approaches can heip to
better understand these areas which are flot specificaiiy covered in broader
theories. By adopting the four-category model (proposed in figure 5) which
includes objective, cognitive, situated and poiitical leveis, we wiIi affempt to
peform a more complete anaiysis.
By four levels of analysis
We can also anaiyze the overali project in terms of the four leveis previousiy
mentioned which were proposed for this particuiar project: objective/rational,
cognitive, situated and political (Figure 27).
Figure 27: Project model with four levels of analysis
I ObjectivelRational Level:
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We can çonsider which elements conttibuted to the actual physical
framework in this project and how this contributed to adoption and utilization
of the framework. The development phase employed a questionnaire to
collect information on important criteria for decision-making in immunization,
which increased the pertinence of the instrument, allowing the content of the
to include elements from the actual context in Canada. The elaborate
revision and consensus building process also allowed the framework to be
revised and modified, again according to comments from stakeholders/
participants in the context. After testing, there was also revision of the
instrument. Subsequent steps allowed the instrument to be revised
according to the desired application also. Therefore globally, the actual
framework evolved over time as a consequence cf interaction with the
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context. This allowed it to be tailored to the actual context, increased its
pertinence, and ultimately facilitated its adoption and utilization. Overali,
objective characteristics of the physical framework developed are important
in determinïng its pertinence and degree of adoption and utilization.
However, the objective approach does not take into account how individuals
perceive or understand the framework, how they use the framework, or the
political factors in the context of application. Therefore, the other
approaches can complement an overali understanding of the intervention.
Il Cognitive Level:
Many steps of the project contributed to knowledge and awareness 0f the
framework. In the initial development phase, a national questionnaire made
key persons in immunization aware of the development of the framework.
Also, presentations to ISC and discussions, and circulation of reports
allowed individuals to know about the framework. Several presentations at
important meetings for those involved in immunization also referred to or
discussed the analytical framework and initiatives to improve immunization
program planning on the federal level. This included presentations at
national immunization conferences, Quebec provincial immunization
conferences (twice), and the Journées Annuelles de Santé publique (JASP)
in Québec. Therefore, we can consider that the objective framework existed
also on another level in terms of knowledge by potential users, which was
influenced by their contact with and understanding of this framework in
various contexts.
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III Situated Level:
The situated level involved going beyond simple knowledge about and
familiarity with the framework to actually test this tool in specific activities,
such as evaluation 0f vaccines, or structuring reports or presentations. By
testing the framework in different contexts, its use and integration passed to
another level than simple knowledge of the tool. Ihis ailowed the instrument
to be integrated into actual processes. These could be artificiai processes
such as the vaccine evaluation activities, or actual use of the framework in
preparing a report, or conducting an actual committee meeting on a
particular program. This can be considered ta buiid on knowledge of this tool
and demonstrate to potential users how this tool can be used in their
particular context.
IV Political Level:
By considering the partïcular political context(s), structures and processes
related to the project, we can interpret the intervention at a more global
level. These factors were present in and affected ail aspects of this project.
Because the implementation of new immunization programs requires new
government funding, obtaining of this funding is necessarily embedded in a
political process. In this project, political factors were present in ail aspects
and had impacts on the various stages of the project. Interestingly, the
intervention on the federal level acted on these structures and processes as
part of a process of organizational change that is ongoing. These
organizationai changes impacted the framework and the project on the
objective, cognitive, and situated ievels.
198
Relationships between four levels of analysis
How then are these four levels of analysis related to one another? Overali,
we can compare the objective, cognitive, situated and political approaches
in terms 0f their increasing scope and consideration of contextual factors.
With the specific project to develop the framework, these stages were
interdependent, with existence ot the objective physical tool required to
allow it to be known by users in the cognitive phase. The cognitive
knowledge of thïs tool was in turn required for users to test this framework in
various contexts and develop a situated level of integration 0f this tool. The
political aspect was omnipresent, especially due to the participative and
interjurisdictional nature of this project. Consider for example that the
objective/rational level is concerned with the concrete aspects of the
framework: format, content, etc. This first step 0f creation of the framework
was necessary to develop the cognitive aspect, in which this tool was
known, observed, and understood after diffusion in varlous contexts. This in
turn is necessary for a situated level of application of the framework- actually
using the tool in various contexts. This testïng can surely develop and
enhance the cognitive level (knowledge of the framework), which can also
influence the objective form of the framework by allowing feedback to
ïmprove this tool. This was observed in the modification of the number of
categories 0f the framework after initial testing.
While this emerging four-category model is quite prelimïnary, it provides a
first step in integrating the various types 0f models to explain knowledge
transfer. Further study of intermediate cognitive and situated approaches will
help to more clearly define each type of approach. Other categories may be
added also if further distinctions are required. The use 0f this type 0f
categorization would also have the benefit of making the actual type of
knowledge transfer studied in a particular context more explicit, as well as
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the importance of each factor in that specific context or intervention. Further
testing of this model in othet contexts would be beneficiat in evaluating and
revising the model, and most importantly developing theories which integrate
the various, yet often isolated approaches which currently exist. These four
levels 0f classification were useful in this project. However, iess attention
was paid to the differences between the macro, meso and micro leveis.
Further research couid focus particuiariy on the differences between these
levels. In addition to the integrative framework, the three-category
classification system of knowledge-constitutive interests proposed by
Habermas can also be examined in relation to the four categories (objective,
cognitive, situated, politicat) and the observed resuits.
Correspondence to three levels of knowledge proposed by Habermas
The three levels of knowledge-constitutive interests proposed by Habermas
(1974, 1972), namely technical, practical, and critical, were clearIy observed
in this project. Firstiy, the technical level is very similar to the
objective/rational level, which was concerned with developïng a framework
that inciuded ail important criteria. In this project, the original approach
which involved identification of important criterïa in decisions regarding
vaccines corresponds to a technicai approach. A project invoiving solely the
determination of these criteria and the deveiopment of a comprehensive
model to be more efficient at reaching decisions can be seen to be technical
in nature. However, from the outset, this project strove to develop s tool
which was more than simply an interesting theoretical device, and would
actually be imptemented and used in immunization program planning in
Canada.
Therefore, the practical level was also included in this project. Ihis
corresponds to cognitive and situated leveis, which involved the potentïal
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users and allowed them to modify, and comment on the intervention. This
recognized the importance of the users as subjects having a specific
perspective and specific needs, who are required to make complex choices
in changing contexts. This impiies efforts to educate actors or practitioners
to help them understand more fuliy the consequences of their actions, thus
assisting them in choosing the optimal course of action (Kemmis &
McTaggart, 2000). This corresponds to the analytical framework aliowing
actors to more explicitly examine ail relevant criteria regarding a potential
immunization program to more accurateiy assess potential impacts and
guide the decision about this specific program. The practical approach is
further seen by allowing users to test, evaluate and revise the framework
foilowing use in various contexts. Examination of the overall context of the
intervention by users on a broader level leads to the third perspective
suggested by Habermas.
The critical perspective extends beyond both technical and practicai reason,
considering limits of the current situation on actors and how it couid be
changed. This is similar to the political perspective of negotiation and power
struggies, but goes beyond the current situation to consider and propose
change. This was clearly observed in the project on the federal level, which
examined current structures and processes for decision-making in
immunization and proposed changes. There was aiso some discussion of
federai funding for vaccine purchase, which also relates to this critical
perspective as it implies a change in relationships between the federal and
provincial /territorial governments regarding the responsibility for vaccine
purchase. On the provincial level in Quebec, there was also some presence
of a critical perspective when CIQ members were questioned regarding
potential changes to immunization planning in Quebec. It seems that the
action research perspective aliowed the project to transcend the technical
and practical perspectives and take a critical perspective towards broader
organizational changes. As suggested in the literature (Varey et ai, 2003;
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Ulrïch, 2001; Kemmis & McTaggart, 2000), each of the three levels
suggested by Habermas represented a broader perspective, integrating the
previous levels (Figure 3). In addition to confirming this relationship, the
resuits can allow us to adapt the relationship presented in Figure 3 to
include the four levels proposed by the framework developed in this project:
rational, cognitive, situated and poiitical (Figure 28).
Figure 28: Proposed relationship between various levels of knowledge and analysis*
We can consider these levels in relation to recent observations stating that
technical information or ‘evidence’ constitutes the rational cote of an
innovation, which is encircled by a series of practical problems when applied
to a given context (Denis et aI., 2001). This approach can be useful in being
more specific at the outset regarding knowledge transfer projects in stating
their scope. What technical, cognitive, situated, and political aspects wiII be
addtessed? This emergent model represents an important refinement of
these categoties that can help future research and interventions to go
beyond reseatch /policy or evidence /context dichotomies to a more
encompassing, global view.
*Adapted ftorn figure 3
202
The Richmond & Kotelchuck Model for Public Health Policy
We can also consider this model in light of observations in this project,
particularly how the components cf the knowledge base, political will and
social strategy combine to produce public health policy, adapting it for
immunization in Canada (Figure 29). This project originally focused on the
knowledge base and the transfer and organization of research information,
aiming to improve and facilitate this via the analytical framework. However,
on the federal level, the project was coupled with the development cf a new
social strategy, namely the emergent National Immunization Strategy.
Considering political will, it was observed that this factor can be influenced
by external pressures, such as the media and public in the case of
meningococcal immunization campaigns. The variation in public policy in
terms of currently funded immunization programs previously presented in
Figure 29:Revised Richmond and Kotelchuck Model for the Development of Public Health
Policy in Immunization in canada
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Table I (Sibbald, 2003) illustrates the importance of other factors than simply
the knowledge base in the determination of these public policies. While
there are certainly some variations in the knowledge base between
jurisdictions, these are insufficient to account for the wide variation in
programs. Linking efforts at improving the knowledge base to an
interjurisdictional social strategy such as the National lmmunization Strategy
can help to create more Iinks and similar pathways to influence public health
policy in terms of publicly funded immunization programs in a similar
direction. The type of systemic, multidimensional analysis proposed by this
model is beneficial ta understanding the complexity of knowledge transfer
and policy-making in this area.
Validity
As mentioned in previous sections, action research shou)d be judged from a
slightly different perspective than traditional research. Sacrifices in
methodological complexity are expected ta be balanced by gains in ‘face
validity’, which refers to what extent the change developed is implemented,
successful, and makes sense to participants (Kemmis & Mc Taggart, 2000).
This is indeed indicative of some cf the tradeoifs and different priorities of
action research as compared to more traditional forms of research.
However, despite certain particularities, action or qualitative research does
flot escape from concerns about validity (Silverman, 1994), which need to
be addressed. Due to similarities of action research to case study research,
four tests proposed to examine the validity of empirical social research can
be considered as an initial exercise (Yin, 1994), presented in Table XXVI.
o
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Table XXVI: Case Study Tactics for Four Quality Tests in Social Research
tests Case study tactic Phase of research in which
tactic occurs
Construct Validity -use multiple sources of Data collection
evidence
-establish chahi ofevidence Data collection
-have key informants review Composition
draft case study report
InternaI Validity -do pattem-matching
-do explanation-building Data analysis
-do tirne-series analysis
Extemal Validity -use replication logic in
multiple case stndies Research design
Reliability -use case-study protocol
-develop case study data base Data collection
Adapted from Yin, 1994
Using this framework, we can now consider these types of validïty in turn.
Construct Validity
This involves establishing correct operational measures for the concepts
being studied (Yin, 1994). According to Yin, use 0f multiple sources of
evidence, establishment of a chain 0f evidence, and having key informants
review the draft report can increase this. This project certainly used multiple
sources of evidence in a broad consultation covering a period of years
across Canada, to the extent of available resources for the intervention and
data collection. Another key advantage was that results were systematically
returned to key persons for validation, commentary, updating and correction
as much as possible during the project. This was especially structured in
activities with the ISC, which systematically required circulation of a draft
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report, presentation of a summary at meetings, circulation in individual
jurisdictions. Finally a chain of evidence could be estabiished, as the
methods section described how data was coliected and the context of the
project from which observations were made and conclusions drawn in detail.
One area in which construct validity was flot specifically addressed was in
the categories of the framework, which were not given specific operational
definitions. This was in part due to the fact that exercises with the framework
involved its use as an informai tool to guide discussion rather than a formai
quantitative tool to prioritize programs. On a practical level, there were no
resources avaïlable federally, nor a sufficient interest at this phase 0f the
project to further deveiop and define categories of the framework. In the
Quebec level of the project, an interest was expressed in this type of
exercise by members of the C1Q. Ihïs type of initiative may indeed occur if
the CIQ, NACI, CIC or other commiffees using the framework wish to
develop it into a more formai and explicit tooi.
Internai Validity
This involves inferences of causality in explanatory aspects of a study,
particularly regarding events not directiy observed. In this particular
intervention, relevant questions cou Id include the following:
Did the action research approach improve the scope, quality and
long-term impact of the intervention?
> To what extent do the theoretical framework, various theories of
knowledge transfer, and the three levels of knowledge proposed by
Habermas apply to resu Its?
> To what extent does the Richmond & Kotelchuck modei of public
health policy apply to results?
Yin mentions pattern-matching, which is the comparison of resuits to
multiple predicted patterns, explanation-building, which aims to explain a
chain of events, and time-series analysis which compares chronologicai
evolution of independent and dependent variables. These efforts aim to
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examine convergence of evidence and identify rival explanations or
confounding factors. Proving causality is a compiex endeavor. This action
research study was largely exploratory in nature; however, some aspects of
these strategies were employed. For example in consideration of the impact
0f action research approach on the implementation of the study, there is an
observable chain of events that leU to implementation of the framework and
organizational changes in various contexts. This chain of events stems from
the initial documented interventions to develop the framework, and propose
the new national immunization commiftee. lt is therefore warranted ta
consider that a causal role, whiie unproven, is plausible, especiaily in the
absence of rival explanations. The considerations of how well various
theories apply to results ïs more 0f an exploration of ta what extent they may
be useful in explaining observed phenomena rather than accepting or
rejecting these theories. This was principally undertaken to demonstrate the
partial application of ail theories and promote a more inclusive approach.
External Validity
The question of generaiizability to other cases and contexts was not
addressed in this single case study. Implementation of the framework
occurred in several different contexts (provincial and federal), however these
were not independent cases but rather different levels of the larger overall
case (immunization planning in Canada). However, there was some
question of multiple contexts if the 13 Canadian jurisdictions were
considered, which aIl seemed to have a similar reaction to the framework
and the proposed organizational change despite variations in their specific
contexts. This could be further examined by repeating the exercise in
another country. Also, additionai similar approaches using an action
research orientation, exploring the applicabilïty 0f various theoretical models
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could also be tested in other areas in which interjurisdictional coordination in
health care planning is desired in Canada (i.e. technology assessment).
Similar results in this type of project would address external validity of this
exploratory project.
Relia b il ity
This involves demonstration that the procedures of the study could be
repeated with the same results. In this project, this is achieved by
documenting the data collection process and actual interventions in detail.
Some aspects of the research-action project, such as the reports or
presentations would certainly have been different, and there would probably
be minor differences in the summary of collected data as no clear algorithm
was followed. However if the qualitative approach of representing the
diversity of different responses in data summaries were respected, another
researcher would probably arrive at a very similar result. Because this
project was very context-dependent, one could not expect to replicate the
exact variety of persons involved in particular meetings, nor the external
factors in individual jurisdictions which change over time. However, more
general factors related to the context and the intervention would be
expected to be constant; the intervention should be repeated in a project
that uses multiple data collections and sustained interaction with the
stakeholders to develop a global picture of the situation in this area in
Canada.
Quality
Miles and Huberman (1994) discuss five main issues related to the quality of
studies. It is also useful to consider this project following these five main
themes:
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1. Objectivity I Confirmability
This concerns whether conclusions depend on the subjects and conditions
of the inquiry, rather than on the inquirer (Guba & Lincoln, 1981), has
neutrality and freedom from researcher biases been reached? This can be
demonstrated by detailed description of the study’s general procedures,
data treatment and transformation. In this case there was much objectifiable
data in terms of concrete interventions. Outside of events, the researcher
also depended on data collected and verified from multiple data sources.
Therefore if certain biases were present in representing non-factual data,
such as opinions, there were ample opportunities for responders to correct
these. This strong connection with the context and multiple verifications and
public circulation of reports including detailed primary data ensured the
objectivity of the researcher in this project. On the level of inferences
regarding the application of theories, the increased level of abstraction
allows for greater subjectivity in analysis. However, overali patterns are fairly
C evident and have been based on observations from the study, which tends
to limit the degree of potential bias by the researcher.
2. Relïabïlïty I Dependability I Auditability
In terms of observations and data collection regarding interventions in this
project, there was much congruence between informants, contexts and
through time. No data was available for certain jurisdictions at certain
stages of the project, which may have enriched the data. However, multiple
iterations of data collection enabled compensation for this by completing
missing data. This frequent review by stakeholders of data collected,
analysis and conclusions and convergence of interpretations was in itself an
ongoing audit of the products of this study, and was a form of quality control.
In terms of theoretical explorations, these were emergent and not based on
pre-defined criteria but general observations, and therefore should be
considered as preliminary.
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3. InternaI Validity I Credibility IAuthenticity
This involves whether the findings make sense, give an accurate portrait of
reality, and are credible to the people studied and to readers (Miles &
Huberman, 1994). This study was definitely ‘context rich’, reflecting the
studied contexts. Triangulation of data from different sources strengthened
and converged on the same general conclusions. Areas of uncertainty
identified include the actual higher-level decisions processed in
provinciallterritorïal governments, however the other aspects of the decisîon
making process outside this ‘black box’ were studied in detail. Participants
ratified conclusions at various steps of the intervention. Certain predictions
were indeed accurate, such as the effectiveness of an action research
approach to bridge theory and practice. While observations can be
associated to theories by paffern-matching, this was general, exploratory
and limited in scope due to the absence of specific constructs of these
theories.
4. External Validity I Transferability I Fittingness
This considers to what extent findings can be generalized. This intervention
was largely exploratory and examined a single case. Therefore to s certain
extent, findings are unique to the context of immunization in Canada,
however it is plausible that they may be applicable to other areas in which
interjurisdictional collaboration in health care is desired in Canada (i.e.
coordination of health technology assessment). This must be verified by
similar interventions in different contexts. The effectiveness of the action
research approach to implement changes and bridge the theory-practice
gap corresponds to multiple observations and general conclusions in the
literature.
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5. Utilizatïonl Application! Action Orientation
This level considers what the study does for its participants. This is also
called ‘pragmatic validity’ (Kvale, 1989), and is increasingly important as we
address the use and short-term practical applications of research. This is
parallel to the debate in evaluation studies that considers in addition to
methodological rigor, the impact of a study on decision-makers and policy.
As previously mentioned in considerations cf quality in action research, this
is often considered as the dominant criteria for evaluation. In this area, the
current study has been extremely successful, which is perhaps not
surprising due to its action orientation from its conception in aiming to
implement a useful innovation in collaboration with stakeholders in a given
context. In terms cf evaluation reports, Paffon mentions that the ultimate test
of credibility is the response of decision-makers and users to the report
(Patton, 1990). In this action-research approach, the response has already
started to occur and is continuing based on various interventions before the
final global report, in terms of continuing implementation and use of the
innovation and implementation of organizational change.
One can also judge ‘good’ qualitative research as enhancing levels of
understanding and sophistication and the ability of participants and
stakeholders to take action during and after an inquiry. In this project,
findings were intellectually and physically accessible to users, and
stimulated working hypotheses as a guide for further actions. Many levels of
usable knowledge were produced, ranging from consciousness-raising
about decision-making ptocesses to development of a consensus regarding
organizational change and processes to guide decision-making. The
intervention and findings did have a catalyzing effect leading to changes,
which is a first step towards solving the identified problems. In terms of
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empowerment, we can speak of increasing involvement and participation
leading to increased control of developments in the context of participants.
This project involved learning by participants as they examined decision
making processes, Iearned about new programs, and tested the analytical
tool in evaluating and discussing these programs with other experts. Some
value-based concerns were addressed in aspiring to the principle of
equitable access to health care in Canada.
Therefore we see the trade-off that often occurs between methodologically
complex and practical research. ldeally, we would like research to succeed
on both levels, but this is a challenge given the limited resources for
conducting projects. This can perhaps be better defined by more explicit
examination at the outset of research projects in defining the research
questions and how they refer to adding to knowledge or improving practice.
Specific criteria for assessing action research projects
A list of twenty specific questions have recently been proposed for
assessing action research projects in a recent systematic literature review
on action research (Waterman et aI., 2001) This list is presented in
Appendïx 16. In general, this project responded weIl to these assessment
questions. Briefly, we can consider in some detail how this project responds
to these key considerations. Firstly, the objectives of this study were clear,
and the results were useful to users. Concrete and major changes were
implemented in the area cf immunization planning in Canada and are
continuing. Further research is appropriate to examine mechanisms for
interjurisdictional collaboration, the development of integrative theoretical
frameworks for knowledge transfer, and the potential uses of action
research to bridge the research-policy gap in Canada. The research process
was clearly outlined and the choices for study were justified. Local contexts
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were considered when implementing changes, and the role of the
researcher was clearly defined. The project was managed appropriately,
involving key competent persons and responding to events and participants.
There was an underlying ethical consideration that was the encouragement
of equitable access to vaccines and disease prevention across Canadian
jurisdictions. While the study could have been increased in scope with more
funding and data collection and interventions could have occurred in
additional jurisdictions, data collection was appropriate and the study design
was flexible and responsive to the context. The intervention was explicitly
described and findings were linked to existing knowledge and theories in this
area. The findings of this study may be transferable to other settings, but
further research is required for this. Finally various specific and general
issues regarding the evaluation of this study addressed by the author in
various sections of this report. These guidelines should be useful in
developing more structured methods of conducting and evaluating action
research in the area of health services in the future.
Lîmîts of Study
Action research is admiffedly ‘low tech’, as researchers in this area often
make concessions in methodological and technical complexity in exchange
for more immediate gains in face validity. This is done to generate timely
evidence that can be used and developed in a process of transformation of
practices, practitioners, and practice seftings (Kemmïs & McTaggart, 2000),
concentrating on generation of ideas and implementation of changes. The
focus is on determining and working towards Lwhat can/ should be’ rather
than analyzing ‘what is’ (Waterman et al., 2001). However, as is often the
case with interventions in the context of public health, some levels of the
actual impact of the intervention are difficult to evaluate.
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In this study in particular, the intervention has succeeded in implementing a
decisional tool in varlous jurisdictions and on the federal level, and also an
organizational change at the federal level. However, we do flot yet know if
and how the intervention will actually change decisions regarding
immunization programs in Canada. One problem is the relatively long cycle
of decisions and emergence of new potential programs in immunization.
While many new programs are being considered, the 4 years from the start
of the project to its current stage of implementation have not included a very
large number of decisions which have been exposed to the framework and
the new organizational structures in Canada implemented in November
2003. The process of adoption of new programs and differences between
Canadian jurisdictions in the long term wiII allow some of the impact of the
framework and the new Canadian Immunization Commiftee to be estimated.
Another important limitation is the general Iack of study of the impact of
evidence on the policy-making process in public health in Canada. The
actual decisional processes in individual Ministries of Health can be
considered as similar to ‘black boxes’ in which only some of the inputs and
the final output are known. A decision that follows the recommendation of a
particular report or economic evaluation may not have been caused by that
evidence but rather may be simply a coincidence. Finally, while this single
intervention in a specific context has been successful and is encouraging to
guide efforts in other similar areas, the observations of this study must be
confirmed in other contexts. This justifies that resources be contributed to
furiher study and development of more integrated methods for knowledge
transfer and better decisions in health care planning in Canada.
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Contribution of thesis project
I) Theoretical Level
The resuits of this thesis make several theoretical contributions. Firstly in the
area of immunïzation, the model originally proposed by White and Mathias
has been confirmed in its applicability to immunization, however many
additional factors have been added. This is perhaps in part due to the fact
that this framework was developed over 20 .years ago. The Richmond and
Kotelchuck model for public health policy reflects the interaction of
knowledge with political will and social strategies in determining public
health policy, and can help us to understand the limits of knowledge in
policy-making in public health.
Regarding models commonly used for knowledge transfer, such as the
‘push’ model, the ‘pull’ model, interactive, enhightenment, and political
models, these resu lis indicate that aspects cf each model can be observed,
but no single model can represent the variety of observations in reality. In
addition, some additional factors related b cognitive and situated learning
aspects need to be addressed 10 develop and appropriate theory. Therefore,
a more global model that integrates these approaches is appropriate. The
adaptation of the model proposed by Kemmis & McTaggart developed for
this project is useful in that the objective, cognitive, situated and political
aspects were observed and give a more complete view of reality, and
comprehension of the knowledge transfer process. These theoretical levels
can be furiher developed and explored in further empirical research on
decision-making, and further operationalized in terms of concrete
approaches to knowledge transfer and management.
The technical, practical and critical categories of knowledge-constitutive
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interests suggested by Habermas could also be linked to the four levels of
the emergent theoretical model in this project, which suggests their
usefulness in beffer understanding the various aspects of knowledge use
and transfer. This can help to beffer classify and explain observed
phenomena in the area of knowledge transfer, and also to beffer define the
scope of interventions- will they be technical in nature, or also practical? Is it
desirable to go as far as a critical approach, questioning current
arrangements and proposing new ones? This can help to advance the
current conception of the relation of evidence to context, and research to
policy-making that is being given much attention in recent literature.
Finally, the action research approach does seem to enable reaching of a
reflexive-dialectica view as suggested by Kemmis & McTaggart. In addition
to producing practical solutions to real problems, projects using this
approach can help in theory building and theory development, and ties in to
C recent considerations of new models of knowledge production and
collaboration between researchers and decision-makers in recent literature.
Overail, this development of theory is a small but important first step in
meeting a need for integrative theories in this area, which can translate into
improved understanding and interventions to improve health services
planning and their ultimate quality.
ii) PracticalLevel
This project has contributed in many specific and general ways on the
practical level. Firstly, much information has been collected and circulated
regarding decision-making and planning of immunization programs in
Canada. The general criteria used have been identified and combined to
make and analytical tool that is being used in various contexts in various
jurisdictions and should continue to be developed and used in the future.
Wide diffusion of the tool by various media and eventual publication should
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allow the instrument to be known and perhaps adopted internationally.
Other new tools for economic evaluation have been developed and a new
organïzational structure has just been implemented in Canada. This is
expected to lead to new ways of collaborating on various specific themes
between jurisdictions. These contributions represent numerous concrete
steps towards improved knowledge management, planning and coordination
in the area of immunization in Canada.
In the area of health care in Canada, the success of this approach can be
used to guide other interventions to coordinate and improve knowledge
transfer, decision-making and health care planning. The area of coordination
of technology assessment in Canada is one possible application. This is
especially practical in the current context in Canada in which these themes
are being given much attention by national bodies such as the CIHR, and
the CHRSF. In addition, new federal bodies mandated to improve
coordination in health care have been recently established, such as the
Council 0f the Federation and the National Council on Health Care.
In terms of action research, this project helps to further illustrate the
advantages and potential piffails of such a methodology to guide future
interventions. The success of this method in developing and implementing
tools for decision-making, and even catalyzing broader organizational
changes within a limited time period is truly impressive and can have
multiple applications in the area of public health. Perhaps the most
important contribution that can be noted by this project is to indicate that it is
indeed possible and desirable to combine theory and practice, and despite
certain challenges and limits, to produce research which is valid and makes
significant contributions to these two fields that we are currently striving to
bring together.
CHAPTER VI: CONCLUSIONS
This project is in accordance with a general broadening of public health
research to include more subjective and context-based concems. By
proposing a global classification scheme for various approaches and
theories of knowiedge transfer in the literature, this project aimed firstly to
clarify and make explicit the often unclear differences in the underlying
structure of these approaches. This permitted examination of the relative
rotes of various approaches in this specific intervention in the area of
immunization and to note the presence of observations corresponding to the
four categories. The proposed integrative model for knowledge transfer
allows approaches to be explicitly linked to major streams of social theory. In
the future, these links can be further refined and developed to guide specific
interventions in various contexts.
While the successful sustained interactivity with stakeholders in this project
increased its impact, adoption and success of the project, this represented a
loss of a certain degree of control, and additional challenges in timelines
and data collection in the PhD project, which were only partially controlled by
the researcher. However, with limited resources this project succeeded in
developing a new tool collaboratively with key persons from across Canada,
diffusing it widely and testing it in multiple contexts, leading to multiple
seffings and types of adoption. In addition, this project played a key role in a
process leading to proposai and approval of organizational changes in
immunization in Canada. These changes may provide the foundation for
major changes if federal purchase of vaccines is implemented in the future.
The data collected and interventions occurring during this project cannot be
explained solely by one type of theory on knowledge management, but can
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rather be understood by a variety of approaches addressing both objective
and subjective levels of analysis, as well as those related to large-scale
structure and ïndividual actions. Finally, it is important to consider these
events using intermediate approaches that are mixture of the subjective and
the objective, and the system/structure versus the individual/action. It is
perhaps flot surprising that theories other than positivist, objective
approaches have increased in importance as researchers have moyeU
outside controlled laboratory-type seffings to real-world seftings. WhHe
decision-makers are often considered as being illogical and flot aware of
scientific knowledge that supposedly can be easily applied to rational
decisions, there is a growing awareness of a different Iogic in the real-world
decision-making arena. This should force researchers to admit that much
research can be criticized by decision-makers as being context-poor, or
irrelevant to their specific situations.
Therefore, as has been widely discussed in recent years in Canada, both
researchers and decision-makers can benefit from increased interactions in
many contexts. Projects that are conducted or funded in collaboration with
researchers and the decision-makers, as currently practiced with the
Canadian Health Services Research Foundation (CHSRF), provide a clear
structure and mandate in which to achieve this balance and exchange.
There are certainly multiple areas in which there are common interests and
benefits to be gained in the area of health services research in Canada. A
broad, inclusive theoretical framework such as the one proposed in this
project, combined with an interactive, collaborative approach can be rich in
advancing and improving knowledge transfer and ïts understanding in
Canada and elsewhere.
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Key Implications
b summarize, and return to the varlous themes of this study, here are
some key implications of this study:
The collaborative or action research approach seemed to be a key
factor in the success of the implementation of an innovative tool and
an organizatïonal change in immunization, and merits study in other
areas;
The technicai, practical and criticai leveis of interest proposed by
Habermas were observed and usefui in understanding this
intervention, and an action research approach aliowed the project to
go beyond technical and practical considerations to reach a criticai
perspective and catalyze organizational change;
> Typïcai categories of knowledge transfer were ail represented in
resuits, but no single theory could account for ail observations.
Therefore broader, more integrative theories should be examined,
tested and developed to beffer design, guide and understand
knowledge transfer and management activities in a systematic
fash ion.
> Whiie the dichotomies of subjective versus objective and
system/structure versus individuai/action are usefui in understanding
different approaches, they can be further broken down into
intermediate categories. The expioratory exampie of using the four
categories of rationa l/objective, cognitive, situated, and politicai
approaches on the subjective to objective continuum corresponds to
the levels of knowledge proposed by Habermas, captures
compiementary ieveis of reaiity and warrants further development and
testing in the future.
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Future Directions
Presently in the area cf immunization in Canada, a new Canadian
Immunization Commiffee has just had its first meeting, and the National
Immunization Strategy is part of a $45 million, multiyear initiative. The next
step related to this project may be ongoing testing cf the analytical
framework and the new committee with coordinated evaluation and planning
of new hepatitis A and B immunizatïon programs. Following the Naylor
Report on SARS, $ 100 million has been proposed for purchase of agreed
upon vaccines by the federal government. If this recommendation is
implemented, the new commiffee and the framework should have an
important role in evaluating and reaching decisions on potential programs. A
similar initiative in which interjurisdicticnal collaboration in Canada is
important is in the area cf technology assessment, and CCOHTA has
recently received $45 million to improve and develcp coordination
mechanisms across Canada. However, it is uncertain which structures and
processes will enable different jurisdictions te cptimally work together. The
Council of the Federation has just been formed to increase coordination
between provinces and territories (Dcugherty, 2003). The establishment cf a
new National Health Council, based on recommendations in the Romanow
Report, has just been fcrmally anncunced (CBC news, 2003).
Given the numerous technological advances and budgetary restraints in
health care, there is currently much interest in developing mechanisms for
interjurisdictional and intersectorial collaboration in health care in Europe
and Canada. b effectively strengthen our research capacity in Canada, we
should continue to build and strengthen links between researchers and
decision-makers to be able to address rational and political concerns and
increase chances cf success. Models similar to those used in this project,
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which integrate diverse perspectives, such as subjective and objective
approaches and those based on the individual (action) and the organization
(structure) should allow for more complete and effective interventions and
better understanding in this area, and to situate the targets and approaches
of interventions aiming to improve knowledge transfer. Consideration of
technical, practical and critical types of research and knowledge should help
to situate and define the scope of individual knowledge transfer initiatives.
This project has been an interesting and useful exploratory first step in this
area. However, this type 0f intervention and analytical model should be
further tested and developed by application in other contexts 0f knowledge
transfer and interjurisdictional collaboration in health care in Canada.
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APPENDICIES
Appendix 1: Cover letter and Questionnaire #1 for CMOHs
Identïficatïon of Key Scientific Experts in Immunization
from:
Date: Mon, 10 Jul 2000 18:58:19 —0400
Ta:
TO: Provincial & Territorial Chief Medical Officers 0f Healtli
FROM: Lonny James Erickson, Program Planning in Immunization in Canada Project
SUBJECT: Identification of key Scientific Experts in Immunization Program Planning
July 10, 2000
Dear CCMOH Members,
As part cf the current National Inirnunization Strategy, the Subcommittee
on Immunization of the Public Health Working Group lias conimissioned this
project ta develop an analytical framework to facilitate decision—making across
Canada regarding publicly funded immunization programs.
This ‘Program Planning in mmmunization in Canada’ (PPIC) framework project
includes a researcli team cf Dr. Arlene King (Healtli Canada), Dr. Philippe
De Wals (Univ. de Sherbrooke), Dr. Lambert Farand (Univ de Montréal), and
myself (Université de Mantréal) as part 0f my Ph.D project in Public Health.
) We will solicit collaboration from scientific experts in ah Canadian
provinces and territories ta develop a f ramework that addresses comnion and regional
needs in this area. Your collaboration is essential to identify these experts in
your jurisdiction.
In the attached document, please f111 in the marnes of the key scientific
advisors ta your Ministry cf Health regarding publicly funded mmmunization
programs and respond ta me via fax or e-mail. If na respanse lias been
received by Monday, July l7tli, I will lie recontacting you by fax. Please do net
liesistate to contact me at (450) 928—6777, extension 4060 or at (514) 813—6100
should you have problems apening the document, or for further information.
Thank you for your participation in this project.
Smncerely,
Lonny James Erickson, M.Sc,
PPIC Framework Project
far the Public Health Warking Group Subcammittee on Iinmunization
MB: Document is attached in 2 different formats (Word, and RTF)
(See attaclied file: CMOH Ward form.doc) (Ses attached file: CMOH RTF
form. rtf)
TItis is thefirst step in a cottaborativeproject in which alt (‘anadian provinces and territories witt
be coizsutted and catled b partictpate In the devetopment of an a,tatyticatftamework tofacilitate
program planning regardiitg pubiiciyflinded i,n,nunization programs (docuineittation avaitabte
tipon reqttest- catifor more inforntation). These bidividuais ;vitl then be contacted regarding how
to deveiop structures & processes tofadiitate their evatuation of candidate vaccinesfor pttbticty
fttnded progrants.
Please answer thefollowing ttvo questions (‘copy or add additional pages fnecessary.).
1) Please name the scientific experts having a key advisory role in recent policy decisions
regarding publicly funded immunization programs in yourjurisdiction (‘key role’ means that
this person bas sufficient input to potentially change policy decisions in yourjurisdiction).
NB: add rows to table if necessary
Name of Expert Organization Phone #
2) Please name scientific experts who have played (&Ior wilI play) a key advisory role
in determination of policy regarding the following specific vaccines/programs:
Vaccine/program Name of expert(s) Organization Phone #
a) measles second dose
program
b) pneumococcal
polysacch aride programs
for aduits
c) varicella vaccine for
chiidren
d) aduit perwssis vaccine
e) aduit influenza
vaccination program
(current and next season)
f) pneumococcal
conjugate vaccine for
chiidren
Please return by FAX to U Erickson at (450) 928-3078 or (450) 679-6443. Thank you!
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Appendix 2: Scientific Experts Identified, Contacted and
Responding to Questionnaire
Yves Robert
Monique Landry
Gisèle Trudeau
Horacio Arruda
Gaston De Serres
LSPQ, LNSPQ
RRSSS Lavai
MSSS
MSSS
INSPQ, CSP
E
E
E E
E E
E E
E E
E E
E E
E
g
E
g
Province! Name (s) affitiation(s) Id’d in Q sent Q received
Tenitory Cmoh
Q?
NFLD Medicai Officiers ofHealth in
(8) Regions (6)
1 Dr David Mlison Heaith & Cornrnunity Services-St John’s E E E
Mcd ical Officer ofHealth
2 Dr Jane Pickersgili Health & Cornrnunity Services-Central E E
Medical Officer ofHealth Gander Nf
3 Dr fioyd Harris Grenfeil Regionai Heaith Services E E
Medicai Officer offleaith St Anthony, NF
4Dr Catherine Donovan Heaith & Cornrnunity Services- Eastern E E
Medicai Officer ofHeaith Holyrood
5Dr Minnie Wasrneier Heaith & Cornrnunity Services- Western E E E
Medical Officer ofHeaith Corner Brook, Nf
6 Dr lan feitharn Heaith Labrador Corporation E E
Medicai Officer ofHeaith P0 Box 7000, Happy Vafley, Goose Bay,
LB
7 Dr Rick Cooper St John’s Heaith Care Corporation E E E
8 Dr Faith Stratton Dept ofHeaith & Cornrnunity Services E E E
NS Dr Scott Haipern IWQH-Grace Heaith Centre E E
(2)
Dr Waiiie Schiech QE1I Heaith Care Compiex E E
Dr Mahnaz Farang Mehr E 0
DrJeffScott E
Dr Maureen Baikie E E
NB Dr Wayne McDonald A!CMOI-i, Dept. ofHealth & Weliness E E E NB
(5) eiected to
Or David Assaf Regional MOH E E have one
Lynn Cochrane Immunization Project Manager, Dept of E E coordinated
Health & Wetlness response
Dr Denis Allard Former CMOH- no longer working with E E ftom Lyne
NB Cochrane
Kim Blinco immunization Project Manager E E cornpiled
ftom Dr
Assaf and
Kirn Blinco
PEI Communicable Disease Public Heaith
(2) Nurse
Lamont Sweet ChiefHeaith Officer
QC Bernard Duvai INSPQ, CSP Qc
( 6)
iv
ONT Cmoh only identifed himselftherefore atl members ofACCD were contacted Some
(19) coordination
members ofAdvisory of responses
Committee on Communicable from ACCD
Discases
Dr Lee Ford-Jones Dept. ofPediatrics, The Hospital for Sick E E E
Children
Toronto ON
Dr. lan Gemmili Kingston, frontenac, Lennox & Addington E E
Health Unit
Kingston ON
Dr. Michael John London Heatth Science Centre
$00 Comissioners Road East
London ON
Dr. Mlison McGeer Mount Sinai Hospital Toronto E E E
Marg McReynolds Kingston, Frontenac, Lennox & Addington E E
Flcalth Unit
Kingston
Ms. Susan Plewes Ontario Hospital Association E E
Toronto ON
Dr. Graham Swanson Ontario College of family Physicians of E E E
Canada
Burlington ON
Dr. Sus an Tamblyn (chair) Perth District Health Unit E E E
Stratford ON
Dr. Mary Veamcombe 76 Grenville Street E E
Toronto ON
Dr. Barbara Yaffe Toronto Health Dept. E E
Director of Communicable Toronto ON
Diseases & AMOH
Dr. Colin D’Cunha Public Health Brandi E E
Director, Public 1-lealth Branch Toronto ON
and
ChiefMedical Officer ofHealth
Dr. Barbara Katva Disease Control Service E E
Senior Medical Consultant Public Health Branch
Vaccine Preventable Diseascs & Toronto ON
TB Control
Dr. Chuck Leber Disease Control Service E E
Senior Vetcrinary Consultant Public Heatth Branch
Zoonoses and Food-Bome Toronto ON
Diseases
Dr. Monika Naus Disease Control Service E E E
Physician Manager & Provincial Public Health Branch
Epidemiologist, Toronto ON
Communicable Diseases
Dr. Evelyn Wallace Public Health Branch
Senior Medical Consultant Toronto ON
Sexually Transmitted Diseases
and HIV/AIDS
Disease Control Service
Laboratories Branch Laboratories Branch 0 E O
Dr. Margaret fearon Toronto ON
Medical Virologist
Dr. fran Jamieson Laboratories Branch E E E
Medical Microbiologist Toronto ON
Ms. Dawn Ogram Laboratories Branch E E
VDirector
Monitoring and Quality
Improvement (Specialty
Services) Unit
Dr. James Edney
Toronto ON
Medical Consultant
Toronto ON M7A 1 G2
MAN 1) Dr Digby Home Immunization Medical Officer ofHealth, E E group
(1) Communicable Disease Control Unit, coordinated
Public Health Branch, Winnipeg, Manitoba response
SASK Maiy Scott consultant, public health nursing El E
population hlth branch
(7) Saskatchewan Health
Regina Sask
Dr. Tania Diener CMHO, Regina Health District, E E E
Regina SK
Donna Stockdale Nurse Epidemiologist, Population Health E E E
Unit, Keewatin Yathé Heatth District, , La
Ronge, SK
Laraine Tremblay Communicable Disease Nurse E E
South Central Health District,
Waybum 5K
Dr Mark Vooght Mcd ical Health Officier E E
Mosse Jaw Health District
Moose Jaw, SK
Nida Wurtz Manager, Communicable Diseases & Aids E E
coordinator,
Population Health Bran eh, Sask Health
Regina SK
Dr Eric Young Deputy CMHO Saskatchewan Health E E
Regina SK
Alberta 1Dm Hillary Winters Mcd officer ofHlth E E
(13) Mistahia Hlth Region
2. Dr. James Talbot Prov Lab Pub Hlth, North E E
3. Dr. GeoffTaylor Div Inf Dis E E
U ofMberta
4.Ms Donna Koch Mistahia HIth Region E E
5. Mr Dan Richen Hlth Authority 5 E E
6. Dr. Joan Robinson Pediatric/infectious diseases E E
U ofMberta
7. Dr Paul Hasselback Mcd OffofHlth E E E
Chinook Hlth Rcgion
8.Dr Tav Jadavji Hcad lnf Dis E E
u of Calgary Alberta Children’s Hospital
9Dr Michele Ovenden Alberta Pediatric Society E E
10. Dr Shaunaleee Mclver Summit Centre Mcd Centre E E
I I Ms Agncs 1-lonish Alberta Hlth & Wellness E E
12. Ms Elaine Sartison Capital Health Region , Edmonton E E E
13. Dr. John Waters Prov Hlth Officer E E E co
Alberta Hlth & Wellness ordinated
response
ftomDrJ.
Waters office
BC 1. Dr Danuta Skotvronski BCCDC E E E
(6) Coordinated
2. Dr. Mark Bigham BCCDC E E rcsponse
3. Dr David Patrick BCCDC E E from Dr.
E E
vi
4. Dr. Peny Kendali
5. Dr. Shawn Peck
6. Dr David Schiefele
YT Sent to Dr Timmermans
BC MOH
BC MOH
UBC
E E
E E
E E
Patrick from
BC
E No response
çfiff rhn,p7
e mail Sent auguSt 4, fax also called no
answer?
NWT 1 Ms Mamie Beil, Chairperson, NWT Advisory Committee on E E
(5) Immunization
DHSS
2 Ms Wanda White Consultant, Communicable Disease E E E
Control, DHSS
3 Dr Nicole Chatel Pediatrician, Stanton Regional Hospital E E
4 Dr André Corriveau, CMHO DHSS E 0
5 Glenn Whiteway Regional Pharmacist, Stanton Regional E E
Hospital
NUNV’T Dre Anne Roberts CMOH Nunavut E e-mail
(1) response
TOTAL
75
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Appendix 3: Questionnaire #2 for Key persons in immunization in
Canada
Dear
________
On behaif of the Immunization $ubcommittee of the Public Health Worldng Group, I
invite you to participate in tins project, winch aims to create a framework, structures
and processes to facilitate immunization program planning in Canada. One objective is
the development of an analytical ftamework for publicly ftrnded immunization
programs, which can be used to provide a “report card” on any potential or existing
immunization program in Canada. Tins is one of a number of initiatives contained in
the Canadian National Immunization Strategy.
The first step is collection of information regarding your role in immimization program
planning, the way in which immunization program planning is performed in your
jurisdiction, and identification of other scientific experts active in immunization
program planning in your jurisdiction. In addition, we would like your suggestions or
ideas on what could facilitate immunization program planning in Canada.
Your responses are strictly conlidential, and will be aggregated with those of other
participants to create a recomrnended framework, structures and processes winch will
be submitted to a consensus-building process with yourself and other participants
before testing. Please respond by friday, $eptember xx, 2000 by
Tins project bas the potential to improve the way iinmunization is planned, delivered
and evaluated in Canada, and will ultimately maximize the benefits of immunization
for our citizens.
Thank you in advance for your valuable participation.
LI Erickson, PPIC project
for the Jmmunization Subcommittee ofthe Public Health Working Group
VIII
PÏease answer thefoïlowing questions. Use additional pages ifnecesswy.
1 .Does your province/territory have goals and objectives for immunization
programs?
(Ifso, please describe them below)
2. What structures and processes are in place for considering and making decisions
on (new) publicly funded immunization programs? (i.e general cornmittees, working
groupsfor specfic vaccines or specflc issues, etc...)
3. Does your province/territory use a framework for considering new publicly ftinded
immunization programs?
(ifso, please describe theframework used)
4. Please describe your general role/involvement in immunization program planning:
ix
5. Did you have a specific foie fl immunization program planning for the following
recent candidate vaccines?
(Ifso, please describe your role for each vaccine and also indicate the current stage
ofthe planning processfor this vaccine in yourjurisdiction.)
measles 2nd dose:
•. varicella:
.. pneumococcal polysaccharide vaccine for aduits:
.. pneumococcai conjugate vaccine for chiidren:
•. other specific recent programs tspecify:
_________________
X6. for each ofthe specfic immunization programs identfled in 5,), please ident
thefollowing:
Name of vaccine:
________________________________
a) Which (if any) other scientific experts were involved in evaluating that particular
vaccine/potential immunization program in yourjurisdiction?
Narne Vaccine Comments
b) What major criterialfactors came into play in the decision ? (i.e price)
factor/Criteria comments Importance Ranking
1st nd 2rd
I ,L.
c) Please rank the relative importance ofthe criteria mentioned above
PÏease compÏete a copy ofthispagefor each specfic vaccine mentioned
(NB: 3 copies witÏ be included)
7. What type of ftarnework would most help you in immunization program
planning?
xi
8. Considering your previous responses, what elements/factors/criteria should be
included in a framework to assist you in immunization program planning?
9. Currently, what are your major needs/ problems in immunization program
planning?
10. What frameworks, decision-making structures and processes should be in place
to facilitate immunization program planning in Canada?
11. Other comments
Thank yottforyourpartictatio;i. You witt soon receive a surnnwiy of tue resutts
of titis consultation and an invitation to participate in the consensus building
process.
XII
Appendix 4: Structures and Processes for Immunization Program
Planning in Canadian Provinces and Territories
British Columbia
Dedicated staff (medical and nursing) to assess immunization programming. An
expert Provincial immunization advisory committee, the ‘BC Immunization
Advisory Committee’ (BCIAC) gives scientific advice. Epidemiology Services ofthe
BC Centre for Disease Control (BCCDC) lias a coordinating role in preparing
submissions to the Communicable Disease Policy Committee, which makes
recommendations on Programs to the Ministry of Health. Health Officers Council
and Public Health Nurse Administrators provide input and occasionally advocacy.
Provincial ad hoc working groups for vaccine-specific program evaluation.
— — — — — — — — — — — — —
Epidemiology Services, BCCDC I
munization Z \AdvisoryCommittee recommendation
(BCIAC)
______________
Ministry
Communicable I of
Disease — Health
AU hoc working Pollcy
_________
groups Commiffee I
I
for vaccine-specific
program evaluation I
L — — — — — — — — — — — — —
Public
Health
Nurse Health
Administrators Officers
Council
XIII
Alberta
Advisory Committee on Communicable Diseases receives input from the Council of
Medical Officers of Health, the Communicable Disease Nurses Working Group, the
Pediatric Society and other sources and advises Alberta Health and Wellness.
Council
of
Medical
Officers
of
Health
Alberta Health and Wellness
Provincial Health Officer
Minister of
Health
Advisory Committee on
Communicable Disease
Control
Treasury
Boa rd
Government
N
t Working Group forImplementation
Other
i.e NACI
Communicable Pediatric
Disease Society
Nurses
Working
Group
xiv
Saskatchewan
Standing Comrnittee on Immunization made up of representatives from
Saskatchewan Health, representatives from the Medical Health Officers Council of
$askatchewan and the Nurse Managers Group. Committeees for specific vaccines:
i.e.pneumococcal vaccine.
Standing Committee on
Immunization
(representatives from Sask. Health,
MHOC of Sask., Nurse Managers SaskatchewanGroup) Health
Committees for specific vaccines
(i.e pneumococcal vaccine)
xv
Manitoba
Manitoba
Advisory
Ministrv
Committee of
Treasury
Communicable recommendation
Health
Board
and
_________________
I Ilnfectious
Disease
Director,
Public
Heatth
___________
ranch Funded
Immunization
B
Program
Subcommittee
I
xvi
Ontario
Staff at the Ministry of Health and Long-Terni Care receive advice from the
Advisory Committee on Communicable Diseases (ACCD), the Canadian Paediatric
Society, NACI, as weil as working groups within the ministiy. The ACCD has an
Immunization Working Group. The ACCD makes recommendations to ministry
regarding pubiicly-funded vaccine programs. Sometimes a working group or a
subcommittee is created for a special vaccine either to make recommendations (i.e.
regarding target groups), or to plan implementation or evaluation. Recommendations
made by the working group wiil be considered in the elaboration of a proposai by
ministiy staff which considers cost, cost-effectiveness, and impiementation issues.
Sometimes ministry acts by its own mechanism, extemal to the ACCD (i.e. universal
influenza vaccination program, to avoid emergency room overcrowding).
Ontario Ministry 0f Health and
Long-Term Care
Working Groups for
Specific Vaccines
J
Publlc Heafth Branch
Immunization Working
Group I Disease
Control
Ontario Advisory Commiftee Service
onCommunicable Diseases
/iatriiet
Notes: 1) The Ontario Ministry of Health has a ‘business planning
and allocation process’ in its annual budget cycle. 2) Within the
ministry and the government, appropriate policy approvals have to
be obtained for any new program proposais.
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Québec
STRUCTURES AND PROCES SES FOR DECISION-MAKING REGARDING
IMMUNIZATION PROGRAMS IN QUEBEC
1. STRUCTURES
1.1.Ministère de ta santé et des services sociaux du Québec/Quebec Ministry of
Health
The Ministère de la santé et des services sociaux (M8S5) of Quebec is responsible
for publicly ftmnded immunization, including the decision to implement any new
programs, purchase and distribution of vaccines, information to the public and health
care professionals, organization and funding of vaccination activities, measurement
of progress in reaching objectives for vaccine coverage, as well as evaluation of
positive and negative health impacts of programs. liumunization programs are the
responsibility ofthe Directeur de la protection de la santé publique (Director of
Protection of Public Health) who reports toe the sous-ministre adjoint à la santé
publique (Deputy Minister of Public Health). To determine the pertinence of
introducing a new vaccine in the program or the modification of an existing
program, the M$$S asks for recommendations from the Comité sur Ï ‘immunization
du Québec (CIQ), which is affiliated with the Institut national de santé publique du
Québec (INSPO). When a new immunization program is implemented, the M$SS
creates an ad hoc implementation committee composed of members from the MSSS
and health care professionals.
1.2. Institut national de santépublique du Québec (IN$PQ- Quebec Institute of
Public Health)
The INSPQ was established in 199$ has the mandate of supporting and advising the
M$$S and the régies régionales de la santé et des services sociaux (RR$S$- regional
health boards) in their mission with regards to public health, notably regarding
immunization programs. The INSFQ regroups laboratories and scientific experts in
a network. Experts from various regions make up the Groupe scientflque en
immunization (GSI- scientific group on immunization) which addresses questions
regarding immunization and which responds to the Directeur de la protection de la
santé publique. Most GSI members are also members ofthe CIQ and also are also
affihiated with a university and are members of a university research center.
1.3. Comité stcr l’immunisation du Québec fcIQ- Quebec Immunization
Committee)
This permanent expert committee has existed since 1990 and is responsible for
making recommendations and giving recommendations regarding optimal use of
immunizing agents in Québec. More specifically, this committee advises the
Directeur de la santé publique (Director of Public Health) regarding the application
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ofimmunization programs, objectives, strategies, choice ofproducts, and practice
guidelines. The comité is composed of active members chosen for their expertise in
the area ofimmunization and from educational, research and public health settings,
invited members representing organizations and associations, as well as membres
d’office representing the (M$$S). This committee originally reported directly to the
Directeur de la protection de la santé publique ofthe MSSS. In 1999, it was
afflhiated with the Institut national de santé publique du Québec (IN$PQ) and also
reports to Directeur de la protection de la santé publique. To study each new
vaccine and the pertinence of a new immunization program, ad hoc committees are
formed, composed ofmembers ofthe CIQ and invited experts.
1.4. Régies régionales de la santé et des services sociaux (RRSS$- regional
health boards)
The Régies régionales de la santé and des services sociaux (RRSS$) are responsible
for planning, organization, co-ordination and evaluation of health services in the 1$
sociosanitary regions ofthe province ofQuebec. In the area ofimmunization, the
RR$$S mainly distribute vaccines supplied by the M$$S, participate in promotion of
programs, organise and co-ordinate publics and private services to make vaccination
accessible in the entire territory. Administration of public immunization programs is
the responsibility of the Directeur de la santé publiqite who gives this mandate to a
Coordonnateur en maladies transmissibles (Co-ordinator in infectious Disease)
1.5. Table de coordination nationale en santé publique (TCNSP)
The Table de coordination nationale en santé publique (TCNSP) is a tripartite
committee (MSSS-NSPQ-RRSSS) which coordinates public health activities,
notable immunization. It regroups the Directors of public health ofthe 1$ health
boards (RR$$$), the director ofthe INSFQ and is presdied by the Vice-Ministre
adjoint à la santé publique of the M8SS. This table has the mandate of co-ordinating
implementation of immunization prgrams in different regions.
1.6. Table nationale de concertation en maladies transmissibles (TNCMI)
The Table nationale de concertation en maladies transmissibles (TNCMI) is a
consultative tripartite assembly, composed of Infectious Disease Co-ordinators from
each RRSSS, the Directeur de la protection de la santé publique ofthe MSSS and
the Director de la protection de la santé publique ofthe INSPQ. This group is a
subcommittee of the TCNSP and coordinates operational aspects of immunization
programs.
2. DECISION-MAKING PROCESS
The initiative to evaluate the pertinence of a ncw public immunization program
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generaliy cornes from the GIS, whose mernbers are informed of licensing of new
products by the Bureau of Biological products of Health Canada, as weil as
representatives from pharmaceutical companies which produce vaccines. In concert
with the M$SS, a formai request is addressed to the CIQ which establishes an ad hoc
working group. Specifically, the working group must conduct a study on the
pertinence of an imrnunization program inciuding sections on the burden of disease,
vaccine characteristics (immunogenicity, efficacy, security), potential effectiveness
of an inmiunization program, associated costs and risks, as well as program
feasibility. Rather than a single recommendation, the document must describe
different advantages and consequences of possible vaccination strategies, including
total absence of immunization.
Once completed, the study is brought to the CIQ for discussion and approval. To
study the subject in depth, representatives from vaccine manufacturers are invited to
present their produce and present available published and unpublished data. When
the study has been finalized, the report is transmitted for critique and validation to
the Infectious Disease Coordinators of each regional health board (RRSSS, to
professional associations (i.e. pediatric and family physician associations) and public
and private organizations (CLSC and hospital associations, for example). Feedback
is then discussed by the CIQ and a final document is prepared and transmitted to the
Directeur RBEO ofthe INSPQ afier which the INSPO makes officiai
recommendations.
The recommendation is then transmitted to the Directeur de la protection de la santé
publique of the MS$S who must decide upon the optimal strategy, evaluate
feasibiiity of the proposed programme and possibilities for funding. The opportunity
for a new program is decided by the Sous-ministre adjoint à la santé publique
(Deputy Minister of Public Health) afier consultation ofregional directors of public
health in boards (RR$$S) reunited at the Table nationale de coordination en santé
publique (TCNSP), as well as the Public Health Co-ordonators en santé publiques
reunjted at the Table de concertation nationale en maladies infectieuses (rCNMI).
A rninisterial dossier is then prepared, including budgetary estimations. In the case
of a new program with a significant budget requirement, the dossier is transmitted to
the Sozts-ministre à la santé publique and to the Minister of Health who makes the
final decision and announcement.
Once a decision is taken, the MS$S forms an ad hoc committee, which is in charge of
planning implementation of a new programme. At this stage, Infectious Discase
Co-ordinators are consulted, as well as representatives from main groups of
vaccinators (CLSCs, pediatricians and family physicians, for example).
During the entire process, extemal influences can be present. For example, vaccine
manufacturers may interact with members ofthe CIQ, GIS and the MSSS.
Professional associations and parent associations can also be active and the media
also inform decision-makers. Consensus conferences organized by Health Canada
and to which the Directeur de la protection de la santé publique is invited a certain
xx
amount of inter-provincial program harmonisation as to principles, yet littie
regarding timing. Decisions announced by other provinces also influence that of
Québec. Ibis is despite the fact that there is no formal structure for inter-provincial
co-ordination other that the preparation ofthe plan for an influenza pandemic.
1 2-02-2001
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Figure I : Decision-making and Functional Structures in Quebec
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biologiques, environmentaux et
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Sous-ministre adjoint
Directeur protection
GSt
I I I
1
RRSSS
xxii
New Brunswick
The CMOH and project manager review scientific literature, NACI
recommendations, discussions with regional MOH and consultation of infectious
disease experts. Proposai to recommend new program is submifted to senior
management for consideration and budgetary approval
_______________
New
Brunswick
Ministry ofRegional H I hMedical Chief Medical Officer of ea
Officers of Health
Health
Infectious
Disease Project
Experts Manager
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Prince Edward Island
Chef flealth Officer and Communicable Disease public health nurse review
available information on particular vaccines and make recommendations.
Chief Medical Officer
of Health recommendation
Communicable
Disease
Nurse
Ministry
of
Health
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Nova Scotia
Committee with wide representation. Subcommittee usually formed to provide a
discussion paper regarding feasibility of introduction of a new publicly funded
vaccine. Paper is then reviewed by provincial CDC committee, and recommended
option is submitted to public health working committee for approval. If approved by
PHWC, submitted to senior staff in Dept. ofHealth for approval.
t
N
ProvincialSubcommittee Communicable
Ofl DiseaseVaccination Control
Committee
Public
Health
Working
Commiffee
Department of Health
Senior Staff
(for approval)
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Newfoundland and Labrador
Advisory Committee on Infectious Diseases, and Medical officers of HeaÏth
Committee Regional MOUs meet quarterly and make recommendations in
consultation with provincial MOU. In addition to Medical Officers of Health,
Communicable Disease Nurses and nursing managers may provide
recommendations regarding new programs.
Advisory Commiffee
on lnfectious
Disease
Regional Medical
Officers of Health
Communicable
Disease Nurses
Depa rtment
of
Health
and
Community
Services
C h ief
Medical
Officer of
Heatth
recommmendation
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Yukon Territory
Largely informai process following NACI guidelines
The Northwest Terrïtories
The Northwest Territories Advisory Committee on Immunization (NWTACI) has wide representation and is
mandated to provide timcly advice to the Department of Health and Social Services and to health and social
services boards on ail issues related to immunization and specific immunization practices. A subcommiftee of
NWTACI researches new vaccines, epidemiology of vaccine preventable disease in Canada and the NWT,
economic, social and health impacts and prepares a discussion paper on the options, feasibility, and acceptability
of introducing a new vaccine into the NWT schedule. The paper is reviewed by the full NWTACI, discussed,
and recommendations put forward to the Deputy Minister for approval.
Advisory
Committee recommendation Deputy
Minister
Immunization
________________
of
Health
Nunavut
Littie information is currently available, except that there are not a large number of
personnel avaiiable to work in this area. The fact that this territory has only recently
corne into existence as an independent jurisdictional entity must also be taken into
account.
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Appendix 5 : Questionnaire on Goals and Objectives for Canadian
Immunization Programs
QUESTIONNAIRE
GOALS AND OBJECTIVES FOR PUBLICLY FUNDED
IMMUNIZATION PROGRAMS IN CANADA
INSTRUCTIONS FOR COMPLETING QUESTIONNAIRE:
Please complete the questionnaire regarding goals and objectives for ail ofyour
publicly funded vaccination programs.
for each program, please fil out one table per program. Make additional copies if
necessary.
Should you require clarification to complete the questionnaire, please contact Lonny
Erickson at (450 )928-6777, ext. 3087.
Please submit the completed questionnaire electronically or by fax no later than
NOVEMBER 15TH 2001 to:
Julie Pigeon, PHWG $ecretariat
F/P/T Officer / Agente f/p/t
Population and Public Health Branch /
Dir. générale de la santé de la population et de la santé publique
Health Canada I Santé Canada
Tel: (613) 941-3448
Fax/Téléc.: (613) 952-7223
In addition, please transmit any relevant documentation on goals and
objectives from your jurisdiction (i.e. annual reports, etc) to Julie Pigeon.
Thank you for your collaboration.
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i’LB.: Ptease comptete thefottowing table(s) for ail pubtictyfui;ded immuizization
programs.
(make additio,tat copies fnecessaiy)
Vaccine (generic name):
Province/Territory:
Target group (specify)
(complete one table for each
target group)
Strategy D Control
D Elimination
D Eradication
D other
Vaccine schedule
(number of doses, time
interval)
Disease reduction objectives D flot stated
D stated >(specify below)
Data sources for measuring D none
disease reduction D yes (specify below)
Achievements in disease D unknown
reduction D other (specify below)
Vaccine coverage objectives D none
i.e x % by D yes (specify below)
(date) % by
(date)
Data sources for measuring D none
vaccine coverage objectives D yes (speci1,’ below)
* (i.e manufacturer, survey,
etc.)
Achievements in vaccine D unknown
coverage to date D other (specify below)
(i.e x % in
year)
Comments
xxix
Additional questions
1. What new programs are being implemented currently (or in the near future) in
your jurisdiction?
(specify)
2. What are the goals and objectives for these new programs? (specify below)
3. Do you intend to establish additional goals and objectives for immunization programs
in your jurisdiction in the coming year? (if so, specify).
xxx
4. If you will be developing new goals and objectives for immunization in your
jurisdiction, please describe how they will be developed (i.e consultation of experts,
working group, meeting of provincial/territorial infectious disease/immunization
committee, etc.
5. How do you measure goals and objectives for your programs? What are some ofthe
challenges in monitoring goals and objectives in yourjurisdiction? How could these be
overcome?
6. What specific actions on a national level (i.e. as part ofthe National Immunization
$trategy) would best support the development and monitoring of goals and objectives for
immunization programs in yourjurisdiction? (i.e. national meetings, working group,
other...)
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Appendix 8: The OVCD instrument for priority-setting in
communicable diseases
(PHLS,1 999)
Example: Response for rabies
Index Criteria for assessing importance - Areas where further work is required
Score from 1 to 5 tick one or more column(s)
(1= low importance, 5=high)
Burden of Social) Potenfial llealth Gain Public Diagnostic & Surveillance Guidelines Evaluation of Other
ill-health Economic Threat Opportunity Concem specialist interventions
lnipact microbiology
Rabies 1 1 3 1 4 ‘/
Criteria for assessing importance
Present burden of iII-health, assessed according to age and sex-related morbidity
and mortality; and data on Quality Adjusted Life Years.
Social and economic impact, assessed by considering the costs of infections to
individuals and organisations and to health care providers.
Potential threats (next 5-10 years), assessed by considering extrapolations of
current trends including antibiotic resistance; known, suspected or prédicted gaps in
vaccine coverage; changes in animal husbandry and food/water provision, changes
in environment; developments overseas; and demographic changes and population
movements.
Health gain opportunity. Is there an opportunity to affect present and future burden
of ill-health tbrough specific activities such as those listed below?
Public concern and confidence, assessed by considering media and public interest,
and numbers and types ofparliamentary questions relating to infection(s).
xxxv
Appendix 9: FoIIow-up Questionnaire on Analytical Framework
Dear
______
We have recently been studying structures and processes for planning of publiciy
funded immunization programs in Canada, to deveiop ways to support and improve
this process. One aspect of this project is the development and testing of an
analytical framework for immunization program planning (funded by Health Canada
and CIHR). The resuiting tool aims to make the evaluation process for potentiai
new immunization programs more efficient and systematic by identifying ail criteria
that may be important when considering new programs, and can be adapted
according to the needs of users in various contexts.
The current version of the framework has the following 13 categories:
1. Disease Burden
2. Vaccine Characteristics
3. Potential Programs and Vaccination Strategies
4. Social & Economic Costs and Benefits
5. Acceptability of Program
6. Feasibility of Program
7. Capacity to Evaluate Program
8. Research Questions
9. Equity of Program
10. Ethical Considerations
11. Legal Considerations
12. Conformity of Program (with other jurisdictions and countries)
13. Poiitical Considerations
Each category has severai sub-points (see attached document for full version).
It is important to examine how this instrument can be useful in immunization
program planning in Canada, specifically in yourjurisdiction. The following
questions will help us evaluate this.
If you wish to receive a summary cf questionnaire responses, please check the box
at the end of the questionnaire. If you have any questions or comments, you may
contact Lonny Erickson at (514) 813-6100 or at lonny.erickson(aetmis.qouv.gc.ca
You may complete the questionnaire directiy in the Word document and return it by
e-mail. If you prefer, you may also print it out and return it to me by fax at (514)
873-1369.
If you prefer, we couid also complete the questionnaire by telephone. If I don’t
receive your response, i’ll contact you by phone.
Thank you for your collaboration.
Sincerely,
Lonny Erickson
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(N.B.: page Iayout reduced for presentation)
CONFIDENTIAL WHEN COMPLETED (this page wilI be removed)
Name:
________________________________________________
Position:
____ ____ ____ ____ ____ _
Telephone:
_____ ___
Fax:
__ __ ____ _
e-mail:
_
province/territory:
_
If there are additional persons in your province/territory who should be
contacted to complete this questionnaire, please Iist them below:
Name Institution
If you have any questions, please contact Lonny Erickson at (514) 813-
6100. You may now begin the questionnaire.
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Section I: Exposure to Analytical Framework
We would like to know to what extent you have been exposed to this
framework sinGe its development.
1. Have you heard of this framework before?
EINO
D YES specify when & where:
2. Have you seen this framework before?
DNO
D YES specify when & where:
3. Have you personally used this framework before?
DNO
D YES specify when, where and how:
4. To your knowledge, has this been used in your province/territory
framework before?
DNO
D YES specify when & where:
5. To your knowledge, have other tools for immunization program
planning been used in your province/territory?
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DNO
D YES specify which tools, and how they were used:
Section Il: Evaluation ofAnalytical Framework
We would like your evaluation cf the usefulness of the framework since its
development.
Please specify your experience with the use cf this instrument by indicating
the context in which it was used and your evaluation of its usefulness. Add
additional pages if necessary.
5 j) Context in which framework was used:
Evaluation of usefulness of framework in this context:
5 ii) Context in which framework was used:
Evaluation of usefulness of framework in this context:
b) We would like your general evaluation of the usefulness and potential
applications of this framework
6. How could this instrument be used in the immunization planning
process in yourjurisdiction?
XX)dX
7. How could this instrument be used in the immunization planning
process in Canada?
8. Is this a good approach to improving and supporting immunization
program planning in Canada?
Why or why not?
9. What other approaches could be beneficial to support and improve
immunization program planning in Canada?
10. What are currently the main issues/challenges in immunization
program planning in your jurisdiction?
What would help you to beller deal with these issues/challenges?
11. Have there been any recent changes in the immunization program
planning process in your province/territory? (if yes, specify)
12. What changes in the immunization program planning process in
your province/territory do you anticipate in the future?
13. General or additional comments:
Please return to Lonny Erickson: By e-mail at: Ionny.Erickson(aetmis.gouvgc.ca
Or by fax at: (514) 873 7369. Thank you for your collaboration!
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Appendix 10: Experts receiving and responding to Questionnaire
#4
Province! Expert contacted
Territory Responders
BC Monika Naus Monika Naus
AB Agnes Honish
SK Rosalie Tuscherer By telephone
MN Greg Hammond Digby Home
Barbara Law
ON Barbara Kawa
NB Lynn Cochrane
NS Mahnaz Farang Mehr By telephone
PEI Lamont Sweet, CMOH
NF Faith Stratton
YT Donna Marshall
NWT Wanda White Wanda White
NVT Ann Roberts
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Appendix 11: Goals and Objectives for lmmunïzation Programs in
Canada
I. Goals and Objectives for lmmunization
Regarding goals and objectives for immunization, we see that only the objective
for measles has been adopted nationaiiy. However, national goals published in 1995
have been the basis for goals adopted in many regions, ofien with slight
modifications. There has been some formai review of the extent to which these goals
have been met (i.e. in B.C. and Québec), and this has also been conducted informally
in other regions (i.e. Alberta). These goals and objectives should be reviewed and
updated. In addition, efforts to monitor to what extent they have been reached should
be expanded to ailow evaluation of the field effectiveness of immunization programs
in Canada.
At the April 2001 meeting of the Subcommittee on Immunization of the Public
Health Working Group, participants were invited to check the completeness and
accuracy of information pertaining to their jurisdiction, to provide a qualitative
evaluation ofthe adequacy ofthe existing structures and processes, and to envisage
possible change and improvement in light of experience in other provinces and
countries. A second objective ofthe meeting was to discuss the nature and the
performance ofthe structures and processes existing at federal and
interprovinciallterritorial levels and to propose developments which would be
acceptable from political and financial points ofview. The final objective ofthe
meeting was to agree on how this consensus-building exercise should be continued.
1. Provincial and Territorial Goals for Immunization
Following a series of consensus conferences, national goals and objectives for
immunization were created and published (LCDC, 1995). Many provinces have aiso
publicly stated goals for immunization. In the fali of 2000, provinces and territories
were questioned to identify goals and objectives for immunization in their
jurisdictions. The results are summarized in the foilowing table. $ome detaiis follow
for individual provinces, and when avaiiable detailed texts on these goals are
included in the appendices. Note that some regions have general goals for
immunization which could be interpreted to integrate these specific goals.
National and Identifled ProvinciallTerritorial Goals for Immunization in
xlii
Provinces and Territories1
National
Goal BC SIC3 MN ON QC NB PEI NS NF4 YT NWT N2 U
97% V V V V V V V V —
coverage for (95%) (95%) (95%)
vaccines in
schedule
Diphtheria V V V V V V
etimination
Hibtypeb: V V V V V
absence of
prev cases — — — —
flepatitis B V V V
Coverage for
adolescents
Hepatitis B V V V V V
Reduction of
incidence
Measles V V V V V V V V V V V V
Eradication
Mumps V V V V
Pertussis V V V V V
Polio V V V V V V
Rubella V V V V V V
Tetanus V V V V V
Other Goals BC AB 5K MN ON QC NB PEI NS NF YT NWT N
U
Influenza V V V V V V —
Hepatitis A- V
reduction of
incidence
Pneumococeal V V V
coverage — — —
Improvement V V V
ofCold
Chain
Reduction of V V V
vaccine
wastage — — —
‘Subject to verification. Provincial Goals ofien differ slightly from national goals. Detailed
discussion is beyond the scope ofthis report
2 Alberta: more comprehensive goals are stated in the Alberta Immunization Manual (to be
obtained).
Saskatchewan: Goals are being developed
4based on activities stated in Strategies 5 and 6(a), Comrnunity Core Frograins.
British Columbia has detailed goals based on the national goals, and has examined
to what extent these goals have been reached (see following section)- one goal has
been achieved, 6 are ‘partially achieved or on track’, 2 have not yet been achieved,
and there is no information for 3 goals (BC Ministry of Health, 1999).
Alberta: The following targets are mentioned in the Alberta provincial Business
xIiH
Plan.
Percentage of 2 year old chiidren who have received the recommended
immunizations.
Target (2002): 97% (diphtheria, pertussis, tetanus, haemophilus influenza b,
polio)
Target (2002): 98% (measles, mumps, and rubella).
In addition, there are more comprehensive goals in the Alberta Immunization
Manual (a copy will be obtained and reviewed).
Saskatehewan: none in Saskatchewan Inimunization Manual. However,
immunization group within Public Health Services Project is working on possible
goals.
Manitoba has adopted goals following closely the nationally developed goals. There
are also goals for influenza and pneumococcal vaccine coverage.
Ontario has detailed goals for immunization (available online at
hftp ://www.gov.on.calhealth!englishlpub/pubhealthlmanprog/mhp 5 .html#prevdis).
These include many diseases (tetanus, measles, rubella, Hib, diphtheria, ...) and
various objectives regarding continuing absence of indigenous diseases, elimination
of certain diseases by specific dates, and increase of vaccine coverage in target
groups.
Québec: Coverage objectives exist in the Priorities Nationales de Santé Publique,
(see appendix) and there are specific objectives for certain programs such as
hepatitis B vaccination in schools and influenza programs.
Targets by the year 2002:
• 95% of 2 yr. olds vaccinated according to the immunization schedule
• 95% of 1 5-yr. olds vaccinated against hepatitis B (including booster
shots)
• eradicate measles, rubella, diphtheria, mumps and poliomyelitis through
immunization programs
• reduce incidence ofthe following diseases to the following levels:
• invasive H. influenzae type b disease: <50 cases per year
• whooping cough: 50% reduction in # of cases
• hepatitis B: 50% reduction in # of cases in people becoming sexually
active (young people under 25)
• hepatitis A: 50% reduction in number of cases
• at least 80% of institutionalised elderly people vaccinated against
influenza each year
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• 60% ofpeople over 65 living at home vaccinated against influenza
• reduce the percentage of unused vaccines from 10% (annual percentage)
to 5%
• reduce the percentage of vaccines stored at unsafe temperatures from 5%
(1996 figure) to 2%.
New Brunswick: coverage goals for routine childhood immunizations were 95%
coverage at 2 years, 99.5% coverage at school entry, 100% at school leaving. The
target value for influenza vaccine uptake is 80% in identified target groups.
Nova Scotia mentioned that in 1996 goals were developed for each publicly funded
vaccine developed based on national targets.
Newfoundland: Strategies 5 and 6 a) ofthe Community Health Core Programs
mention monitoring and evaluation of immunization programs. While the copy
obtained of this document does not specifically refer to targets for individual
diseases, provincial heaith officiais have indicated that goals exist for the specific
diseases indicated in Table 1.
To what extent have goals been reached?
In 1997, a survey was conducted examining to what extent National Goals had been
reached (Health Canada, 1 99$b). While coverage levels for the first dose of MMR
appear to be near targeted levels, coverage rates for diphtheria, pertussis, and tetanus
were much below target. Other probiem areas such as lack of data and non
standardization of reporting were identified. . 0f note is the fact that there are no
consistent methods ofmeasurement ofto what extent goals are actually reached.
Examptes ofProvincial foltow-iip on Goals:
To date, some information on formai monitoring has been obtained from BC and
Québec. Data on immunization status (% with completed DPT-Polio, MMR, HIB)
as of school entry is also monitored (i.e Newfoundland).
British Columbia
In 1999, overali provincial coverage for MMR at the second birthday was estimated
at over 80%, with much variation by region, and some estimates were available for
influenza vaccine coverage for seniors (BC Ministry ofHealth, 1999). The following
table summarizes progress for specific diseases in the national goals:
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Table --: Progress in Achieving National Goals, British Columbia (1999)
Disease Goaltfarget Status in
BC*
Diphtheria Eliminate_indigenous_cases_by_1997
Invasive Hib Achieve and maintain absence ofpreventable cases in chiidren by I
infections 1997
Hepatitis B Reduce prevalence of indigenously acquired chronic infections in
chiidren_& young_adults_by 90%_by 2015
Measies Achieve incidence of<1 per 100 000 by 2000 I
Eliminate indigenous cases by 2005 1
Mumps Maintain active prevention program to minimize serious effects ?
Pertussis
Reduce iilness and deaths reiated to pertussis X
i-lave ail reported cases managed appropriately ?
X
Reduce_intensive_care_admissions_50%_by_1997
Polio Maintain elimination ofwild indigenous cases V
prevent future imported cases
Rubella Eliminate congenital rubella syndrome by 2000
Tetanus Maintain elimination oftetanus in newborns and chuidren V
Legend: V= achieved, I partially achieved or on track, X= not achieved,
?= no information *Source: BC Provincial Health Officer’s Report, 1999, page 126.
Québec
As part 0f follow-up on implementation ofthe 1997-2002 public health
priorities in Québec, summaries are issued (MSSS 2000; MSSS 2001). The
3rd
summary (3e bilan) is in press and gives estimates for vaccine coverage,
elimination of measles, mumps, diphtheria, rubella and polio; reduction of
incidence of Hib type b infections, pertussis, and type A and B hepatitis;
coverage for influenza vaccination for elderly (institutionalized & non
institutionalized); and finally reduction of vaccine wastage and loss due to
breaks in the cold chain.
Continued work is necessary in this area to examine development of
provincial goals and targets and to what extent these are being reached in
practice. Monitoring of program implementation is a key element in a
successful National I mmunization Strategy
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Appendix 12: Worksheet for Analytïcal Framework, Meeting of the
comité d’immunisation du Québec, March 2003
Questions concernant l’opportunité d’implanter un nouveau
programme de vaccination
1. Le fardeau de la maladie justifie-t-il un programme de
contrôle/élimination/érad ication?
2. Les caractéristiques du vaccin vont-elles permettre la mise en oeuvre
d’un programme efficace et sécuritaire?
3. Existe-t-il une stratégie d’immunisation permettant d’atteindre le but
visé par le programme de contrôle, les objectifs sanitaires et
opérationnels?
4. Est-il possible de financer le programme et les indices coût-efficacité
sont-ils comparables à ceux d’autres interventions de santé?
5. Un niveau élevé de demande ou d’acceptation existe-t-il pour le
programme d’immunisation?
6. L’implantation du programme est-elle faisable compte tenu des
ressources existantes?
7. Les différents aspects du programme seront-ils évaluables?
8. Existe-t-il d’importantes questions de recherche qui conditionnent la
mise en oeuvre du programme?
9. Le programme est-il équitable en terme d’accessibilité du vaccin pour
l’ensemble des groupes cibles?
10. Existe-t-il des problèmes d’éthique qui conditionnent la mise en
oeuvre du programme?
11. Existe-t-il des problèmes juridiques qui conditionnent la mise en
oeuvre du programme?
12. Le programme planifié est-il conforme avec ceux planifiées ou
implantés dans d’autres endroits?
13. Le programme risque-t-il de faire l’objet d’une controverse et son
implantation présente-t-elle des bénéfices politiques immédiats?
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CADRE D’ANALYSE
1. Fardeau de la maladie
Question f: Le fardeau de la maladie justifie-t-il la mise en oeuvre d’un programme de
contrôle?
Cochez une des cases suivantes:
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
u u
1.1 Nature et caractéristiques de l’agent infectieux, incluant les réservoirs, les modes de transmission
et les mécanismes pathogènes.
1.2. Manifestations cliniques et complications.
1.3.Épidémiotogie de ta maladie, incluant l’incidence, les tendances temporelles, les variations
saisonnières et géographiques, l’agrégation des cas.
1.4. Les populations spécifiquement touchées et les facteurs de risque.
1.5. Traitement actuel de la maladie et prévention par des moyens autres que l’immunisation.
1.6. Impact sanitaire de la maladie dans la population, incluant la fréquence des cas, des décès et la
perte d’années de vie.
1.7. Impact social de la maladie, incluant l’intensité des souffrances, la nature des séquelles chez les
survivants, la diminution de qualité de vie chez les personnes affectées, ainsi que la perte d’années de
vie ajustées pour la qualité, les invalidités et handicaps, l’impact sur les familles et le personnel
soignant, la peur de la maladie, le stress pour les communautés.
1.8. Impact économique de la maladie, incluant les coûts directs et indirects pour les patients et les
familles, les pertes de productivité, l’utilisation du service de santé et les coûts pour le système de
santé.
2. Caractéristiques du vaccin
Question 2 : Les caractéristiques du vaccin vont-elles permettre la mise en
oeuvre d’un programme d’immunisation efficace et sécuritaire?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
D
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2.1. Nature et caractéristiques de l’agent immunitaire (ex: produit vivant ou non, atténué, absorbé ou
non, viral ou bactérien)..
2.2. Caractéristiques des produits commerciaux (ex: préparation, agents stabilisateurs et de
conservation, dosage, combinaison, entreposage, manipulation, conservation, format du produit).
2.3. Fabrication du vaccin, capacité de production et approvisionnement au Canada.
2.4. Délais d’administration, nombre de doses, association avec d’autres vaccins.
2.5. Nature et caractéristiques de la réponse immunitaire.
2.6. Inmmnogénicité dans différents groupes de population.
2.7. Efficacité du vaccin à court et à long terme, incluant la diminution de la maladie et les risques de
décès.
2.8. Effet du vaccin sur la transmission des organismes pathogènes (ex: réduction du taux de portage,
remplacement).
2.9. Efficacité à court et à long terme pour la population (ex: impact sur la réduction du fardeau de la
maladie, incluant l’immunité de groupe).
2.10. Sécurité: taux et gravité des effets indésirables, contre-indications, précautions.
2.11. Possible interaction avec d’autres vaccins.
2.12. Possible impact du programme d’inmiunisation sur la résistance aux antibiotiques et antiviraux.
3. Stratégie et programme d’immunisation
Question 3: Existe-t-II une stratégie d7mmunisation permettant d’atteindre le but visé par le
programme de contrôle, les objectifs sanitaires et opérationnels?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
LI D D
3.1. Recommandations et lignes directrices existantes pour l’utilisation du vaccin (ex: CCNI,
conférences de consensus, ACIP, AAP, monographie du produit).
3.2. But de la prévention: contrôle, élimination, ou éradication de la maladie.
3.3. Autres stratégies et programmes d’immunisation alternatifs pour atteindre le but visé (ex:
programmes d’inmiunisation sélectifs ou universels, programmes de rattrapage).
3.4. Stratégies et modes d’administration des vaccins: infirmières ou médecins, privé ou public,
diversité des lieux de vaccination (ex: écoles, cliniques privées, centres de santé).
3.5. Objectifs spécifiques du programme en termes de réduction de l’incidence, des complications, des
séquelles et de la mortalité.
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3.6. Objectifs spécifiques opérationnels en termes de couverture vaccinale pour différents groupes
cibles et de perte de vaccin.
4. Coût-efficacité du programme
Question 4: Les indices coût-efficacité du programme sont-ils comparables
à ceux d’autres interventions de santé?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
L] Li Li Li Li
4.1. Coût du vaccin qui est déterminé, entre autres, par le nombre de compagnies distribuant le vaccin
au Canada et leur stratégie de marketing.
4.2. Coût du programme dans une perspective sociétale, incluant les coûts directs et indirects pour les
familles et le système de santé, les coûts pour la mise en oeuvre et le déroulement du programme.
4.3. Preuve de l’efficacité du programme à court et à long terme, incluant la diminution de l’incidence
de la maladie, les complications, les séquelles et la mortalité.
4.4. Bénéfices sociaux et économiques associés au programme, incluant la diminution des coûts de
soins de santé, l’amélioration de l’espérance de vie, de la qualité de vie des individus, des familles, du
personnel soignant et des communautés, ainsi que des gains de productivité.
4.5. Autres bénéfices indirects (ex: diminution de la résistance microbienne, diminution de
l’engorgement dans les salles d’urgence).
4.6. Évaluation économique: les coûts présents nets et les ratios coûts-bénéfices (dans une perspective
sociétale et de celle du système de santé) du programme par rapport au stratégies alternatives (en
termes de vies sauvées, de cas prévenus, d’années de vie gagnées, d’années de vie gagnées ajustées
pour la qualité), discussion des hypothèses sous-jacentes, évaluation de la robustesse du modèle
économique utilisant les analyses de sensibilité, comparaison avec d’autres études, pertinence du
modèle pour le contexte local et comparaison avec d’autres interventions de santé).
4.7. Comparaison des indices coût-efficacité du programme d’immunisation proposé avec ceux
d’autres programmes d’immunisation et d’autres interventions de santé à visée curative ou préventive.
5. Acceptabilité du programme
Question 5: Un niveau élevé de demande ou d’acceptation existe-t-il pour le
programme d’immunisation?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
U LI LI U
5.1. Perception du public du risque de maladie et de sa gravité, l’appréhension d’une épidémie.
5.2. La demande pour un programme de contrôle de la maladie, l’acceptabilité d’un programme
d’immunisation pour les groupes cibles, le grand public, les professionnels de la santé (infirmières,
médecins, personnel de santé publique) et les autorités politiques.
5.3. Priorité pour un nouveau programme tout en respectant les autres programmes
potentiels/approuvés.
6. Faisabilité du programme
Question 6: L’implantation du programme est-elle réalisable compte tenu des
ressources existantes?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
LI LI U LI LI
6.1. Disponibilité du vaccin et approvisionnement à long terme.
6.2. Disponibilité du fmancement pour l’achat du vaccin, incluant le rattrapage.
6.3. Opportunité de mise en oeuvre d’un nouveau programme (ex: autre programme d’immunisation
visant le même groupe).
6.4. Existence d’un plan opérationnel et d’un comité d’exécution.
6.5. Intégration d’un nouveau vaccin dans les programmes d’immunisation et les calendriers de
vaccination existants.
6.6. Impacts du programme (incluant le rattrapage) sur les services d’immunisation existants et les
autres secteurs de soins de santé (médecins, établissements de soins de longue durée, hôpitaux,
établissements professionnels...).
6.7. Accessibilité de la population ciblée et niveaux attendus de couverture des groupes cibles.
6.$. Disponibilité des ressources humaines, techniques et financiers pour la distribution, la
conservation (stabilité de la chaîne du froid) et l’administration des vaccins, incluant la mise en oeuvre
du nouveau programme et du rattrapage.
6.9. Disponibilité de la documentation appropriée et des formulaires de consentement pour la
population et les fournisseurs de soins de santé.
6.10. Disponibilité d’un système d’enregistrement de l’administration du vaccin ou de son inscription
dans un registre.
6.11. Disponibilité des ressources pour la mise en marché et la communication avec le public, accès à
l’information et formation des professionnels de la santé.
7. Capacité d’évaluation des programmes
Question 7: Les différents aspects du programme seront-ils évaluables?
Pas du tout Plutôt on Ni oui Plutôt oui Tout à fait
ni non
Li C] Li
7.1. Souhait d’évaluation pour les familles, les professionnels (infirmières, médecins, personnel de
santé publique) et les autorités politiques.
7.2. Disponibilité de systèmes d’information afm de mesurer la couverture (y compris les registres de
vaccination) et l’utilisation du vaccin, ainsi que la qualité des services de vaccination.
7.3. Disponibilité de systèmes d’information pour contrôler la réduction de l’incidence de la maladie,
les complications, les séquelles et la mortalité.
7.4. Disponibilité de systèmes d’information pour évaluer les effets indésirables associés à
l’administration du vaccin.
7.5. Disponibilité de systèmes de liaison entre les bases de données, les registres d’immunisation et les
registres de population.
8. Questions de recherche
Question 8: Existe-t-il d’importantes questions de recherche qui
conditionnent la mise en oeuvre du programme?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
Li Li Li
8.1. Importantes incertitudes concernant les effets du vaccin et les impacts du programme
8.2. Projets de recherche en cours et en préparation dans le domaine du développement du vaccin, de
l’immunogénicité, de l’efficacité et de la sécurité.
8.3. Besoins de recherche pour l’évaluation, la planification et la prise de décision concernant le
programme et propositions pour répondre à ces besoins de manière appropriée.
lii
8.4. Nécessité d’avoir un programme pilote d’immunisation.
9. Équité du programme
Question 9: Le programme est-il équitable en termes d’accessibilité du
vaccin pour l’ensemble des groupes cibles?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ninon
Li Li Li Li
9.1. Équité d’un nouveau programme incluant universalité, accessibilité et gratuité des services pour la
plupart des groupes de population vulnérables.
10. Considération éthique
Question 10: Existe-t-il des problèmes d’éthique qui conditionnent la mise en oeuvre
du programme?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
Li Li Li Li Li
10.1. Les considérations éthiques, incluant le consentement avisé, et la protection de la confidentialité
de l’information médicale.
11. Considérations légales
Question 11: Existe-t-II des problèmes juridiques qui conditionnent la mise en oeuvre
du programme?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
Li Li Li Li
11.1. Les considérations légales concernant l’utilisation du vaccin (ex: à partir des recommandations
liii
du fabricant).
12. Conformité du programme
Question 12: Le programme planifié est-il conforme avec ceux planifiés ou
implantés dans d’autres endroits?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
D D D D D
12.1. Conformité du nouveau programme avec les programmes planifiés ou existants dans d’autres
juridictions et pays.
13. Considération politique
Question 13: L’implantation du programme présente-t-elle des bénéfices
politiques immédiats?
Pas du tout Plutôt non Ni oui Plutôt oui Tout à fait
ni non
D D D
13.1. Bénéfices politiques possibles.
Controverses possibles et risques politiques associés à la mise en oeuvre du
nouveau programme.
liv
Appendix 13 : Questionnaire and Responses on Testing of
Analytical Framework, CIQ meeting, March 2003
Évaluation du cadre analytique pour les programmes d’immunisation
1. Quelle est votre appréciation de l’utilisation du cadre analyltique qui a
été fait pendant cette réunion du CIQ?
-excellente- je l’ai utilisé à plusieurs réprises avec des étudiants en
médecine pour les sensibiliser aux difficultés de la prise de décision en
immunisation
-aidant
-bon, mais beaucoup d’emphase sur le politique, ethique, légal, etc... et peu•
d’emphase sur l’efficacité, sécurité, et bénéfice de court terme versus long
terme.
-certaines questions me paraissent avoir plus de poids que d’autres
-certaines catégories sont difficiles à évaluer.
-toutes les catégories ne devraient pas avoir le même poids.
-cela semble tout de même un bon outil de base mais ne devrait pas être le
seul.
-le cadre est très utile pour systématiser. Il faut améliorer sa modalité
d’utilisation.
-bien, mais trop de catégories et sous-catégories (2 fois)
-utile
-l’utilité serait plus grande après qu’une stratégie de programme est retenue
car les réponses sur des éléments de faisabilité/acceptabilité/ éthique, etc...
sont grandement dépendant de la stratégie.
-informations trop larges pour pouvoir répondre aux questions. Les
questions devraient être en fonction de stratégies précises.
-pas utilsé systématiquement, un peu rapidement, +1- grande appréciation
du processus.
-très bien- mieux préciser les catégories, en particulier 8 (questions de
recherche), 9(équité/accessibilité), et 11 (considérations légales).
-C’est un outil intéressant qui aide à systématiser la demarche. Mais elle est
lourde et comporte trop de sous-catégories
-très intéressant mais difficile d’y répondre sans préciser la stratégie
proposée (i.e. questions sur stratégies, coûts/bénéfices, acceptabilité et
faisabilité du programme, équité et accessibilité)
-manque de temps pour en faire une utilisation optimale
- stratégie d’immunisation non-précisée
- fort intéressant de faire cet exercice de façon systématique
- intéressant maïs difficile de compléter la grille soumise pendant la
ré u n ion
- suggestion de fournir les définitions des catégories au verso de la grille.
- Prendre un peu plus de temps pour ré-expliqer les catégories avant de
Iv
remplir la grille
- Difficultés d’interprétation risquent de diminuer la valeur des réponses
2. Quels outils (ou autres processus) serait-il souhaitable d’utiliser au
sein du CIQ à l’avenir?
-animation des réunions mieux structurée
-cadre analytique avec standardisation des critères et des réponses
possibles
-évaluer des stratégies précises
-la même mais + schematisés
-utiliser (dans la mesure du possible) le cadre analytique lots de ls rédaction
des documents futurs du CIQ.
3. Avez-vous utilisé cet outil dans d’autres contextes?
-non (3 fois)
-formation des résidents en santé communautaire
-avec des étudiants
-cadre de référence pour préparer questions d’examen de spécialité en
médecine communautaire
-je l’ai utilisé à plusieurs reprises avec des étudiants en médecine pour les
sensibiliser aux difficultés de la prise de décision en immunisation
-aidant
4. Quelles autres applications de cet outil seraient souhaitables à
l’avenir? (i.e. formation des professionnels, discussions avec divers
acteurs en santé publique, échange d’informations avec d’autres
juridictions, etc...)
-préparer programme de recherche pré-décision
-outil pour les directeurs de santé publique, décideurs, etc (ceux qui auront
à prendre des décisions sur l’ensemble de l’information)
-si le nombre de catégories est réduit, utile pour la formation! discussion
avec des acteurs de santé publique
-discussions avec divers acteurs en santé publique, échange d’informations
avec d’autres juridictions.
-formatiàn
-je pense aussi qu’au niveau des décideurs, cet outil est intéressant
-utilisation avec nos partenaires CLSC/MD lors de formation
-à utiliser avec nos directeurs de santé publique
-éducation des décideurs (directeurs de santé publique, ministre de la
santé)
-formation des étudiants en médecine et en sciences infirmiers
-proposer cet outil à Santé Canda et au CCNI (NACI).
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5. Tenant compte des changements anticipés dans les 10 prochaines
années (nouveaux vaccins, modes d’administration, augmentation des
prix), quelles actions devraient être entreprises pour soutenir la
planification des nouveaux programmes d’immunisation publics au
Québec?
-lien avec média
-promotion de la vaccination mieux structurée
-augmenter capacité de recherche pré-décision, en particulier sur le volet
économique
-intégration des spécialistes en économie de la santé sur une base régulière
et non pas aU hoc.
-informer plus les décideurs et le public, non seulement des effets
bénéfiques potentiels des programmes, mais aussi de toutes les contraintes
lieés à ces choix (ex. coûts d’opportunité).
-positionnement du CIQ par rapport à sa considération des aspects de
faisabilité I acceptabilité p/r à 1 vaccin et plr à une stratégie globale de
promotion de vaccination
-production de recommandations bien étoffées comme il se fait
actuellement
-meilleur connaissance des nouveaux vaccins qui sont plausibles avec
d’une meilleure planification des activités de recherche et de connaissances
préalables : les délais de priorisations et d’opétationnalisation sont trop
courts actuellement.
-plus de données coût-bénéfice
-meilleur programme de surveillance des maladies évitables par la
vaccination
-sensibilisation des directions de santé publique et autres décideurs
-développement de ce genre d’outil
-utilisation plus large
- démarche plus systématisée
- augmenter les ressources financières et humaines (agents de recherche,
inromations, sécretariat allouées au CIQ
- sensibliser les décideurs concernant la vaccination (coûts-bénéfices) à
titre de mesure préventive
- assurer l’implantation d’un registre sur la vaccination
- avoir une stratégie ‘nationale’ fédérale d’immunisation
6. autres commentaires:
-démarche essentielle à poursuivre, qui peut sûrement avoir une influence
bénéfique sur le réseau de la santé publique au niveau provincial et fédéral.
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-bon cadre, mais trop de catégories et sous catégories, et I’interpretation
des questions principales peut varier d’un individu à un autre à moins qu’il
prend le temps de lire les nombreuses sous-questions (et même là il
pourrait y avoir des différences d’interprétation).
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Append ix 14: Public Health Working Group (PHWG) Sub
Committee on Immunization Meeting, November 14th 2000;
Sheraton Gateway
— Toronto; Record of Decisions
Participants:
Members
Cathy O’Keefe (NF)
Joanne MacDonald (PEI)
Lynn Cochrane (NB)
Mahnaz FathangMehr (NS)
Mary Scott (SK)
André Corriveau (NWT)
Digby Home (MAN)
Pat Mandi (YT, via teleconference)
Danuta Skowronski (BC)
John Waters (AB)
Colin D’Cunha (ON)
Greg Hammond (MN, co-chair)
Health Canada
Arlene King (co-chair)
Susan Vent (Secretariat)
Others
Lonny Erickson (Université de Montréal)
Laura Oster (Transpolar)
1. Introduction (A. Corriveau, A. Kïng)
Andre Corriveau and Arlene King welcomed members to the first face to
face meeting of the PHWG Sub-Committee on Immunization. André
advised that since he has recently accepted to co-chair the PHWG he
would be stepping down as co-chair of the Sub-Committee on
Immunization; however he will remain as a Sub-Committee member.
Greg Hammond was introduced and welcomed as the new provincial co
chair for the Sub-Committee on Immunization.
The Agenda was approved.
2. Overview of National Immunization Strategy (A. Corriveau, A. King)
André Corriveau advised that at the October llth - 13th 2000 PHWG and
ACPH meetings it was agreed that Vaccine Safety would be added as a fifth
component of the National Immunization Strategy.
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Arlene King presented an overview of the National Immunization Strategy
referencing the June 1999 background document which members had
received when the Sub-committee was initiated. She spoke to the major
issues regarding immunization that have been identified and suggested
that members couid embeilish these issues at a later date. A brief overview
of the national goals and each component of the strategy was provided. (A
copy of the presentation was disseminated at the meeting)
Ariene introduced Lonny Erickson who has been contracted to complete the
“Program Planning for immunization in Canada” (PPIC) project and Laura
Oster from Transpolar Technology who has been contracted to complete
the “Vaccine Procurement Review”.
Questions were raised with respect to the National immunization Records
Network Message and Ariene clarified that the “message” is in reference to
the data to be transferred between jurisdictions. It was suggested that
national legisiation needs to be considered to effectively facilitate portability
of data. Ariene advised that the opportunity does exist now to provide input
in this area as the Federal Health Protection legislation is being reviewed.
4. Program Planning in Immunization in Canada (Lonny Erickson)
Lonny Erickson provided the background and objectives of the program
planning in Immunization in Canada project. (Presentation was
disseminated at the meeting)
Lonny reviewed the questions that were used in the project and elaborated
on the findings as outiined in the presentation. Impiementation concerns,
human resource, public perception, cost-benefit issues ail need to be
addressed.
Nova Scotia and Saskatchewan submitted copies of their program planning
framework which was forwarded to members. Other provinces have also
submitted to Lonny copies of their frameworks. lt was suggested that ail
existing rr frameworks be shared with members. Members commented on
their existing frameworks and how they work. It was agreed that at a
national level asystematic framework is required to effectively evaluate
program planning. It was questioned whether there any fundamentai
differences between current frameworks being used.
Members comments:
The need to look at ail aspects, such as social and political considerations,
which influence decision making was also identified. Structures and
processes which can withstand political change are required.
It was observed that the framework is one component and other aspects
Ix
need to be considered. Discussions ensued regarding advisory bodies such
as NACI and consensus conferences and how they could contribute. It was
suggested that the NACI statement on conjugate pneumococcal vaccine
which wiII be available in February 2001 could be used for further
discussions. NACI as a scientific body provides recommendations to the
federal government on the optimal use of vaccines. NACI does not
effectively address the issues of immunization programs and the delivery cf
vaccines se some additional mechanism is required te take the scientific
recommendations to an implementation phase.
Members agreed that a stepwise, collaborative approach would be effective
to develop a national framework, structure and process. It was suggested
that a concrete pilot be used to test the framework and the conjugate
pneumococcal vaccine could be considered.
It was also agreed that the Sub-committee will be responsible for identifying
and developing the recommendations on the framework, processes and
structures including funding requirements and implementation. It was
suggested that consideration be given to presenting the draft framework at
the proposed Pneumococcal Consensus Conference to have broad
discussion on public health implications. The question was raised as to
whether consensus conferences should be considered an integral part of
the framework of the program planning process. FPT deputies need to be
advised if consensus conferences are an integral part of the process which
allow the science to become public policy. Members agreed that there was
significant value of the consensus conferences.
Next Steps
Initial report (draft framework) will be validated and circulated to members
and others as required.
Draft framework to be completed in March for presentation/approval to Sub
Committee.
NACI statement on conjugate pneumococcal vaccine to be obtained in
February/March for discussion.
Suggest that next Sub-Committee meeting in late March be used to test
draft framework and develop recommendations to bring forward to PHWG.
Present and seek approval from PHWG/ACPH at their May meeting.
Actions:
Available P/T frameworks to be forwarded to members. L. Erickson, S.
Vent
Approval from PHWG to use conjugate pneumococcal vaccine to test
framework to be requested at the PHWG January meeting. Co-chairs
Draft framework to be presented to PHWG/ACPH May meeting for their
approval.
L. Erickson, Go-chairs
NACI statement on conjugate pneumococcal vaccine to be forwarded to
mem bers for future discussion.
Go-chairs, S. Vent
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5.
6. Pneumococcal Conjugate Vaccines (T. Tam via teleconference)
Theresa Tam provided an update on pneumococcal conjugate vaccines. It
was suggested that the Sub-committee on Immunization could consider
using this vaccine as a “test case” on decision making concerning vaccine
programs in the P/Ts.
A detailed update is attached at the end cf this document.
Action:
The possibility of using the new pneumococcal conjugate vaccines as a test
case for PPIC is to be reviewed. L. Erïckson, Co-chairs
6. Workplan
Considering the logistics to obtain the various levels of approval for ail the
components, it was suggested that the workplan timelines be reviewed by
the co-chairs and then distributed to members. Members aise requested an
organizational chart which identifies ACPH/ PHWG.
Actions:
Workpian timelines to be developed and distributed to members. Co
chairs, S. Vent
Teleconference and meeting dates to be forwarded to members.
S. Vent
ACPH bookiet to be forwarded to mem bers. S. Vent
Future Teleconferences and Meetings
Teleconference: January 9th, 2001
Vaccine Procurement Review - Report
January 16th 2001
PPIC - review of report
Vaccine Safety report
Meeting: End of Match beginning of April - to be determined
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Appendix 16: Twenty Guïdance Questions for assessing action
research proposais and projects
(Waterman et al., 2001)
1. Is there a clear statement of the aims and objectives of each
stage of the research?
2. Was the action research relevant to practitioners and/or users?
3. Were the phases of the project clearly identified?
4. Were the participants and stakeholders clearly identified and
j ustified?
5. Was consideration given to the local context while
implementing change?
6. Was the relationship between researchers and participants
adequately considered?
7. Was the project managed appropriately?
8. Were ethical issues encountered and how were they dealth
with?
9. Was the study adequately funded/supported?
10. Was the length and timetable of the project realistic?
11. Were data collected in a way that addressed the research
issue?
12. Were steps taken to promote the rigour of the findings?
13. Were data analyses sufficiently rigorous?
14. Was the study design flexible and responsive?
15. Are there clear statements of the findings and outcomes for
each phase of the study?
16. Do researchers link the data that are presented to their own
commentary and interpretation?
17. Is the connection to an existing body of knowledge made
clear?
18. Is the extent to which aims and objectives were achieved at
each stage discussed?
19. Are the findings transferabie?
20. Have the authors articulated the criteria on which their own
work is to be read/judged?
lxiv
Appendix 17: Chronology of PhD project
Date Event Comments
Aug. ProposaI for developing an
1999 analyticai framework
deveioped
Sept Letters written to officiais Letters proposing participation in the development
1999 at Québec MSSS and of an anaTyticai framework for evaluating new
Health Canada immunization programs
April 18, Examen de synthèse
2000
Juiy Questionnaire mailout to
2000 CMOHs to identify key
persons in immunization
August Questionnaire mailout to
2000 key persons in
immunization in Canada
11-12 8e Colloque provincial en Presentation on immunization planning (P. De
mai, maladies infectieuses, HuIl, Wals) mentioning framework for immunizationQuebec2000 program planning
October Questionnaire mailout on
2000 structures and processes
for immunization program
planning
Nov. 14, Meeting Subcommitte on Presentation on Immunization Program planning in
2000 Immunization, Toronto, Canada and proposed analytical framework
Ontario
Dec. National Immunization Presentations on National Immunization Strategy
2000 Conference, Halifax N.S. with mention cf analytical framework
January Teleconference with co- Suggested testing cf framework with
2001 chairs cf ISC meningococcal and pneumoccal conjugate
immunization programs
Feb 5, Meeting with Arlene King, Meeting to discuss advancement cf project
2001 Health Canada
Feb Contact cf provincial Key persons were contacted by phone, e-mail or
2001 /territorial representatives fax to collect more detailed information regarding
for additional information the structures and processes for immunization
on structures and program planning in theirjurisdictions.
processes for
immunization planning
Mat 1, Submission cf preliminary Submitted for comments and discussion from ISC
2001 report for April meeting cc-chairs
April 2 Meeting, Subcommittee on Presentation and highlights cf report on program
2001 Immunization, Toronto, planning in immunization in Canada and framework
Ontatio
April Collection cf comments from participants and
lxv
2001 revision of report presented at April 2 meeting
May l-2 Conference on Influenza Presentation on the economic impact of influenza
2001 Control and Vaccines in Canada. This conference addresses national
coordination of influenza control measures
May 9, Public Health Working Preparation of brieting notes for presentatation of
2001 Group Meeting summary of activities on immunization program
planning
May 22, Draft Report: Equitable 46 pages
2001 Access to Vaccination
June Meeting at Health Canada Presentation of structures and processes for
2001 with senior staff immunization planning in Canada and
recommendations
Presentation To Assistant deputy minister; Director, bureau of
infectious disease ; Assistant director, centre for
Tunney’s Pasture, Ottawa infectious disease prevention and control (Health
Canada) and Chair, Advisory Committee on
Population Health ; Chair National Advisory
Committee on Immunization, co-chair, Public
Health Working Group
July Meeting on National Meeting with Dr Arlene King, Division of
2001 Immunization Strategy, Immunization, Health Canada, Dr Horracio Arruda,
Direction Générale de la santé publiqe, MSSS, Dr.
Centre de santé publique, Greg Hammond, Dept of lnfectious Disease,
Beauport, Québec Manitoba, PHWG co-chair.
August ACPH Teleconference To inform ACPH members of decisions made by
2001 the PHWG in June regarding the National
Immunization Strategy.
August Meeting at Health Canada b discuss advancement of NIS
24 2001 with senior staff Presentation on national goals and objectives for
immunization programs and testing of analytical
Tunney’s Pasture, Ottawa framework
Sept.- Contract on Goals and Objectives
Dec. Survey and Report (tollowed by presentation)
Feb 5, Meeting with Arlene King, Meeting to plan February meeting in Toronto
2002 Health Canada, Tunney’s
Pasture, Ottawa, Ontario
Feb Meeting of ISC Presentation of goals and objectives project
2002 Toronto, Ont Activity for testing of framework
18-19 Colloque provincial en Presentation on decision-making structures and
avril, maladies infectieuses, processes for immunization.
2002) Québec City, Québec
Nov (?) Journées Annuelles de Presentation of analytical framework as part of a
2002 Santé publique, Quebec seminar on technology assessment and decision
City, Québec making in immunization
